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Abstract  
Traumatic cartilage injuries are a known risk factor for development of 
osteoarthritis (OA). Classically cartilage is seen as poorly repairing, however, 
cartilage injuries in very young animals have been observed to heal although the 
mechanism of this repair is unknown. The aim of this project was to investigate if 
mesenchymal stem cells (MSCs) in the joint tissue can respond to cartilage injury 
and are involved in the potential cartilage repair mechanisms.  
Fluorescently-labelled synovial fluid-derived MSCs (SF MSCs) specifically 
adhered along the edges of the injured cartilage. SF MSCs and bone marrow-
derived MSCs (BM MSCs) migrated in significantly greater numbers to injured 
cartilage compared to non-injured cartilage. Incubation of freshly chopped 
articular cartilage with serum –free media gave an injury conditioned medium 
(IJCM) which significantly stimulated cell migration of both SF and BM MSCs in 
classical ‘Scratch’ assays. Migration of MSCs in response to IJCM was 
significantly reduced by pre-treating the IJCM with immobilised heparin or using 
neutralising antibodies to TGFβ3, FGF2 and CXCL12, and the CXCR4 receptor 
inhibitor AMD3100. No SF MSC migration was observed with IJCM in cell 
exclusion zone migration assays (no ‘wound’ is created in the cell layer in this 
assay protocol). However, migration in response to IJCM was observed in this 
system when a cell injury was created (by scraping off a thin line of cells) close to 
the cell exclusion zone. Creating the ‘scratch’ wound caused release of µM 
amounts of ATP from the injured cells as determined by an ATP-bioluminescence 
assay. Supplementation of IJCM with ATP or UTP or the stable purine analogues 
ATP-γS or UTP- γS stimulated MSC migration in the cell exclusion zone assays, 
suggesting a role for a putative P2 receptor in priming of SF MSCs for migration. 
Furthermore, IJCM-stimulated SF MSC migration could be completely inhibited 
in scratch assays using the P2 purine receptor antagonist suramin.  
The results suggested that articular cartilage released ATP, CXCL12, TGFβ3 and 
FGF2 following injury and these factors together stimulated MSC migration to 
injured cartilage. Extracellular nucleotides such as ATP and UTP are required to 
prime the SF MSCs before CXCL12 and TGFβ3 stimulates cell migration to the 
injury site. In contrast, BM MSCs do not require any priming signal before their 
migration along the chemotactic gradient of CXCL12, FGF2 and TGFβ3.  
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1.1 Rationale for the study 
Osteoarthritis (OA) is the most common form of arthritis [1] (approximately 1 in 5 people 
over the age of 50 have symptomatic OA in one or both knees [2] ) and poses a major 
problem for the ageing populations worldwide. Due to increasing life expectancy, OA is 
predicted to be the 4
th
 leading cause of functional disability in the ageing global 
population by 2020 [3]. OA, also known as degenerative joint disease is characterised by 
gradual loss of cartilage structure and function accompanied by alterations in the 
subchondral bone and limited intra-articular inflammation and synovitis [4]. OA also 
involves deformity, limited joint movement and pain which in turn lead to restricted 
motion and chronic disability. Due to this, OA has a sizeable economic impact on the 
healthcare system of 1-2% of GDP in industrialised countries [5, 6].  
Current surgical interventions in place that attempt to stimulate regeneration of injured 
cartilage include joint washout, tissue debridement and microfracture technique [7] to 
release the mesenchymal stem cells (MSCs) from the underlying bone marrow. These 
procedures provide some symptomatic relieve from pain but the repair tissue is 
fibrocartilaginous in nature which is unable to withstand compressive load over time. 
Therefore, these procedures do not arrest joint degeneration and loss of joint function 
over time. Ultimately, patients may need to resort to joint replacement surgery. Joint 
replacement has a high success rate in hip and knee OA [8]. Over 79,000 primary knee 
replacements and more than 71,000 primary hip replacements were performed in the 
England and Wales during 2011, at an estimated cost of £1.65 billion [8]. However, joint 
prostheses have a limited lifespan (20-25 years) and around 5% of the patients suffer 
prosthesis loosening which requires further invasive revision surgery [8, 9]. Loosening is 
particularly problematic in younger patients under the age of 60 who tend to place higher 
demands on their prostheses due to their active lifestyles. Since, a limited number of 
revision surgeries are recommended and population longevity is increasing, there is both 
a clinical and societal need to prolong the life of the natural joint. Newer regenerative 
medicine technologies involving autologous chondrocyte or MSC implantation have been 
developed over the past decade to regenerate cartilage and improve the functional life of 
damaged joints [10, 11]. These treatments have largely been directed at patients less than 
50 years of age with focal cartilage defects rather than OA.  Several studies have reported 
safe and effective clinical outcome, although none have included a placebo control [12-
14]. Autogenous re-implantation is expensive, requires multiple surgical procedures, and 
is associated with donor site morbidity. Tissue outcome is variable with one study 
showing 78% of patients had fibrocartilaginous repair [15].  
The question of whether cartilage is capable of repairing itself, so called “intrinsic” 
repair, is an important one. Although, once believed to be a tissue that had little reparative 
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activity, a number of recent studies in human and animals show that repair does occur. 
Young patients with isolated partial thickness injuries or full- thickness injuries in an 
otherwise healthy joint regained full knee function without requiring any aggressive 
treatment approach [16, 17] suggesting that these focal lesions repair spontaneously. A 
14-year clinical and radiographical follow-up of 28 young athletes with isolated partial 
thickness injuries showed that 22 of these patients were able to return to their pre-injury 
level sport activities [16]. Spontaneous healing of partial thickness injuries has been seen 
on arthroscopy [18]. Furthermore, regrowth of cartilage is seen in advanced OA patients 
when the joint is off-loaded  by “joint distraction” (6 week treatment with an external 
metal fixator ) [19, 20] or by realignment osteotomy [21, 22]. Intrinsic repair and 
integration with the surrounding cartilage has also been consistently observed in the 
cartilage donor site in patients who are undergoing ACI treatment for lesions elsewhere in 
the joint [23]. Repair of experimentally-induced partial-thickness injuries have also been 
observed  in animal models such as rabbits [24], foetal lambs [25] and pigs [26]. 
Increasing evidence suggests the importance of mesenchymal stem cells (MSCs) as a 
source of repair cells. Indeed, in microfracture the repair is largely mediated by the 
proliferation and differentiation of bone marrow derived MSCs [27]. MSCs have been 
identified in synovial fluid (SF) [28-30] which are increased 7-fold in arthritic patients 
compared to normal controls suggesting that synovial fluid MSCs may play a role in 
attempted homeostatic repair. Furthermore, a recent study by McGonagle et al suggested 
that knee joint distraction promoted intrinsic repair of cartilage by favouring adhesion of 
synovial fluid derived MSCs to the cartilage surface [31]. There is also evidence of 
intrinsic repair in young animals mediated by MSCs. Using a rabbit model of partial 
thickness injury, Hunziker et at found that topical application of growth factors such as 
FGF2 or TGFβ1 stimulated MSC migration from the synovial membrane and subsynovial 
space into the defect void [32]. Similarly, it was suggested that spontaneous healing of 
full-thickness injuries seen in DBA/1 mice strain was promoted by mesenchymal 
progenitor cells populating the wound [33]. This paper was particularly interesting 
because it shows that repair is not only strain dependent (genetic influence) but also age 
dependent (older mice failed to repair).  
Therefore, the purpose of this study was to investigate if MSCs in the joint tissues respond to 
articular cartilage injury and are involved in potential repair mechanisms. If successful, this 
knowledge can be used to harness the power of the intrinsic repair mechanism used by the 
cartilage to develop therapeutic strategies for promoting cartilage regeneration.  
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2.1 Synovial joints 
Synovial joints are complex biomechanical structures which makes pain-free 
movement possible. They are formed by multiple tissues including joint capsule, 
ligaments, menisci, synovium, hyaline articular cartilage and the subchondral 
bone (Figure 2.1). The tissue that confers the most to the exceptional functional 
capacities of the synovial joints is the articular cartilage covering the surfaces of 
the articulating bones. Articular cartilage serves two main functions; it act as a 
‘biological shock absorber’ so to limit the stress applied to the bone extremities 
and provide a smooth low friction surface which is necessary for efficient joint 
function and pain-free locomotion [34]. Even though the cartilage consists of the 
same components in all synovial joints and mediates the same function, it varies 
in thickness, mechanical properties, cell density and matrix composition within 
the same joint, among different joints in the body and among the same joints in 
different species [35]. Although, its thickness is at most only a few millimetres, it 
has extraordinary stiffness to resilience and compression and extraordinary ability 
for load distribution which reduces stress on the underlying subchondral bone. 
Furthermore, under normal physiological conditions it has exceptional durability 
and can mediate normal joint functions for over 80 years or longer.  
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Figure 2.1: Schematic of a synovial joint. Articular cartilage is found in 
between two articulating bones where it acts as a shock absorber, allowing 
bones to move on top of each other with low frictional resistance and 
thereby enables a smooth, painless joint movement.  
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2.2 Articular cartilage composition  
Articular cartilage appears to be a simple inert tissue upon gross examination. 
Light microscopic examination shows that the cartilage primarily consist of 
extracellular matrix (ECM) with sparsely distributed cells and devoid of blood 
vessels, lymphatics and nerves [36].  
 
2.2.1 Extracellular matrix  
The principle components of the cartilage ECM are tissue fluid and the structural 
macromolecules which provide the tissue with its characteristic form and stability. 
Furthermore, it is the interaction between the tissue fluid and the macromolecules 
that gives the cartilage its mechanical stiffness and resilience. 65-80% of cartilage 
is composed of water which is important for the load-dependent cartilage 
deformation. Other than water, tissue fluid also contains small proteins, gases, 
metabolites and a high concentration of positively charged ions such as sodium 
(Na
+
; 250-350 mM), potassium, (K
+
; 8-10 mM)  and calcium (Ca
2+
; up to 20 mM) 
to balance the negatively charged proteoglycans [37]. The behaviour and volume 
of water within the cartilage is mainly dependent on its interaction with the local 
proteoglycans which also helps to maintain the osmolarity of the cartilage [35, 
37].  
The structural macromolecules of the cartilage are proteoglycans, collagens, non-
collagenous proteins and glycoproteins [35, 37]. Proteoglycans consist of a 
protein core with covalently attached chains of glycosaminoglycans (GAGs). 
GAGs are long chain heteropolysaccharides formed from repeating disaccharide 
units. The disaccharide unit is formed by glycosidic bond between a hexosamine 
and a non-nitrogenous sugar molecule. Different types of GAG found in the 
cartilage include chondroitin sulphate, hyaluronic acid, keratan sulphate and 
dermatan sulphate. The concentration of GAG molecules varies between different 
locations within the cartilage and can also be altered with age, injury and in 
disease states.  
Cartilage proteoglycans are further divided into two major classes: large 
aggregating molecules called aggrecans and smaller proteoglycans including 
fibromodulin, biglycan and decorin. Furthermore, type IX collagen is also 
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sometimes considered a proteoglycan due to its GAG component [35]. Aggrecans 
consist of high numbers of keratan sulphate and chondroitin sulphate chains 
covalently linked to the protein core. 90% of the total proteoglycan mass is 
formed by aggrecans which fill the interfibrillar space within the cartilage matrix. 
The remaining 10% is formed by the large non-aggregating proteoglycans.  
The aggregan molecules non-covalently interact with hyaluronic acid 
(hyaluronan) to form proteoglycan aggregates. These interactions are critical for 
stabilising proteoglycans within the ECM and to prevent the proteoglycans from 
being displaced by cartilage deformation during movement. Furthermore, these 
interactions are also important for allowing interaction between the collagen 
network and the proteoglycans. The smaller proteoglycans do not directly 
contribute to the mechanical properties of the cartilage. Instead, they influence the 
functions of chondrocytes and bind to macromolecules within the cartilage. For 
example, fibromodulin and decorin binds with type II collagen and this interaction 
may play a role in stabilisation of the collagen meshwork. Similarly, biglycan 
which is highly concentrated within the pericellular matrix also binds to type VI 
collagen. Furthermore, these small proteoglycans may also bind to growth factors 
and cytokines and allow these factors to sequester in the matrix.   
Cartilage matrix also contains multiple types of genetically distinct collagen. 
These include type II, VI, IX, X and XI. Type II is the major collagen type in the 
cartilage. It is responsible for the tensile strength of the tissue and confines the 
degree of swelling of aggrecans to allow the tissue to develop swelling pressure. 
This swelling pressure is essential to enable the cartilage to withstand 
compressive loading [37, 38]. Type VI collagen is found in the pericellular 
matrix, surrounding the chondrocytes where they help chondrocytes to attach to 
the matrix. Type X collagen is found in the hypertrophic zone of the growth plate 
and close to the cells that forms the calcified zone. This suggests that type X 
collagen might have a role in the cartilage mineralisation.  
Matrix component of the articular cartilage varies based on the topography of the 
tissue. For example, the superficial layer of the cartilage contains the highest 
amount of collagen which gradually decreases with the cartilage depth. In 
contrast, keratan and chondroitin sulphate are highest in the deeper layers of the 
cartilage and are lowest towards the outermost layers [38].  
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2.2.2 Zones 
The smallest unit of the articular cartilage is called a chondron. It consists of a 
singular chondrocyte linked to the pericellular glycocalyx. This pericellular matrix 
is in turn surrounded by a fibrillary pericellular capsule [39]. The pericellular 
capsule is surrounded by the territorial matrix which is in turn surrounded by the 
interterritorial compartments going from near to the chondrocytes to further 
removed from the chondrocytes. Articular cartilage contains three unmineralised 
zones, although a clear boundary among the different zones cannot always be 
precisely defined; nevertheless, the organisational differences among the zones 
are important for the cartilage function. These zones are however, sharply 
delineated against the fourth zone called the calcified zone, by the tidemark. The 
three unmineralised zone are: superficial, middle, and deep [35, 36, 39]. Calcified 
zone is separated from the bone along the osteochondral junction by an interface 
that has staining properties similar to cement lines in bones [38].  
The superficial zone is the thinnest and the outermost layer of the articular 
cartilage and is composed of two layers. The outer layer is acellular and formed 
by thin fibrils with little polysaccharides. The second layer contains flattened dics-
shaped chondrocytes that are arranged with the long axis parallel to the articular 
surface [35]. The matrix of the superficial zone contains a high concentration of 
collagen, fibronectin and water and low concentration of proteoglycans compared 
to the other zones. The dense meshwork formed by the high collagen 
concentration at the superficial zone is important for determining the mechanical 
properties of the cartilage and exchange of molecules between the cartilage and 
the surrounding fluid. For example, one of the first changes observed following 
experimental induction of OA is the disruption and remodelling of the collagen 
network in the superficial zone.  
This suggests that the changes in the biocmechanical properties and permeability 
of the tissue arising from the changes in the superficial zone might play an 
important role in the development of OA. Moreover, the tangential orientation 
also allows this zone to act as a filter for cell nutrients from the synovial fluid and 
as a barrier to tissue damage from the larger molecules of the immune system. In 
the middle zone, chondrocytes show rounded or spherical cellular profiles and are 
randomly distributed in a matrix with high proteoglycan content. The collagen 
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fibres decussate in oblique directions to provide a transitional network which is an 
intermediate between the superficial zone and the radial deep zone. Within the 
deeper zone, the cells increase further in size, where the rounded chondrocytes are 
arranged in columns surrounded by matrix which has highest proteoglycan 
content, lowest water content and largest diameter collagen fibres relative to the 
other zones [38, 39].  
 
2.2.3 Chondrocytes  
Cartilage contains only one type of cell called the chondrocyte which occupy 1-
10% of the matrix volume and are responsible for the production, organisation 
and maintenance of the ECM [37, 40]. The chondrocytes are remarkable cells; 
they can maintain the ECM and produce unique ECM components far away from 
the nutritional sources or any clear control mechanisms. All chondrocytes have a 
deeply crenated contour which increases the surface area : volume ratio but have 
variations in distribution, size and shape depending on the area of the tissue. 
Chondrocyte of the adult cartilage have a low respiratory activity and show both 
regional and local diversity in rates of synthesis and types of secretory products 
they produce. Chondrocytes are sparsely spread within the matrix and the cells in 
their lacunae are separated from one another by variable amount of matrix, lying 
either singly or in small clusters [37].  
Due to the lack of precise boundaries between each zone, it is difficult to define 
cell densities at each zone. However, cell density decreases going from the 
outermost layer to the deeper layers of the cartilage [41]. Histological assessment 
suggests that the highest cell density is found in the superficial zone where these 
cells might act as a metabolic centre to regulate the environment of the entire 
tissue. Ultrastructural and autoradiographic analysis suggests that even though all 
chondrocytes are involved in production of the ECM molecules, some cells 
containing higher endoplasmic reticulum (ER) primarily synthesise collagen 
whereas glycogen-rich chondrocytes mainly synthesise proteoglycans [42].  
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2.2.4 Extracellular matrix receptors  
Interaction between chondrocytes and the ECM is important for chondrocyte 
function and metabolism and these interactions are partly mediated by a family of 
matrix receptors called the integrins [43].  Integrins are transmembrane receptors 
made of an α subunit and a β subunit. To date, 15α and 8β subunit have been 
reported whose variations in pairing creates a multitude of integrin receptors. 
Whereas, some integrin receptors specifically bind to some matrix molecules, 
other integrins are promiscuous in their matrix protein interactions. Binding of the 
ligands to the integrin molecules either increases the affinity of the receptor for 
other ligands or stimulates chondrocyte activation.  
Chondrocytes express a number of integrin receptors which binds to collagen type 
II and VI (α1β1, α2β1, α11β1), fibronectin (α5β1) osteopontin and vitronectin 
(αVβ1) and laminin (α6β1). Interaction of the chondrocytes with the collagen via 
the integrin receptors have been shown to be critical for chondrocyte survival. 
Integrins are also found in the matrix itself where they help to organise the matrix 
and take part in the matrix development.  Other important matrix receptors 
include the hyaluronan receptor CD44 which also affects chondrocyte functions 
and cartilage tissue homeostasis.  
 
2.2.5 Cartilage matrix and soluble mediators   
Cartilage binds, store and releases soluble mediators such as growth factors and 
cytokines which are important for both regulating cellular behaviour and 
maintaining tissue homeostasis [43]. One soluble mediator found abundantly in 
the cartilage matrix is TGFβ which is produced in a latent form by the 
chondrocytes and stored in the matrix in this form. Small proteoglycans such as 
decorin, fibromodulin and biglycan regulates the activity of TGFβ by sequestering 
the growth factor within the matrix [44]. Another important growth factor is FGF2 
which binds tightly to heparin forming a heparin-growth factor complex [45]. 
Formation of this complex is important for the activity of the growth factor as this 
complex protects FGF2 from being degraded. Furthermore, binding to heparin 
might also increase the activity of the growth factor by preventing its 
sequestration in the matrix [45]. The physiological significance of binding soluble 
mediators by the matrix appears to be that it establishes a reservoir of molecules 
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in the matrix to be either used by the chondrocytes or released following 
mechanical injury as a signal to indicate that damage has occurred [46]. 
Furthermore, it can also partially explain the differentiation-inducing and growth-
promoting effects of the matrix.  
 
2.3 Osteoarthritis  
Osteoarthritis (OA) also known as degenerative joint disease is characterised by 
gradual loss of cartilage structure and function accompanied by alterations in the 
subchondral bone and limited intra-articular inflammation and synovitis [4]. 
Along with cartilage degeneration and structural alterations of the synovial joint, 
OA also causes joint deformity, limited joint movement and pain which in turn 
lead to restricted motion and chronic disability. OA can affect any synovial joint 
in the body including knee, hip, spine, foot, hand and the temporomandibular 
joint. Traumatic joint injuries, aging, genetic defects and obesity are all risk 
factors for development of OA [4].  
 
2.3.1 Effect of traumatic cartilage injuries on development of OA 
Despite the resilience of the articular cartilage, any forces that will exceed the 
capacity of the cartilage to maintain tissue homeostasis and structural integrity 
will cause injury to cartilage resulting in lesions in the cartilage structure [36]. 
Such cartilage lesions can be caused as a result of direct or indirect trauma (e.g. 
intraarticular fracture and high-intensity impact) or mechanical injuries during 
surgical management of the tissue [47]. Cartilage lesions/defects are classified 
according to the depth of the defect, as either osteochondral (involving the 
cartilage and underlying bone) or chondral in which only the cartilage is affected 
[40]. Articular cartilage has poor intrinsic tissue repair capacity. The degree of 
intrinsic repair depends on whether the lesion is confined within the cartilage 
layer (partial thickness defects) or extends through the cartilage and through the 
subchondral bone into vascular BM (osteochondral and full-thickness chondral 
defects).  
Partial thickness defects have a very poor healing capacity with little endogenous 
cartilage tissue formation. Furthermore, using a goat defect model it was 
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demonstrated that larger osteochondral injuries extending to greater than 6mm in 
diameter also rarely heals and leads to progressive cartilage degeneration around 
the injury [48]. Full thickness defects which reach the underlying subchondral 
bone can undergo a reparative process in which the defect becomes filled by a 
fibrocartilage and not hyaline cartilage [48-50]. Using a rabbit model of full-
thickness injury it was demonstrated that following creation of injury, the newly 
synthesised repair tissue was fibrocartilaginous. Moreover, even though at 12 
weeks, under light microscopy, the repaired tissue looked stably integrated with 
the existing tissue, by 48 weeks the connection had ruptured leading to cartilage 
degeneration in almost every test animal [27]. Hence, the new tissue cannot 
withstand load-bearing functions. Under such conditions there is an increase in 
load transfer and changes in the pattern of load distribution which can lead to 
development of OA.  
The cellular response to biomechanical alterations includes upregulation of the 
metabolic activity or increase in the production of inflammatory cytokines. 
Studies investigating the effect of injurious mechanical loading reported that 
inappropriate static compression induces proteoglycan depletion, collagen 
meshwork damage, reduces the production of cartilage matrix proteins and 
increases the synthesis of proteinases that degrade the cartilage [51]. Furthermore, 
following matrix degradation by proteinases, resulting products positively 
feedback to upregulate the cellular events causing further cartilage damage.  
 
2.4 Clinical procedures for cartilage repair  
In the UK, over 10,000 cartilage injuries occur annually which warrant repair, of 
which around 40% are predicted to lead onto the development of OA [2]. 
Moreover, even though the primary clinical symptom of OA is pain, the structural 
degeneration of the synovial joint which characterises the disease is the major 
contributor to the impaired quality of life and disability of the patient. Therefore, 
joint repair and restoration is important to improve patients’ quality of life both 
before and after the development of OA. Major challenges involved in repair of 
cartilage include restoration of the 3D ECM structure and integration of the 
repaired tissue with the original tissue [4].  
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Current clinical interventions in place for the repair of the injured cartilage 
include joint washout, tissue debridement and microfracture technique to release 
the mesenchymal stem cells (MSCs) from the underlying BM. These procedures 
provide symptomatic relieve from pain but the repair tissue is fibrocartilaginous in 
nature which is unable to withstand compressive loading over time and therefore 
will degenerate. Ultimately, patients may need to replace the arthritic joint with a 
prosthetic joint to restore joint mobility. Joint replacement surgeries have a high 
success rate with over 150,000 primary knee and hip replacements carried out per 
year in England and Wales [2]. However, joint prostheses have a limited lifespan 
(20-25 years) and around 5% of the patients suffer prosthesis loosening which 
requires further revision surgery. Loosening is particularly problematic in younger 
patients under the age of 60. Since, a limited number of revision surgeries are 
possible per patients, those patients who can no longer undergo revision surgeries 
will be wheel chair bound. In the UK, over 92000 knee replacement surgeries (on 
average £10000/surgery) and 15000 revision surgeries are done per year [2]. 
Therefore, there is both a clinical and societal need to prolong the life of the 
natural joint.  
New techniques have been developed over the past decade to improve the 
integrity of the repair tissue. These include cell grafting using either autogenous 
or allogenous chondrocytes (autologous chondrocyte implantation; ACI) or MSCs 
at the focal injuries to enhance repair by providing added number of cells [50, 52-
54] (Figure 2.2). Whereas allografts have the risk of transmission of infectious 
diseases and host immune reaction, autogenous re-implantation have 
disadvantages relating to cost, multiple surgical procedures, donor site morbidity 
and chondrocyte de-differentiation during in vitro culture. Further, studies 
assessing the success of ACI treatments have reported repair tissue of varying 
characteristics; one study reported 78% patients showed fibrocartilaginous repair 
[15]. Similarly, using an equine femoropatellar joint model it was demonstrated 
that MACI (matrix assisted chondrocyte implantation) only improved the early 
healing response and not the long-term repair [55]. Nevertheless, these cell-based 
therapies do show that regeneration of hyaline cartilage is possible.  
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Increasing evidence suggests the importance of MSCs as a source of repair cells 
in wound healing and inflammatory diseases. MSCs are pluripotent precursor 
cells of the connective tissues such as bone, muscle, cartilage, tendon and fat. 
Microfracture technique where the repair is mediated completely by the 
proliferation and differentiation of BM MSCs [27] demonstrates the importance of 
BM MSCs as a source of repair cells for cartilage injury. More recently, MSCs 
have been identified in synovial fluid (SF) [28-30] which increased 7-fold in 
arthritic patients compared to normal patients. This suggests that SF MSCs may 
also play a role in homeostatic repair during cartilage diseases.   
Even though classically, cartilage is seen as a poorly repairing tissue, more recent 
evidence suggested that cartilage injuries in very young animals can repair. For 
example, application of FGF2 promoted cartilage repair in partial-thickness 
injuries in immature rabbits [24] and spontaneous repair of superficial cartilage 
injuries were also observed in foetal lambs [25].  It is possible that these repairs 
Figure 2.2: Principles of autologous chondrocyte transplantation (ACI) 
and matrix assisted chondrocyte implantation (MACI). This novel 
therapeutic approach involves taking a biopsy from a donor site, growing the 
chondrocytes in vitro and transplanting them back into the injured region either 
directly or through assistance of a matrix (MACI). 
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were mediated by SF and BM MSCs. The exact mechanism of in situ tissue 
regeneration by endogenous MSC migration and recruitment is still unknown. 
 
2.5 Mesenchymal stem cells (MSCs) 
In 1970 it was demonstrated that BM contains a rare population of plastic-
adherent cells along with non-adherent hematopoietic cells. The plastic-adherent 
cells formed colonies derived from single cells and proliferated into fibroblastoid 
cells when cultured in media supplemented with 10% foetal calf serum (FCS). 
This observation let to the coining of the term Colony Forming Unit- fibroblasts 
(CFU-F). These fibroblast forming colonies differed little in morphology 
depending on the tissue of origin but differed in their properties. When the BM 
derived adherent cells were transplanted back in vivo, they formed bone tissue 
whereas under the same conditions adherent-cells from spleen cultures formed 
reticular tissues. These experiments led to the suggestion that fibroblasts from the 
cultures created a specific microenvironment which is characteristic of the 
corresponding hematopoietic organ. They were also pioneers in demonstrating 
that the heterogeneous adherent-cells could proliferate and differentiate into 
mature cells of mesenchymal lineages such as chondrocytes or osteoblasts [56-
58].  
 
Further phenotypic characterisation and proliferation studies established that 
culture expanded CFU-F retain their full developmental potency to differentiate 
into chondrocytes, adipocytes, osteoblasts and even myoblasts. Frequency of 
CFU-F varied between BM donors and was age dependent along with how 
healthy the donors were. Caplan referred to these cells as MSCs because they 
have the capacity to differentiate into variety of non-hematopoietic cells of the 
mesenchymal lineages [59]. He further defined the fundamental aspects of 
multilineage pathways in the mesengenic process. Since, MSCs originate from the 
BM supporting structures and may be used as a feeder layer for haematopoietic 
stem cells (HSC) cultures; MSCs have also been referred as marrow stromal cells.  
 
The precise definition of MSCs, whether to consider them as progenitor cells with 
multipotentiality or true stem cells is still under debate. Currently, they are 
defined as ‘plastic-adherent cell population that can be directed to differentiate in 
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vitro into cells of osteogenic, chondrogenic, adipogenic, myogenic and other 
lineages’[60]. Since, MSCs can divide to form new cells with the same phenotype 
and gene expression pattern, thereby maintaining their stemness, the ability to 
self-renew and differentiate are the two characteristics that defined MSCs as stem 
cells. This definition of MSCs, however, is only based on the in vitro analysis of 
culture expanded MSCs. And no clear descriptions have been reported to date of 
the characteristics shown by non-cultured MSCs. The role and location of MSCs 
in their native tissues have also not been identified. This is because unlike HSCs 
that can be isolated based on their surface marker (CD34), MSCs lack a specific 
surface marker for unambiguous identification [61].  
 
Human BM MSCs have been isolated using the CD105 surface marker (endoglin). 
Such approach allowed characterisation of freshly isolated BM MSCs. However, 
few studies have suggested that phenotypic alterations during in vitro culture 
where MSCs do not express some surface markers and express new ones [62]. For 
example, it was reported that freshly isolated BM MSCs expressed CD31 and 
CD45 whose expression reduced following culture expansion, suggesting 
differences in abilities and phenotypes between in vivo and in vitro MSCs. 
Alteration of their natural microenvironment and exposure to chemical and 
physical growth conditions may play a role in the differences observed. Growing 
interest in MSC-based cell therapies demand identification of MSCs in a 
definitive way for clinical and regulatory requirements. In general,, cultured 
MSCs are characterised either based on their cell surface marker or validated 
based on their multipotency. In 2006, the Mesenchymal and Tissue Stem Cell 
Committee of the International Society of Cellular Therapy proposed that the 
minimal criteria for MSC identification are: 1. Plastic-adherence under standard 
culture conditions and formation of CFU-U; 2. Expression of CD105, CD73 and 
CD90 surface markers and absence of CD45, CD34, CD14 or CD11b, CD79α or 
CD19 and HLA-DR surface molecules as assessed by FACS analysis; 3. 
Multipotency [63].   
 
MSCs have been isolated from several species which includes cows, mice and 
humans and several adult tissues [30]. These tissues include the BM, synovial 
membrane [64], SF [29], articular cartilage, adipose tissue [65] and peripheral 
blood. These cells show marked differences in their biological properties such as 
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phenotype, proliferative capacity and differentiation potential along with different 
growth abilities and expression profile of common surface markers based on their 
tissue of origin. 
 
MSCs need to be isolated from tissues and their multipotency validated before 
their use in experimental work. Adherent cells of hematopoietic origin present 
during the first few days of in vitro culture poses a challenge in isolating MSCs 
based on their plastic adherence. One way to bypass this problem is to isolate 
MSCs based on their cell surface markers (immunoisolation). This could be either 
positive selection where MSCs are selected [62] or negative selection [66] where 
other cells types such as HSCs are removed. However, this is also difficult due to 
lack of specific MSC markers and the in vitro phenotypic plasticity demonstrated 
by MSCs. CD271 (LNGFR) commonly expressed by BM MSCs and CD49a 
along with others reported by International Society for Cell Therapy are currently 
used to define an MSC [67]. Studies are ongoing to identify marker sets for both 
positive and negative selection which would allow MSC enrichment and ideally 
purification from native tissues for consistent and clinically required potency (a 
pre-requirement for developing standardised, GMP-compliant clinically 
applicable cell-therapy).  
 
Stem cells are characterised by their multipotency. Previous studies reported that 
MSC can differentiate into osteoblasts and chondrocytes depending on the 
surrounding environment. For example, differentiation into osteoblasts required 
close proximity to vasculature whereas chondrocytes did not have this 
requirement [57, 59]. Chondrogenic differentiation was dependent on the 
coordination between two fundamental parameters: growth factors and cell 
density. Therefore, chondrogenic differentiation can only be performed in three-
dimensional (3D) culture systems such as pellet cultures or micromasses. During 
differentiation, MSCs secreted ECM component of the hyaline cartilage including 
proteoglycans, aggrecans and type II collagen. Glucocorticoids such as 
dexamethasone played an important role in this by stimulating collagen II 
upregulation and inducing the matrix components dermatopontin, collagen XI and 
aggrecan. Induction was detected by identifying cells which expressed cartilage-
specific proteins such as GAGs using alcian blue staining or using antibody for 
matrix markers aggrecan (ACAN) and collagen 2A1 (COL2A1) [68, 69].  
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Similar to chondrogenesis, in vitro differentiation of MSCs down an osteogenic 
lineage requires multiple soluble inducers. Dexamethasone is an essential 
component and its continual supplementation is required, but the mechanism by 
which it promoted osteogenesis is poorly understood. Ascorbic acid enhances 
collagen production and β-glycerolphosphate provides favourable conditions for 
culture mineralisation. This mineralisation can be detected at the cell membrane 
as calcium deposition. The enzyme alkaline phosphatase is essential for ECM 
mineralisation and is a marker of an osteoblastic phenotype and therefore 
detection of alkaline phosphatase can also be used for identifying osteogenesis 
[69, 70]. In adipogenesis, differentiated cells accumulate lipid-rich vacuoles and 
express markers which are consistent with adipocytes. These markers include 
perioxisome proliferation-activated receptor-γ2 (PPARγ2), fatty acid binding 
protein ap2 and lipoprotein lipase. Therefore, adipogenic differentiation of MSCs 
can be identified by detecting the appearance of lipid vacuoles inside the cells 
using Oil red O staining [69, 71].  
 
MSC differentiation is mainly dependent on two molecular pathways: first 
intracellular pathway is that utilised by the TGFβ family and the second pathway 
is the canonical Wnt I pathway. Wnt I are soluble glycoproteins that bind to 
receptor complexes composed of Lrp5/6 proteins and stimulate intracellular 
cascades which mediates cell proliferation and differentiation. The canonical Wnt 
signalling promotes osteoblast proliferation and supresses chondrocyte formation 
via β-catenin [72]. The TGFβ pathway on the other hand regulates MSC 
differentiation into chondrocytes by upregulating chondrocyte specific genes 
including ERK1/2 (extracellular-signal regulated kinase), SMAD proteins, MAPK 
(mitogen activated protein kinase), p38 and JNK. Several other regulatory 
molecules including EGF (epidermal growth factor), PDGF (platelet derived 
growth factor) and FGF (fibroblast growth factor) have been reported to regulate 
MSC differentiation, probably through their interaction with the Wnt and TGFβ 
signalling pathways [73].  
 
2.6 Factors regulating MSC migration  
Previous study has shown that MSCs express a number of chemokine receptors 
namely CXCR1, CXCR2, CXCR4, CXCR5, CXCR6, CCR1, CCR2, CCR7 and 
CCR9 [74] which are a class of receptors shown to be involved in homeostatic 
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trafficking of leukocytes. The same study also showed that chemokines 
corresponding to these respective surface receptors could induce migration of BM 
MSC in transwell assays. Further, addition of CXCL12 in particular induced F-
actin polymerisation into organised filamentous stress fibres associated with cell 
mobilisation [75]. These findings support the hypothesis that chemokines, 
particularly CXCL12 may play a role in BM MSC migration. Another study 
investigating the effect of cytokines on MSC migration to damaged tissues 
compared 26 growth factors and cytokines using human and rabbit MSCs in 
microchemotaxis chamber. They reported that platelet-derived growth factor 
(PDGF-BB and PDGF-AB), TGF-α, insulin growth factor (IGF-I), hepatocyte 
growth factor (HGF) and fibroblast growth factor (FGF-2) in particular 
reproducibly induced MSC migration [76]. Further, since combination of these 
growth factors enhanced migration, it was suggested that maybe combination of 
growth factors is important to elicit optimum chemotactic migration. Other studies 
have reported metalloproteinases such as MMP-2 and MMP membrane type I 
(MT1-MMP) and tissue inhibitor of MMP-1 (TIMP-1) to be involved in MSC 
migration. Inflammatory cytokines including monocyte chemotactic protein 1 and 
3 (MCP-1 and MCP-3) have also been suggested by the same study to affect MSC 
migration.     
Furthermore, extracellular nucleotides such as adenosine triphosphates (ATP) and 
uridine triphosphates (UTP) have recently been characterised as important 
chemotactic factor for hematopoietic stem cell (HSCs) functions. For example, 
activation of purinoceptors by ATP and UTP stimulates HSC migration in 
synergy with other cytokines. Moreover, in nonobese diabetic/severe combined 
immunodeficiency (NOD/SCID) mice, preincubation with UTP expanded the 
number of marrow-repopulating HSCs [77]. 
Previous studies have shown that human BM derived MSCs express almost all 
P2R subtypes identified to date with P2X4R showing the highest expression. The 
role of this subtype outside the nervous system is unknown. In the nervous system 
it is thought to be one of the main mediators of neuropathic pain and is 
upregulated in the spinal cord following injury. Human BM MSCs also expressed 
p2X7R which acts as a cytotoxic receptor in different cell types. However, ATP 
did not have any cytotoxic effect on BM MSCs as seen from the lack of release of 
cell death markers and changes in mitochondrial network following incubation 
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with ATP. ATP-treated MSCs however, showed decreased expression of cell-
cycle related genes and increased expression of growth arrest genes thereby 
having an inhibitory effect on the cell proliferation. Therefore, it is possible that 
extracellular nucleotides also play a role in the migration of MSCs [78]. 
 
2.7 Migration assays  
The term migration is used to define any directed cell movement in the body, 
allowing cells to alter their position either between two tissues or within the same 
tissue [79, 80]. Only a small proportion of highly specialised cells in the body can 
actively and autonomously migrate. These include tumour cells, leukocytes, 
sperm cells, fibroblasts and stem cells. Only recently, studies have focused on 
migration of stem cells since it has been reported that stem cells not only reside in 
tissues such as the BM but also migrate to the other sites where they take part in 
functional in situ tissue regeneration. A range of assays have already been 
developed to study cell migration in details, each having its own advantages and 
disadvantages. Therefore, before choosing a certain type of migration assay, it is 
first important to consider the aims of the experiment.  
 
Most migration assays are end-point experiments and does not allow investigation 
of the intermediary stages of the cell migration. These onsets to end-point assays 
are advantageous for screening studies and not suitable for studies requiring 
constant observation of cells during the time of the migration. Moreover, some of 
these assays are catered towards studying directed cell movement (chemotaxis) 
over undirected random migration (chemokinesis) [81]. In our study, we used 
three different types of cell migration assays to investigate MSC migration. These 
are: Transwell assay (to study chemotaxis), scratch assay (to study intermediate 
stages of migration at different time points) and cell exclusion zone assay (to 
study migration in the absence of cell injury).  
 
2.7.1 Transwell assay  
Transwell assay was first developed by Boyden to study leukocyte chemotactic 
responses. Briefly, there are two wells separated by a porous membrane through 
which cells can move. The size of the pore is dependent on the cells being studied 
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to avoid unspecific dropping of the cells. Membranes with different pore sizes 
ranging from 3 to 12 µm are commercially available. Cells are usually seeded in 
the top well in serum free medium and can migrate vertically through the pore 
towards an attractant present in the bottom well. Incubation time to allow cell 
migration needs to be determined as this can vary between different cell types 
[81].  
 
Cell migration can be detected and quantified by two different methods. With the 
first method, cotton swab is used to remove the non-migrated cells from the top 
side of the membrane and the migrated cells are fixed on the bottom side of the 
membrane and stained with cytological dyes such as toluidine blue, haematoxylin 
or crystal violet. Stained cells are then counted to quantify the number of migrated 
cells. Alternatively, migrated cells can be fluorescently stained, removed from the 
membrane using trypsin and fluorescence can be quantified using a microplate 
reader. Light transmission from the non-migrated cells can also be blocked using 
dark porous membranes which negates the need to remove the migrated cells from 
the upper side of the membrane. Dark porous membranes (FluoroBlok) are 
commercially available from Becton Dickson. Given the range of commercially 
available culture inserts with various pore sizes, the short lasting chemotactic 
gradient between the two wells and the lack of need for any specialised equipment 
besides the culture inserts, transwell assays are powerful techniques to study cell 
migration.   
 
2.7.2 Scratch assay  
Scratch assay is based on the principle that upon creation of an artificial gap 
(wound/scratch) on a confluent cell monolayer, cells respond to the disruption of 
the cell to cell contact by migrating towards the gap to heal the wound [82]. Such 
migration not only reflects cell behaviour on individual levels but also the sheet of 
cells as a surrogate tissue. Wound is generally created using a pipette tip or 
syringe needle and the assay is performed either on a multi-well tissue culture 
plate or on a cover slip. The closing of the gap can be observed within 3 to 24 hrs, 
where cells at the edge of the wound polarise and protrude towards the gap and 
migrate to close the wound. Migration can be monitored either by imaging wells 
at certain time points or by time-lapse microscopy. As a result scratch assays can 
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be used to study various cell behaviours such as matrix remodelling, cell 
polarisation, cell migration, validation of molecules that affect migration, 
metastasis and angiogenesis. For example, the role of Rho family GTPases, 
CDc42, Rho and Rac in cell polarity and actin cytoskeletal regulation have been 
studied using scratch assays. Further, involvement of p53 in cell migration and 
orientation of the microtubule organisation centre (MTOC) and the Golgi 
apparatus have also been studied using scratch assays [81].  
 
2.7.3 Cell exclusion zone assay  
An alternative form of scratch assay is cell exclusion zone assay where the wound 
is created by seeding cells in two separate wells [81]. This produces sharp borders 
and avoids problems such as unevenly thick gap created by cell scraping and 
reattachment of the floating cells in the wound area. Further, stoppers increase 
assay reproducibility as the wound width remains the same with each repeat. This 
assay also allows study of migratory behaviour and interaction between two 
different cell types, seeded in separate wells of the stopper. Similar to scratch 
assays, migration can be observed at various time points using light or time-lapse 
microscopy. It also allows quantification of migration using microplate reader if 
the cells are fluorescently labelled prior to seeding. This is done by masking the 
region where the cells are seeded and detecting the cells once they leave the 
masked region and into the gap. Cells are detected as fluorescent signals which 
are then quantified using the microplate reader. Schematics of this technique can 
be found in the Materials and Methods sections on pages 68-69 (Figure 3.12 – 
3.13).  
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Aim 
The overall aims of this study were to:  
1. Investigate the potential role of MSCs in the joint tissues in the healing of 
cartilage defects when articular cartilage is damaged by trauma. 
2. Investigate the potential migration and repair mechanisms used by MSCs to 
regenerate hyaline cartilage lesions caused by trauma. 
 
Objectives 
1. To establish protocol for in vitro isolation of synovial fluid-derived (SF) and 
bone marrow-derived (BM) mesenchymal stem cells (MSCs). 
2. To establish and optimise in vitro migration assays for MSCs.  
3. To determine if SF and BM MSCs will migrate to articular cartilage in vitro in 
response to non-injured, experimentally –induced injured and dead cartilage.    
4. Investigate whether in vitro injured articular cartilage releases agents (i.e. 
‘injury factors’) which promote migration of SF and BM MSCs and characterise 
any ‘injury factors’ which are released by articular cartilage injured in vitro.  
5. Investigate if SF and BM MSCs need to be primed before migration in response 
to the injury factors.  
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Materials  
Table 3.1: Joint dissection and tissue collection 
Materials Source Information 
Bovine 
metacarpophalangeal 
joints 
Local abattoir  Healthy and skeletally 
matured animals aged 
less than 30 months. 
Collected within 4h of 
commercial slaughter  
Dissection tray, scalpel, 
scalpel handle, tweezers 
and spatula 
Scientific Laboratory 
Supplies, UK 
No. 11 and 22 scalpel 
blades attached to no.3 
and 4 scalpel handles 
respectively 
Post mortem knife  Swann Morton, 
Sheffield, UK 
No.44 blade  
Aluminium foil Sainsbury, UK Standard kitchen foil 
Trigene Scientific Laboratory 
Supplies, Nottingham, 
UK 
Disinfectant 
70% Industrial methylated 
spirit (IMS) 
Genta Medical, York, 
UK 
Diluted 7 parts IMS with 
3 parts distilled water 
Dulbecco’s phosphate 
buffered saline (PBS) 
Sigma-Aldrich, Poole, 
UK 
Without calcium 
chloride and magnesium 
chloride.  
50 ml universal tubes BD Biosciences, Oxford, 
UK 
 
Pasteur pipette  Fisher Scientific 
Loughborough, UK 
 
RJ162VK reciprocating 
saw 
Ryobi, UK  
Petri dish  BD Biosciences, Oxford, 
UK 
 
Class 2 laminar flow 
cabinet  
Walker Safety Cabinets 
Ltd, UK 
 
Sturat mini orbital shaker  Scientific Laboratory 
Supplies, UK 
Used at 29 RPM  
Cell strainer (sterile) BD Biosciences, Oxford, 
UK 
70 μm pore size, nylon 
mesh 
Bacterial collagenase  Sigma-Aldrich, Poole, 
UK 
From clostridium 
histolyticum type I; 2 
mg/ml in complete 
media. Filter sterilised 
before use.  
Hammer and Chisel  Homebase, UK  
Dremel  Homebase, UK  
Dremel cut-off wheel 
blades  
Homebase, UK  
Biopsy punch  Selles Medical, UK Disposable  
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Table 3.2: SF and BM MSC and chondrocyte expansion 
Materials Source Information 
Class 2 laminar flow 
cabinet  
Walker Safety Cabinets 
Ltd, UK 
 
Galaxy R Plus CO2 
incubator  
Eppendorf, UK 37°C, 5% CO2, 95% 
humidity  
Dulbecco’s modification 
of eagle’s medium  
Sigma-Aldrich, Poole, 
UK 
Low glucose (1000 mg/l) 
and high glucose (4500 
mg/l). Both were sodium 
bicarbonate buffered 
without L-glutamine and 
sodium pyruvate 
MSC specified foetal 
bovine serum  
Life Technologies Ltd 
Paisley, UK 
Used only for culturing 
MSCs. Batch no. 
12662029 
Foetal calf serum  Sigma-Aldrich, Poole, 
UK 
Used for culturing 
chondrocytes. Batch no. 
F9665 
L-alanyl-Lglutamine Sigma-Aldrich, Poole, 
UK 
200 mM stock solution. 2 
mM used for preparation 
of cell culture media 
Penicillin-Streptomycin  Sigma-Aldrich, Poole, 
UK 
10 000 units/ml penicillin 
with 10 mg/ml 
streptomycin stock 
solution. 10 μl/ml used 
for preparation of cell 
culture media  
HEPES buffer  Sigma-Aldrich, Poole, 
UK 
100x stock. 10 μl/ml used 
for preparation of cell 
culture media 
MEM non-essential 
amino acids  
Sigma-Aldrich, Poole, 
UK 
1 M stock. 10 μl/ml used 
for preparation of cell 
culture media 
Human fibroblast growth 
factor 2 (FGF2) 
PeproTech, London, UK 1 μl/ml stock. Final 
concentration used in the 
culture media: 5 μg/ml 
for MSC culture media 
and 10 μg/ml for 
chondrocyte culture 
media 
Syringe filter  Nalgene, Hereford, UK 0.2 μm pore size, 
cellulose acetate 
membrane  
20 ml Luer syringe  BD Biosciences, Oxford, 
UK 
 
T25 and T75 tissue 
culture flasks  
Sarstedt Yellow capped. Used 
only for MSC culture  
T75 tissue culture flasks Greiner Bio-One, 
Stonehouse, UK 
Red capped. Used for 
chondrocyte culure 
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Table 3.2: SF and BM MSC and chondrocyte expansion 
Materials Source Information 
Trypsin/EDTA  Sigma-Aldrich, Poole, 
UK 
 
Centrifuge    
Dulbecco’s phosphate 
buffered saline (PBS) 
Sigma-Aldrich, Poole, 
UK 
Without calcium chloride 
and magnesium chloride.  
 
Table 3.3: Materials used for migration assay   
Materials Source Information 
Corning® Costar® 
Transwell® culture inserts 
Sigma-Aldrich, Poole, 
UK 
8 μm pore size, non-
treated membrane, 12 
inserts in a 24 well plate 
24 well plates  Greiner Bio-One, 
Stonehouse, UK 
 
Ibidi culture inserts  Thistle Scientific, UK Creates 500 μm cell free 
gap 
Oris
TM
 Cell migration 
assembly Kit- FLEX  
Platypus technologies  96-well format 
Fibronectin  Sigma-Aldrich, Poole, 
UK 
6.5 μg/ml 
Bovine Serum Albumin 
(BSA) 
Sigma-Aldrich, Poole, 
UK 
Crystalline grade, from 
bovine serum  
MSC specified foetal 
bovine serum  
Life Technologies Ltd 
Paisley, UK 
Used only for culturing 
MSCs. Batch no. 
12662029 
Formaldehyde  Sigma-Aldrich, Poole, 
UK 
 
Crystal Violet  Sigma-Aldrich, Poole , 
UK 
0.1% Crystal violet in 
distilled water  
Distilled water    
Glass slides Thermo Scientific, USA Superfrosted  
Glass coverslips  VWR International, UK  
DPX slide mounting 
medium 
Fisher Scientific, 
Loughborough, UK 
 
Scalpel, scalpel handle, 
tweezers and spatula 
Scientific Laboratory 
Supplies, UK 
No. 11 scalpel blades 
attached to no.3 scalpel 
handles  
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Table 3.4: Materials used for chondrogenic differentiation assay  
Materials Source Final concentration  
Dulbecco’s modification 
of eagle’s medium 
(DMEM) 
Sigma-Aldrich, Poole, 
UK 
High glucose (4500 mg/l) 
with sodium bicarbonate 
buffer without L-
glutamine and sodium 
pyruvate 
TGFβ1 PeproTech, London, UK 10 ng/ml 
Dexamethasone  Sigma-Aldrich, Poole, 
UK 
100 nM 
Insulin transferrin 
selenium (ITS) 
Sigma-Aldrich, Poole, 
UK 
10 μg/ml insulin + 5.5 
μg/ml transferrin + 0.5 
μg/ml selenium + 4.7 
μg/ml linoleic acid + 4.7 
μg/ml oleic acids 
Ascorbic acid  Sigma-Aldrich, Poole, 
UK 
50 μg/ml 
Alcian blue Sigma-Aldrich, Poole, 
UK 
1 g Alcian blue dissolved 
in 100 ml of 3% acetic 
acid (pH 2.5) 
30% hydrogen peroxide  Sigma-Aldrich, Poole, 
UK 
 
Tris buffered saline (TBS) Sigma-Aldrich, Poole, 
UK 
6.1 g/l tris 
(hydroxymethyl 
aminomethane, plus 8.1 
g/l NaCl and 0.86% (v/v) 
5 M HCl in distilled 
water  
TBS/Tween20® Sigma-Aldrich, Poole, 
UK 
TBS supplemented with 
0.05% Tween 20® 
Triton X100 Sigma-Aldrich, Poole, 
UK 
 
Methanol Fisher Scientific, 
Loughborough, UK  
 
Dulbecco’s phosphate 
buffered saline (PBS) 
Sigma-Aldrich, Poole, 
UK 
Without calcium chloride 
and magnesium chloride.  
Hyaluronidase  Sigma-Aldrich, Poole, 
UK 
From bovine testes, 
618.4 units/mg activity  
Pronase  Sigma-Aldrich, Poole, 
UK 
From Streptomyces 
griseus, 5.55 units/mg 
activity  
Bovine Serum Albumin 
(BSA) 
Sigma-Aldrich, Poole, 
UK 
Crystalline grade, from 
bovine serum  
BSA blocking solution  Sigma-Aldrich, Poole, 
UK 
PBS +1% BSA+ 1% 
NHS + 0.05% Triton 
x100 
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Table 3.5: Materials used for chondrogenic differentiation assay  
Materials Source Final concentration 
Type II collagen primary 
antibody  
Southern Biotech, UK Anti-bovine collagen 
type II, produced in goat. 
0.4 mg/ml diluted 1 in 
100 parts in 
TBS/Tween20® buffer  
Rabbit anti-goat IgG Vector Laboratories, UK  
ABC reagents Vector Laboratories, UK Avidin biotinylated 
enzyme complex  
DAB kit 
(diaminobenzidine 
tetrahydrochloride 
peroxide substrate)  
Vector Laboratories, UK  
 
Table 3.6: Materials used for osteogenic and adipogenic differentiation assay  
Materials Source Final concentration  
Dulbecco’s modification 
of eagle’s medium  
Sigma-Aldrich, Poole, 
UK 
Low glucose (1000 mg/l) 
with  sodium bicarbonate 
buffer without L-
glutamine and sodium 
pyruvate 
Bovine Serum Albumin 
(BSA) 
Sigma-Aldrich, Poole, 
UK 
Crystalline grade, from 
bovine serum  
Dexamethasone  Sigma-Aldrich, Poole, 
UK 
10 nM for osteogenesis; 
10 μM for adipogenesis 
Ascorbic acid  Sigma-Aldrich, Poole, 
UK 
50 μg/ml 
Β-glycerol phosphate  Sigma-Aldrich, Poole, 
UK  
10 mM 
MSC specified foetal 
bovine serum  
Life Technologies Ltd 
Paisley, UK 
Used only for culturing 
MSCs. Batch no. 
12662029 
Dulbecco’s phosphate 
buffered saline (PBS) 
Sigma-Aldrich, Poole, 
UK 
Without calcium chloride 
and magnesium chloride.  
Methanol Fisher Scientific, 
Loughborough, UK  
 
SIGMA FAST
TM
 
BCIP/NBT (5-Bromo-4-
chloro-3-indolyl 
phosphate/Nitro blue 
tetrazolium) 
Sigma-Aldrich, Poole, 
UK 
1 tablet in 10 ml distilled 
water  
IBMX Sigma-Aldrich, Poole, 
UK 
100 μM indomethacin + 
0.5 mM 3-isobutyl-1-
methyl xanthine  
2% Gluteraldehyde    
Oil Red O Sigma-Aldrich, Poole, 
UK 
0.5 g Oil Red O in 100 
ml isopropanol. Sterilised 
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Table 3.7 Materials used for characterisation of injury conditioned media 
(IJCM)  
 Materials Source Final concentration  
Growth factors  TGFβ3 PeproTech, 
London, UK 
10 ng/ml 
FGF2 PeproTech, 
London, UK 
5 ng/ml 
Cytokines  CCL2 Sigma-Aldrich, 
Poole, UK 
30 ng/ml 
CCL3 Sigma-Aldrich, 
Poole, UK 
50 ng/ml 
CCL5 Sigma-Aldrich, 
Poole, UK 
50 ng/ml 
TNFα Sigma-Aldrich, 
Poole, UK 
50 ng/ml 
CXCL12 Sigma-Aldrich, 
Poole, UK 
400 ng/ml 
Antibodies 
against 
cytokines and 
growth factors  
CX3CL1 R&D Systems, 
UK 
1.5 μg/ml 
CXCL12 Sigma-Aldrich, 
Poole, UK 
3.6 μg/ml 
TGFβ3 Sigma-Aldrich, 
Poole, UK 
0.3 μg/ml 
FGF2 Sigma-Aldrich, 
Poole, UK 
5 μg/ml  
Receptor 
antagonists  
CCL3 Sigma-Aldrich, 
Poole, UK 
10 μg/ml 
CCL5 Sigma-Aldrich, 
Poole, UK 
7 μg/ml 
AMD3100  Sigma-Aldrich, 
Poole, UK 
6.29 μM 
Extracellular 
nucleotides  
ATP Sigma-Aldrich, 
Poole, UK 
250 μM 
UTP Sigma-Aldrich, 
Poole, UK 
250 μM 
ATPγS Sigma-Aldrich, 
Poole, UK 
250 μM 
UTPγS Sigma-Aldrich, 
Poole, UK 
250 μM 
P2 Receptor 
blocker 
Suramin  Tocris 
Biosciences  
1 mM 
Heparin-
treatment of 
IJCM 
Heparin  Sigma-Aldrich, 
Poole, UK 
50 μg/ml  
Heparin-binding 
plates  
Becton Dickson  96-well format. 
Wells plasma 
polymerised with 
allyl amine 
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Table 3.7: Materials used for characterisation of injury conditioned media 
(IJCM)  
 
Table 3.8: Materials used for fluorescently labelling cells    
Materials Source Final concentration   
Dulbecco’s 
modification of eagle’s 
medium  
Sigma-Aldrich, Poole, 
UK 
High glucose (4500 mg/l) 
with  sodium bicarbonate 
buffer without L-glutamine 
and sodium pyruvate 
CMFDA cell tracker 
Green
TM
 (5’-
chloromethylfluorescein 
diacetate)  
Invitrogen Ltd, 
Paisley, UK 
Dissolved in 20 μl dimethyl 
sulphoxide (DMSO). Final 
concentration:10 μM  
PI (propidium iodide)  Invitrogen Ltd, 
Paisley, UK 
Final concentration: 10 μM 
Zeiss Axioskop 
LSM510 Confocal laser 
scanning microscopy  
Carl Zeiss AG, 
Germany  
 
LSM image browser 
software  
Carl Zeiss AG, 
Germany 
 
Formaldehyde  Sigma-Aldrich, Poole, 
UK 
 
PKH67 Green 
Fluorescent Cell Linker 
Kit 
Sigma-Aldrich   
 
 Materials  Source Final concentration 
Protein inhibitor Cycloheximide  Sigma-Aldrich, 
Poole, UK 
10 μg/ml 
Matrix 
metalloproteinase 
inhibitor 
Marimastat R&D Systems, 
UK 
10 μg/ml 
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Table 3.9: Materials used for histological assessment of MSC migration  
Materials Source Information 
Mayer’s Haematoxylin Fisher Scientific, 
Loughborough, UK 
 
Eosin Y stain   Fisher Scientific, 
Loughborough, UK 
 
Automated H&E 
staining line 
  
Formaldehyde  Sigma-Aldrich, Poole, 
UK 
 
Glass slides Thermo Scientific, 
USA 
Superfrosted  
Glass coverslips  VWR International, UK  
DPX slide mounting 
medium 
Fisher Scientific, 
Loughborough, UK 
 
Leica CM3050S 
cryostat 
Leica Biosystems, 
Milton Keynes, UK 
 
Optimal cutting 
temperature sample 
mounting media (OCT) 
VMR International, UK  
20 mm cork Fisher Scientific, 
Loughborough, UK 
 
Aluminium foil  Sainsbury, UK   
Liquid nitrogen    
 
Table 3.10: Materials used for ATP Bioluminescence assay  
Materials Source Information 
ATP Bioluminescence 
assay kit HS II 
Sigma-Aldrich, Poole, 
UK 
Reagents prepared according 
to manufacturer’s instructions  
Infinite® M2100 
Microplate reader 
Tecan, Switzerland   
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Methods  
3.1 Media composition for culturing different cell types  
Five different cell types were used. Three of them were primary cell types which 
were isolated from the bovine metacarpophalangeal joints (MCPs). These were 
chondrocytes, BM and SF MSCs. The osteoblastic MG-63 cell line was purchased 
from Sigma-Aldrich and human BM MSCs were purchased from PromoCells. 
Different compositions of media were used for culturing the different cell types to 
provide optimal culture conditions. Both BM and SF MSCs were cultured in basic 
medium [Dulbecco’s Modification of Eagle’s Medium, DMEM (low glucose 
formulation containing 1000 mg glucose/litre; Sigma-Aldrich, UK) supplemented 
with penicillin (100 U/ml), streptomycin (100 µg/ml; Sigma-Aldrich, UK) and 
non-essential amino acids (NEAA, Sigma Aldrich, UK).  
Unless stated otherwise, all DMEM with a formulation of 1000 mg glucose/litre 
were supplemented with the above mentioned concentration of penicillin, 
streptomycin and NEAA and will be known as low glucose DMEM. MSC 
qualified foetal calf serum (FCS) was batch tested for MSC viability and 
proliferation and will be known as MSC serum. Unless stated otherwise, all cell 
lines of MSCs from both bovine and human tissues were cultured in low glucose 
DMEM supplemented with 10% MSC serum and 5 ng/ml fibroblast growth factor 
2 (FGF2) and will be known as MSC complete media.  
Chondrocytes and cartilage explants were cultured in basic media [Dulbecco’s 
Modification of Eagle’s Medium, DMEM (high glucose formulation containing 
4500 mg glucose/litre; Sigma-Aldrich, UK)] supplemented with penicillin (100 
U/ml), streptomycin (100 µg/ml; Sigma-Aldrich, UK), 10 mM HEPES buffer pH 
7.4 (Sigma-Aldrich, UK) and non-essential amino acids (NEAA, Sigma-Aldrich, 
UK). Unless stated otherwise, all DMEM with a formulation of 4500 mg 
glucose/litre were supplemented with the above mentioned concentration of 
penicillin, streptomycin, HEPES and NEAA and will be known as high glucose 
DMEM. Foetal bovine serum (FBS) was batch tested for chondrocyte viability 
and proliferation and will be known as chondrocyte serum. Chondrocytes were 
cultured in high glucose DMEM supplemented with 10% chondrocyte serum and 
10 ng/ml of FGF-2 and this media composition will be called chondrocyte 
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complete media.  MG-63 cells were cultured in basic media in chondrocyte 
complete media.  
 
3.2 Tissue culture flasks used for different cell lines 
Due to differential adherence capacity of the cell lines used, cells were cultured in 
different tissue culture flasks. Corning® cell culture flasks with canted neck and 
red vented caps were used for chondrocytes and MG-63 cell lines. Sarstedt cell 
culture flasks with yellow vented caps were used for all types of MSCs.  
 
3.3 Collection of bovine chondral explants  
3.3.1 Source of chondral explants   
Metacarpal phalangeal joints (MCP) from cows aged less than 30 months were 
obtained from a local abattoir within 4 hours of slaughter.  Joints were sprayed 
with TriGene disinfectant, skinned using a P40 blade attached to a post-mortem 
knife and further disinfected using IMS (industrial methylated spirit). Joints were 
opened under aseptic condition inside a Class II sterile cabinet. A small incision 
was made into the joint cavity using a number 22 scalpel blade attached to a 
number 4 scalpel handle and the SF was aspirated. Joints were opened by 
reflecting the distal limbs to expose the proximal articular surface. Condylar 
cartilage was collected either as chondral flakes or as osteochondral explants.  
 
3.3.2 Development of an in vitro cartilage injury model  
To study the effect of cartilage injury it was important to first develop an in vitro 
chondral model. The four proximal sesamoid bones of bovine MCP joints were 
used to create osteochondral explants. In our preliminary experiments a hammer 
and a chisel were used (Figure 3.1) to harvest the osteochondral explants. This 
produced curved osteochondral explants with irregular edges which could not be 
studied due to its inconsistent shape and the issues with reproducibility.  A dremel 
was then used to improve the reproducibility of the collection of osteochondral 
explants. To do this, at first, the four proximal sesamoid bones were separated 
from the joint using a Ryobi RJ162VK Reciprocating Saw. The separated bones 
were immediately wrapped in gauge soaked in phosphate buffered saline (PBS) 
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solution (PBS) to prevent the cartilage from drying out. Then the osteochondral 
explants were collected using 8 mm diameter cutting disc attached to a hand 
dremel.  
The cartilage- drill edge was flushed with PBS at 1 min intervals to cool the 
cutting edge and four explants were collected per MCP joint. The explants were 
cut to approximately 5 mm in length and washed in DMEM. Each explant was 
then placed in individual wells in a 24 well plate containing complete chondrocyte 
media and kept overnight in culture media to verify sterility. To prevent the 
release of substances from the injured bone in to the media it was first required to 
excise the cartilage from the osteochondral explants. This method was also not 
reproducible, producing cartilage explants of various sizes and further injured the 
cartilage (Figure 3.1).
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Figure 3.1: Development of a model to harvest chondral explants for 
studying MSC migration in response to injured cartilage. In our 
preliminary experiments various tools were tested for collection of chondral 
explants with consistent thickness and height. (a) Bovine 
metacarpophalangeal joints were opened under sterile conditions but 
following dissection explants were harvested under non-sterile conditions. 
(b) Chisel produced osteochondral flakes with inconsistent cartilage to bone 
ratio with curvature in the middle or at the edges. (c) Dremel reproducibly 
produced consistent square osteochondral explants. However, prolonged 
exposure of cartilage to air and increased temperature at the cutting edge of 
the saw led to cartilage drying and heat-induced injury respectively. d) It 
was possible to excise the cartilage from the osteochondral explants 
however; it was difficult to reproducibly excise cartilage with the same 
thickness and height.   
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Next the chondral flakes were harvested using no.11 scalpel blades attached to a 
no.4 scalpel handle. Chondral flakes with irregular edges were collected which 
were then trimmed to obtain regular, rectangular shaped chondral flakes. 
However, there was inconsistency in the thickness of the flakes collected and it 
was not possible to reproducibly collect flakes with the same thickness (Figure 
3.2).  
 
 
 
 
 
 
 
 
 
Figure 3.2: Use of scalpel to harvest chondral explants. (a) Bovine 
metacarpophalangeal joint was opened under sterile conditions. (b) 
Chondral flakes with irregular edges were collected using no. 11 scalpel 
blades attached to no.4 scalpel handle. Even though blades were frequently 
replaced to maintain blade sharpness, it was not possible to ensure that all 
chondral flakes had similar level of blunt and sharp injuries. (c) Schematic 
of cutting irregular edges of the chondral strips using a No.11 scalpel blade 
to obtain trimmed strips with four straight edges. Each flake was re-cut 
into four stripes and strip 1 and 4 were discarded. (d) Following trimming, 
chondral explants with four straigh edges were obtained.  
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A 6 mm biopsy punch was used to reproducibly collect 6 mm × 1.5 mm cartilage 
discs without attached subchondral bone. The cartilage discs were then ‘rested’ by 
incubating in media supplemented with 10
-7
 M dexamethasone for 72 h before 
being used in experiments (Figure 3.3).  
 
 
Figure 3.3: Collection of cartilage discs using 6mm biopsy punch. (a) 
Bovine metacarpophalangeal joints were opened and discs were collected under 
sterile conditions. (b) 6mm biopsy punch was used to punch the cartilage and 
discs were cut from the joint using no.11 scalpel blade. (c) Cartilage discs of 6 
mm in diameter and 1.5 mm thickness were consistently obtained by this 
method.  
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3.4 Processing of bovine articular cartilage to obtain non-injured, injured 
and dead cartilage  
3.4.1 Non injured cartilage 
Full thickness hyaline cartilage with no attached subchondral bone was harvested 
from the bovine MCP using no. 11 scalpel blade. Initially the chondral strips were 
processed using the following method.  The chondral strips were immediately 
placed in complete chondrocyte media (refer section 3.1). For experiments using 
‘non-injured cartilage’  cartilage discs were initially maintained in an incubator at 
37°C in a humidified 95% air  5% CO2 for 72 h in complete chondrocyte culture 
medium to rest the tissue. For later experiments the method of resting the cartilage 
was changed to 72 h incubation in complete chondrocyte medium containing 10
-
6
m dexamethasone. The 72 h resting period was to allow any areas of the cartilage 
that were potentially injured during the harvesting procedure to recover to a basal 
non-injured state.  
3.4.2 Injured cartilage 
Rested, non-injured cartilage flakes were injured by cutting individual cartilage 
discs 5 times with no.11 scalpel blade.  
3.4.3 Devitalised/dead cartilage  
To obtain ‘dead cartilage’, cartilage discs were treated in initial experiments to 2 
cycles of freezing the tissue at -20°C followed by thawing it to ambient 
temperature. The free-thawed tissue was then stored at -20°C.  
In later experiments the devitalising procedure was optimised and freshly isolated 
cartilage discs were treated with microwave irradiation for 30 sec at power 30 
(Figure 3.4). This killed the cartilage instantaneously by denaturing and 
precipitating out the cartilage proteins. Following irradiation, the cartilage flakes 
were frozen down at -20°C.  
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Figure 3.4: Processing cartilage discs to obtain non-injured, injured 
and dead cartilage. Following collection, cartilage discs were either 
allowed to rest in DMEM supplemented with chondrocyte serum and 
dexamethasone to obtain non-injured cartilage or irradiated with 
microwave radiation and subsequently frozen down at -20°C to obtain 
dead cartilage. Injured cartilage was obtained by re-cutting rested cartilage 
several times with scalpel blade.  
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3.5 Assessing cartilage viability using PrestoBlue
®
  
Viability of ‘non-injured’, ‘injured’ and ‘dead’ cartilage was assessed using 
PrestoBlue
® 
which is a commercially available preparation of the resazurin dye. 
Rezazurin enters the living cells and is reduced to resorufin in the mitochondria. 
In this form resorufin can freely diffuse out of the cells and can be flurometrically 
detected in the media. Following termination of transwell migration assay to 
investigate MSC migration to chondral pieces, cartilage samples were moved 
from the transwell plates to fresh 24 well plates. 900 µl of DMEM* supplemented 
with 0.1% BSA and 100 µl of PrestoBlue® was added to each cartilage sample. 
The samples were incubated in the PrestoBlue for an hour and following hour 
incubation 200 µl of the supernatant from each sample was transferred into a 96-
well plate. Data was analysed as fluorescent intensity measured using the 
microplate reader at an excitation wavelength of 570 nm and emission wavelength 
of 600 nm.  
 
3.6 Isolation and culture of bovine synovial fluid mesenchymal stem cells 
(bSF MSCs) and bone marrow mesenchymal stem cells (BM MSCs) 
The method of Jones et al [29, 62] was used. All tissues were dissected under 
aseptic conditions. A small incision was made at the skin surrounding the 
proximal sesamoid bones using a no. 22 scalpel blade attached to a no. 4 scalpel 
handle. SF was aspirated through the incision using a sterile Pasteur pipette. 
Approximately 5-10 ml of SF was collected on average per MCP. The fluid was 
then diluted with PBS at a 1:3 ratio. Diluted fluid was filtered using a cell strainer 
to remove the synovial membrane debris. Filtered fluid was centrifuged for 10 
mins at 300 g to isolate the SF MSCs. The supernatant fluid was discarded and the 
remaining cell pellet was re-suspended in PBS and centrifuged again for 10 mins 
at 192 g. The supernatant was discarded and the cell pellet was re-suspended in 1 
ml of complete MSC media. The cell suspension was added into the cell culture 
flask and further 3 ml of complete media was added to the flask. For a single 
experiment SFs were collected from five different animals and cultured in 
separate flasks to reduce the risk of contamination. Cultures of SF-MSCs were 
incubated at 37ᵒC in a humidified atmosphere containing 5% CO2. Non-adherent 
cells were removed by changing the media after 4 days. Following the initial 4 
days, media was changed every 5-7 days and the cells passaged when 70% 
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confluent. Following the first expansion after isolation (passage 0), SF MSCs 
were pooled and cultured till passage 3 before using them for experiments. 
Therefore, a single experiment was performed using SF MSCs from five different 
animals.  
The femoral cavities of the MCPs were exposed by drilling and the BM was 
drawn from the femoral marrow cavity using a sterile spatula. BMs were digested 
in collagenase for 4 h to increase the recovery of the MSCs. Digested BMs were 
centrifuged for 10 mins at 300 g. The supernatant fluid was discarded and the 
remaining cell pellet was re-suspended in PBS and centrifuged again for 10 mins 
at 192 g. The supernatant was discarded and the cell pellet was re-suspended in 1 
ml of complete MSC media and cultured using the same protocol used for SF 
MSCs. For a single experiment BMs were collected from five different animals 
and cultured separately to avoid contamination. Following the first expansion 
after isolation (passage 0), BM MSCs were pooled and cultured till passage 3 
before using them for experiments. Therefore, a single experiment was performed 
using BM MSCs from five different animals. 
 
3.7 Differentiation assays  
3.7.1 Chondrogenesis assays 
Chondrogenesis was assessed using 3D micromass and pellet cultures.  
 
3.7.1.1 Micromass cultures 
To form micromass cultures, MSCs (5×10
5
 cells/ 50 µl) were placed as a 50 µl 
droplet in the middle of the wells in 24 well culture plates and cells were allowed 
to attach over 24 h. Following incubation, the medium was carefully removed 
from each well and replaced with serum-free standard chondroinductive medium 
consisting of high glucose DMEM, 1 mg/ml BSA, 100 nM dexamethasone, 10 
µg/ml insulin, 5.5 µg/ml transferrin, 0.5 µg/ml selenium and 4.7 µg/ml each of 
linoleic and oleic acids (ITS) 50 ug/ml ascorbic acid and 10 ng/ml transforming 
growth factor-1 (TGFβ-1) [83]. For control experiments, micromasses were 
incubated in complete MSC media. Micromasses were incubated in the specified 
medium and cultured at 37°C in a humidified atmosphere containing 5% CO2 for 
21 days by replacing with fresh medium every 2 days. Following 21 days culture, 
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each micromass was washed with sterile PBS and fixed in methanol at -20°C for 
30 min. Fixed micromasses were further washed twice with PBS and sulphated 
glycosaminoglycans (GAG) were visualised by staining with 0.5% alcian blue for 
18 h. This consisted of incubating cells with 3% (v/v) acetic acid for 1 min 
followed by 1% (v/v) alcian blue (1 g alcian blue in 100 ml 3% v/v acetic acid, pH 
2.5) for 18 h at ambient temperature, counterstained with 0.05% (w/v) neutral red 
(0.5 g neutral red in 100 ml distilled water). Stains were removed and cells 
washed five times with distilled water before imaging using light microscopy.  
 
3.7.1.2 MSC pellet cultures 
For preparation of MSC pellets, aliquots of 5×10
5
 cells in 1 ml of low glucose 
DMEM supplemented with 10% FCS were spun down at 250 g for 5 mins in 20 
ml universal tubes with conical bottoms. Tubes containing the cell pellets were 
incubated at 37°C in a humidified atmosphere containing 5% CO2 for 24 h. 
Following incubation, the medium was carefully removed from each tube and 
replaced with serum-free standard chondroinductive medium consisting of high 
glucose DMEM, 1 mg/ml BSA, 100 nM dexamethasone, 10 µg/ml insulin, 5.5 
µg/ml transferrin, 0.5 µg/ml selenium and 4.7 µg/ml each of linoleic and oleic 
acids (ITS) 50 ug/ml ascorbic acid and 10 ng/ml transforming growth factor-1 
(TGFβ-1). For control experiments, pellets were incubated in complete MSC 
medium. Pellets were incubated in the specified medium and cultured at 37°C in a 
humidified atmosphere containing 5% CO2 for 21 days by replacing with fresh 
medium every 2 days.  
 
3.7.1.3 Measurement of proteoglycan content  
Pellets were assessed for proteoglycan content by quantifying the level of 
sulphated glycosaminoglycans (GAGs) using 1,9-dimethylmethylene blue (DMB; 
Sigma-Aldrich, UK) assay [84]. DMB binds to glycosaminoglycans generating a 
metachromatic shift that peaks at A525-530 and can be quantified 
spectrophotometrically. Each pellet was digested with papain solution consisting 
of 200 mM phosphate buffer, 1 mM EDTA, 0.05% w/v % papain and 0.96 w/v% 
N-acetyl cysteine and incubated at 60°C for 4 h. Following the 4 h digestion, the 
supernatant was collected and stored at 4°C until GAG assay was carried out. 20 
µl of chondroitin sulphate standard solutions prepared at concentrations from 0-50 
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µg/ml and 20 µl of each cell pellet sample were placed in a 96-well plate. 250 µl 
of DMB solution was added to each well and the optical density was quantified at 
530 nm using a microplate reader.  
 
3.7.1.4 Collagen Type II immunoassay for assessment of chondrogenesis  
3D micromasses were fixed with formaldehyde. Following fixation, micromasses 
were treated with 10 mg/ml hyaluronidase in PBS for 30 mins followed by 
washing in PBS. The PBS was removed and 3mg/ml pronase in PBS added to the 
micromasses and incubated at 37°C for 30 mins. 3% v/v hydrogen peroxide in 
methanol and PBS was used to quench the enzymatic activity for 5 mins. To 
inhibit any non-specific hydrophobic binding interactions, 1% BSA in 
TBS/Tween20® buffer (blocking solution) was applied for 1h at ambient 
temperature. The blocking solution was then removed and primary collagen II 
antibody was added (0.4 mg/ml diluted 1 in 100 parts in TBS/Tween20® buffer)  
to each micromass and incubated at 4°C. Following an overnight incubation at 
4°C, all sections were washed three times with TBS/0.05% Tween 20® with each 
wash lasting for 5 mins. The secondary antibody was added to all wells and 
incubated for 1h in ambient temperature. The ABC reagent was prepared 
according to the manufacturer’s instructions and left to stand for 30 mins. Then 
micromasses were incubated in ambient temperature for 30 mins with the ABC 
reagent. All wells were washed three times with TBS/0.05% Tween 20® with 
each wash lasting for 5 mins. DAB reagent which was prepared according to the 
manufacturer’s instructions was applied to each well and left for 10 mins. All 
wells were washed with distilled water and imaged using light microscopy.  
 
3.7.3 Osteogenesis  
MSCs were plated out at a density of 5×10
5
 cells per well in a six-well culture 
plates in low glucose DMEM supplemented with MSC serum for 72 h to allow 
cell adhesion and formation of confluent monolayer. Osteogenic differentiation 
was induced by subjecting triplicate cultures to standard osteoinductive media 
consisting of low glucose DMEM, 2% FCS, 1mg/ml BSA, 10 nM dexamethasone, 
50 ug/ml ascorbic acid and 10 mM β-glycerophosphate [70]. Control media 
contained low glucose DMEM supplemented with 10% MSC serum. The cultures 
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were maintained for 14 days with change of medium every 2 days. After 14 days 
cells were washed with sterile PBS and fixed in cold methanol at -20°C for 30 
minutes. Fixed cells were washed twice with distilled water and SIGMA FAST
TM
 
BCIP/NBT (5-Bromo-4-chloro-3-indolyl phosphate/Nitro blue tetrazolium) 
tablets were used as immunohistochemical stains for detection of alkaline 
phosphatase activity. 
 
3.7.4 Adipogenesis  
For adipogenesis, MSC were plated out at a density of 5×10
5
 cells per well in a 
six well plate in low glucose DMEM supplemented with 10% MSC serum for 72 
h to allow cell adhesion and formation of confluent monolayer. MSCs were 
cultured in triplicate in either standard adipo-inductive media or control media for 
72 h. Adipo-inductive media contained low glucose DMEM, 2% FCS, 1 mg/ml 
BSA, 10 µM dexamethasone, 100 µM indomethacin and 0.5 mM 3-isobutyl-1-
methyl xanthine (IBMX) [71]. Control media contained low glucose DMEM 
supplemented with 10% MSC serum. Following 72 h, adipo-inductive medium 
containing cultures were washed with PBS and replaced with maintenance 
medium consisting of low glucose DMEM, 1mg/ml BSA and 10 µg/ml of insulin 
while control cultures were maintained in control media for 5 days. Following the 
5 days, cultures were washed with sterile PBS and fixed with 2% gluteraldehyde 
for 30 min at room temperature. Fixed cells were then washed twice with distilled 
water and subsequently stained with 0.5% oil red O (0.5 g Oil Red O in 100 ml 
Isopropanol) for 2 min to detect adipogenic differentiation. Stains were removed 
and cells were washed five times with distilled water before imaging. 
 
3.8 Collection of bovine chondral explants 
Chondral flakes were collected from the four proximal sesamoid bones of fresh 
MCP joints for isolation of chondrocytes and collection of injury conditioned 
media (IJCM).  Full thickness hyaline cartilage with no attached subchondral bone 
was harvested using a no. 22 scalpel blade attached to a no.4 scalpel handle. 
Flakes were processed in two different ways depending on their use. For isolation 
of chondrocytes, flakes were immediately placed in complete chondrocyte media. 
For IJCM, flakes were placed in low glucose DMEM supplemented with 0.1% 
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bovine serum albumin (BSA). Table below summarises the different ways 
chondral flakes were processed following collection.  
 
Table 3.40: Chondral flakes were collected for isolation of chondrocytes, 
collection of injury conditioned media and migration assays involving 
cartilage. Therefore, following collection they were placed in different media 
combinations. DMEM: Dulbeccos modified Eagles medium; FCS: Foetal calf 
serum; BSA: bovine serum albumin.  
 
Reason for collection of 
chondral flakes 
Constituents of complete media 
Chondral 
flakes 
Isolation of 
chondrocytes 
DMEM (high glucose formulation 
containing 4500 mg glucose/litre) 
supplemented with 10% FCS 
Collection of injury 
conditioned media 
(IJCM) 
DMEM (low glucose formulation 
containing 1000 mg glucose/litre) 
supplemented with 0.1% BSA 
 
3.9 SF MSC labelling with PKH67  
SF MSCs were labelled with green fluorescent cell linker PKH67 using 
previously described procedure [85]. Briefly, PKH67 dye was prepared according 
to the instructors manual immediately prior to staining and added to 1 ml of re-
suspended SF MSCs (0.4 µM PKH67/ 2×10
6
 cells). Cells were incubated with the 
fluorescent dye for 25 mins at ambient temperature following which the staining 
reaction was terminated using serum free DMEM.  
 
3.10 Use of fluorescent probes to assess chondrocyte viability following 
mechanical injury of cartilage  
CMFDA cell tracker Green
TM
 (5’-chloromethylfluorescein diacetate) and PI 
(propidium iodide) was used to stain live and dead cells respectively. As a 
hydrophobic dye, CMFDA can freely pass through the cell membrane of an intact 
cell. Once the dye enters the cell, it is hydrolysed by intracellular esterases which 
break down the diacetate group to form CMF (chloromethyl-fluorescein). In this 
form, the dye is hydrophilic and therefore cannot leave the cells. CMF is a 
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fluorescent compound and fluoresce green, thereby enabling the visualisation of 
live cells. In contrast, PI can only enter the cell when the cell is no longer intact 
and the cell membrane is disintegrated. Inside the cell it binds to intra-nuclear 
DNA of dead cells and makes the nucleus fluoresce red.  
CMFDA (Invitrogen Ltd, Paisley, UK) was dissolved in 20 µl of dimethyl 
sulphoxide (DMSO) and added to DMEM (high glucose formulation; 4500 mg 
glucose/litre) to give a final concentration of 10 µM. 10 µl of PI was added to 
the DMEM to give a final concentration of 10 µM. Osteochondral and chondral 
strips were incubated in the DMEM containing the CMFDA and PI for 1 h at 
room temperature. Following 1 h incubation, strips were fixed in formaldehyde 
solution (4% v/v; Fisher Scientific, UK) for 30 mins at room temperature and 
stored in PBS at 4ᵒC overnight before microscopy.  
 
3.11 Confocal laser scanning microscopy (CLSM) 
Fluorescently labelled and fixed cartilage explants were placed on a microscope 
slide with the articular surface uppermost. An upright Zeiss Axioskop LSM 510 
meta confocal laser scanning microscopy (Carl Zeiss Ltd, UK) with a ×10 (EC 
Plan-Neofluar 10×/0.30) and ×5 (EC Plan-Neofluar 5×/0.16) dry objective lens 
was used to acquire optical sections (512 × 512 pixels). Argon and Helium-Neon 
laser multi-track protocol was used. This protocol allowed alternate excitation of 
each fluorophore (CMFDA (λex = 488nm, λem= 517nm) and PI (λex = 543nm, 
λem = 650nm) and thereby dual visualisation of live and dead cells within 
individual optical sections. The sensitivity and detector gain were manually 
adjusted before image acquire to avoid pixel saturation and optimal imaging of 
each optical sections. The diameter of the pinhole was set to 1 Airy Unit (diameter 
which allowed rejection of out-of-focus light) for detection of red and then 
manually adjusted for detection of green to get the same optical slices for both 
fluorophore. Using these parameters, the superficial zone (approx. 30 µm deep; z-
axis) of the articular cartilage was imaged in multiple optical sections and the 
sections were reconstructed using an image analyser (LSM image browser) to 
produce CLSM projections.  
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B. 
A. 
Figure 3.5: Confocal laser scanning microscopy. A. Exclusion 
of out-of-focus light by the pinhole allows detection of only in-
focus light and imaging tissues at high-resolution. B. Optical 
sections of cartilage will be imaged top-down from the articular 
surface to a depth of ~ 30 μm into the tissue.  
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3.12 Isolation of chondrocytes  
Chondral flakes with no attached subchondral bones were harvested from the 
bovine MCP using a no. 11 scalpel blade. Flakes were immediately placed in 
complete chondrocyte media until the tissue collection was completed. The media 
was then removed and 2.5% (w/v) trypsin was added and the cartilage pieces were 
incubated for 30 mins at 37°C. Following incubation cartilage pieces were washed 
twice with PBS and placed in complete chondrocyte media and 2mg/ml of 
collagenase. Chondral flakes were further incubated for 24 h on an orbital shaker 
at 37°C to allow tissue digestion. Following 24 h incubation, media containing 
digested cartilage was placed in centrifuge tubes and centrifuged at 1000 rpm (192 
g) for 10 min to pellet the chondrocytes. After centrifugation, the supernatant 
containing the collagenase was removed and the cell pellet was re-suspended in 
PBS. Cell suspension in PBS was further centrifuged for 10 min at 1000 rpm and 
this whole washing process was repeated twice. The final chondrocyte pellet was 
re-suspended in chondrocyte complete media (2 × 10
6
 cells/11 ml media) and 
plated in tissue culture flasks [86]. Only chondrocytes at P0 passage number were 
used for migration assays.  
 
3.13 Passaging cells 
Medium was removed from the tissue culture flasks and each flask was rinsed 
once with 5 ml of PBS. Diluted typsin/EDTA solution [Trypsin/EDTA (0.05% 
trypsin and 0.02% EDTA) was diluted with PBS at a 3:1 ratio] was added to the 
culture flask and the flasks were incubated at 37ᵒC for 2 mins at which time 90% 
of the cells lift up from the flask. After the cells had detached, they were quickly 
transferred to a sterile 50 ml centrifuge tube and the trypsin/EDTA in the flask 
was neutralised using 1 ml serum. Cell specific serums were used in each case. 
The flask was then rinsed once with PBS to collect the residual cells, the rinse was 
added to the centrifuge tube and the whole solution was centrifuged for 5 min at 
192 g. Cell pellets were suspended and cultured in their cell specific complete 
media in cell specific tissue culture flasks.   
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3.14 Collection of conditioned media from injured cartilage: Injury 
conditioned media (IJCM) 
Cartilage pieces were finely cut using no.11 scalpel blades. Media were 
conditioned by placing the finely cut pieces of cartilage (approximately 3 mm × 1 
mm; 600 mg/15 ml) in serum-free DMEM containing 1g/l glucose, 100 U/ml 
penicillin, 100 µg/ml streptomycin, 1% non-essential amino acid and 0.1% bovine 
serum albumin (BSA) (DMEM+0.1% BSA) and incubating at 37° C in a 
humidified atmosphere at 5% CO2 for 24 h. Media were collected as injury 
conditioned media (IJCM) for either immediate use or stored at -20° C (Figure 
3.6).   
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Figure 3.6: Collection of injury conditioned media (IJCM) Bovine 
metacarpophalangeal joints obtained from the local abattoir were 
dissected and opened under sterile conditions. Hyaline cartilage was 
harvested from the condyles using no.11 scalpel blade attached to 
no.3 scalpel holder. Cartilage was finely cut into pieces using no.22 
scalpel blade attached to no.4 scalpel holder in the presence of serum 
free media supplemented with 0.1% bovine serum albumin (BSA). 
Cut pieces of cartilage were incubated in the same serum free media 
for 24 h at 37°C and 5% CO2. Following 24 h incubation, cartilage 
pieces were discarded and media was collected as injury conditioned 
media (IJCM) for either immediate use or stored at -20°C for later 
use.  
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3.15 Heparin-treatment of injury conditioned medium (IJCM) 
A wide variety of proteins such as growth factors, proteolytic enzymes and 
chemokines sequester in the cartilage matrix through their interactions with GAGs 
found ubiquitously on the cell surface and in the ECM. One typical GAG 
molecule that binds to chemokines and growth factors is heparin. Study of 
protein-binding properties of heparin sulphate (HS), heparin and other GAGs have 
been limited by the requirement for chemical modification prior to attachment to 
inert or derivatised surfaces and also by the lack of a simple method for analysis. 
96-well heparin-binding plates offer a simple solution to this problem. Cold 
plasma polymerisation was used to coat the microtiter plates with allyl amine 
which generates a surface for non-covalent immobilisation of heparin in a 
functionally active state. These heparin-binding plates were then used to treat 
IJCM and remove any heparin-binding proteins present in the IJCM. To coat the 
plate with heparin, 200 µl of heparin solution (50 µg/ml in PBS) was added to 
each well and the plate incubated at 4°C overnight [87]. Following overnight 
incubation, the heparin solution was removed from each well and the wells were 
washed twice with PBS. The PBS was removed and 300 µl IJCM was then added 
to each well and the plate further incubated at 4°C for 24 h. Following incubation, 
the heparin-treated IJCM was collected for either immediate use or stored at -
20°C. 
 
3.16 Migration assays  
3.16.1 Induction and quantitative assessment of mesenchymal stem cell 
migration in the 24-Well Transwell
TM
 assay 
Due to insufficient reports in literature on assessment of SF MSC chemotactic 
migration using Transwell assays it was first important to establish the protocol 
and conditions for the analysis of MSC migration seeded in 24-Well Transwell 
chambers and reliably identify the translocated cells. Transwell inserts of 
dimension 12 mm in diameter and 1.12 cm
2
 membrane growth area were used. 
The membranes contained 8-µm diameter pores. 650 µl of serum was added to the 
lower wells and 100 µl of cell suspension containing 2 ×10
6
 cells per ml of serum 
free media supplemented with 0.1% bovine serum albumin (BSA) was added in 
triplicate to the top wells (Figure 3.7). Plates were incubated at 37°C in a 
humidified atmosphere at 5% CO2. Cells attached to the lower part of the 
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membrane were fixed with formaldehyde in combination with cell wipes to 
remove non-migrated cells from the upper side of the membranes and a crystal 
violet staining step to mark the migrated cells. 5 different microscopic fields were 
imaged per membrane at x20 magnification and number of cells in each image 
was counted using the Image-J software (Figure 3.8) [88].  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3.7: Side (a) and top (b) schematics of one transwell insert. The 
insert is 12 mm in diameter with membrane pore diameter of 8 µm. The 
insert sits on top of the well which keeps the insert membrane about 1 mm 
off the bottom of the well. This prevents membrane disturbance when added 
to the 24 well plates. (c).MSCs were seeded in DMEM+0.1% BSA in the 
upper well and the cells can migrate in vertical direction through the pores 
(8 µm) on the membrane in response to attractants on the lower well. 
Migrated cells attach to the bottom of the membrane. (d). Membranes from 
the upper wells were cut from the inserts, stained with crystal violet, 
mounted on glass microscope slides and imaged using light microscopy to 
count the number of cells.  
Transwell migration assay   
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5 different microscopic fields were imaged per membrane at x20 magnification 
and number of cells in each image was counted using the Image-J software.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 3.8: Digital image of a representative membrane 
imaged at x4 magnification. For cell counting, five different 
microscopic regions (R1-R5) as labelled were imaged at x20 
magnification producing 5 images per membrane. Total 
number of migrated cells per membrane was quantified by 
addition of the number of migrated cells quantified per region 
(R1+R2+R3+R4+R5). Cells were counted using the Image-J 
software. Please scan the QR code to watch a video of the 
analysis process using Image-J.  
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3.16.2 Quantifying cell migration using calcien AM: comparison between 
calcein AM and crystal violet staining method 
An alternative to crystal violet staining to quantify cell migration in transwell 
assays is to fluorescently label the cells and quantify fluorescence from the 
migrated cells using a microplate reader. We assessed and compared this method 
with the crystal violet staining method in order to optimise the quantification step 
of the assay. Cells were stained with calcein-AM which is the acetomethoxy 
derivative of calcein. It is a hydrophobic compound which can freely pass through 
the cell membrane. Once inside the cell, intracellular esterases hydrolyse calcein-
AM to remove the acetomethoxy group. In this form calcein is hydrophilic, gets 
trapped inside the cells and gives out strong green fluorescence which can then be 
quantified using a plate reader (Figure 3.9). This simplifies the detection of the 
migrated cells by eliminating the need to remove the remaining cells from the top-
side of the membrane and to manually count the number of cells in each 
membrane. Cells were stained by adding calcein-AM to the bottom well, thereby 
only immersing the migrated cells in the fluorescent label. Trypsin/EDTA was 
used to detach the migrated cells from the membrane and the eluted solution was 
read in a microplate reader at an excitation >485 nm and emission at 520 nm in 
96-well plates.  
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3.16.3 Assessment of MSC migration using scratch assays 
Even though the widely used transwell assay reliably detects differences in cell 
migration in response to varying stimulus, it offers less readout options because it 
is an end point assay. In comparison, wound healing assay also known as scratch 
assay is an easy and economical method to measure cell migration in vitro. The 
basic principle of this method is based on the observation that upon creation of an 
artificial gap (scratch) on a confluent cell monolayer, cells on the edge of the 
scratch will move towards the gap to close the scratch until new cell to cell 
contacts are established again (Figure 3.10).  
 
Scratch assays were performed in 24 well plates and each well was seeded with 
300,000 cells. This cell seeding density was chosen based on preliminary 
experiments looking at various cell densities (100,000 – 500,000 cells/ well). 
Plates were maintained at 37° and 5% CO2 for 24 h to allow cell attachment and 
formation of a confluent monolayer. If confluent monolayer did not form within 
24 h then the plates were maintained till 100% confluency was achieved. 
Figure 3.9: Use of calcein-AM to quantify number of migrated cells 
following Transwell assay. Calcein-AM is a hydrophobic compound 
which can pass through the cell membrane. Once inside the cell, esterases 
hydrolyse calcein-AM to produce calcein which is hydrophilic and cannot 
leave the cell. As calcein is fluorescent, when trapped inside the cell it 
makes the cell fluoresce which can be quantified using a plate reader.   
Calcein- AM  
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Complete media was then removed and replaced with serum free media 
(DMEM+0.1% BSA). These confluent monolayers were then ‘wounded’ by 
scraping off an area of the monolayer using a 200 µl pipette tip to create a gap of 
approximately 500 µm in width. Wound closure was monitored microscopically 
and images were taken at x10 magnification at various time intervals until the 
wound was completely closed or no longer progressing. Images were analysed 
and the width of the wound was measured using Image-J (Figure 3.11). Data was 
presented as % reduction in wound width from the time of the creation of the 
wound width (T0) and final image taken (T duration of the experiment) [82]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Principle of scratch assay.  (a) Cells are grown to 
confluence in 24 well plates.  (b) The monolayer is ‘wounded’ by 
scraping off an area of cells using a 200 µl pipette tip. (c) 
Monolayer is imaged immediately following creation of wound and 
(d) monitored microscopically and imaged at various time intervals 
to quantify cell migration as percentage reduction in wound width 
over time.  
Cell 
monolayer 
200 µl pipette 
tip  
Wound  
(a) 
(d) 
(c) 
(b) 
Scratch assay   
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(a) 
(b) 
Figure 3.11: Wound width measurement and the variability between 
triplicate measurements at 0 h (immediately after creation of the wound).  
(a) A representative image of one scratch assay immediately after creation of the 
wound. In order to measure the width of the wound this image was imported into 
the ImageJ software. The image was then overlaid with a grid (60000 pixels
2
) to 
divide the image uniformly (shown in green). This grid overlay creates 9 
columns. Width measurements were taken in the middle of 2nd column (width 
1), 5
th
 column (width 2) and 8
th
 column (width 3). The mean value of the three 
width measurements {(width 1 + width 2 + width 3)/3} was used as the width 
measurement for that particular image.  (b) Graph showing the variability 
amongst the three width measurements (width 1, width 2 and width 3) in 
individual images. Mean variation amongst these three width measurements 
(standard deviation) amongst these 10 individual images was 40 µM. (c) Graph 
showing mean width measurements among triplicate assays. Variation in mean 
width between triplicate assays was on average 75 µM.  
 
(c) 
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3.16.3 Assessment of MSC migration using cell exclusion zone assays 
Cell exclusion zone assays were used to assess the requirement for cell activation 
or cell injury for MSC migration. This assay is based on the same principle as the 
scratch assay with the exception that the wound is created using silicon inserts 
instead of a pipette tip. Using these inserts also avoided problems such as 
unevenly thick gap created by cell scraping, and reattachment of floating cells in 
the wound area which then migrate towards the monolayer which have the risk of 
providing adulterated results. We used two different inserts available 
commercially from Ibidi (Figure 3.12) and Platypus Technologies Inc (Figure 
3.13).  
 
3.16.4 Ibidi inserts  
With Ibidi inserts, two cell culture compartments separated by 500 µm thick wall 
were formed when the silicon insert is placed on the 24-well plate. 300,000 cells 
were seeded in both the compartments in complete MSC media and maintained at 
37° and 5% CO2 for 24 h to allow cell attachment and formation of a confluent 
monolayer. If confluent monolayer did not form within 24h then the plates were 
maintained till 100% confluency was achieved. Removal of the silicon insert from 
the surface of the culture plate resulted in two defined cell patches separated by a 
500 µm cell free gap. Complete media was then removed and replaced with serum 
free media (DMEM+0.1% BSA). Migration into the cell exclusion zone was 
followed microscopically until the wound was completely closed or no longer 
progressing and images were analysed using Image-J with same protocol as used 
for scratch assays.  
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3.16.5 Oris-FLEX inserts  
Even though the cell exclusion zone assays with Ibidi inserts were well-
standardised, easy to set up and does not require any special analysing equipment, 
care had to be taken that the stoppers tightly attached to the tissue culture plate. In 
our experience, silicon stoppers provided by Ibidi tend to lose their plate adhesive 
properties with multiple use and cells entered the exclusion zone beneath the 
stopper. To avoid this problem, we used small silicon stoppers designed by 
Platypus Technologies Inc. that fit into each well of a 96-well plate. The 96-well 
plates were also provided by Platypus Technologies. 100,000 cells were seeded 
per well and maintained for 24 h at 37° and 5% CO2 for 24 h to allow cell 
attachment and formation of a confluent monolayer. This cell seeding density was 
chosen based on preliminary experiments looking at various cell densities 
(100,000 – 300,000 cells/ well). Complete media was then removed and replaced 
with serum free media (DMEM+0.1% BSA). Removal of the stoppers following 
cell adhesion created a 2 mm diameter circular cell free gap with sharp borders 
where the cells can then migrate to.  
Figure 3.12: Cell exclusion zone assay using Ibidi inserts. (a) Single 
Ibidi culture insert in a well plate. (b) Principle of cell exclusion zone assay 
using Ibidi inserts. Cells are grown to confluence in Ibidi culture inserts 
over 24h to allow formation of two separate monolayers. Removal of the 
insert creates a cell-free gap between the two monolayers. Cell migration 
into the gap is monitored microscopically and quantified as percentage 
reduction in wound width similar to scratch assay.  
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3.17 MSC migration in response to growth factors, cytokines, extracellular 
nucleotides   
Cytokines and growth factors tested were: CXCL12 (400 ng/ml), TGFβ3 (10 
ng/ml), FGF2 (5 ng/ml), CCL2 (30 ng/ml), CCL3 (50 ng/ml), CCL5 (50 ng/ml) 
Figure 3.13: Principle of cell exclusion zone assay using Oris-Flex inserts. 
Cells are grown to confluence in Oris-Flex culture inserts in 96-well plates 
over 24 h to allow formation of monolayer. Removal of the insert creates a 
circular cell-free gap in the middle of the monolayer. Cell migration into the 
gap is monitored microscopically. Wound diameter is measured to calculate 
the wound area. Percentage reduction in wound area over time is used to 
quantify cell migration.  
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and TNFα (50 ng/ml). The concentrations were chosen based on the 
recommended concentration on the product data sheet.  
Factors were supplemented to DMEM (1000 mg/ml glucose) with 0.1% BSA and 
the media was added directly to cell monolayers.  The effect of the following 
purine compounds were also studied: ATP (250 μM) and UTP (250 μM) and 
stable purine analogues ATPγS (Adenosine-5'-(γ-thio)-triphosphate tetralithium 
salt; 250 μM) and UTPγS (Adenosine-5'-(γ-thio)-triphosphate tetralithium salt; 
250 μM ) on SF MSC migration. Nucleotides were either supplemented to DMEM 
(1000 mg/ml glucose) with 0.1% BSA or IJCM before being added to the cell 
monolayers.  
 
3.18 Characterisation of IJCM using antibody and receptor antagonists 
against common heparin-binding chemokines  
In order to characterise and identify the MSC migration stimulatory factors 
present in the IJCM, neutralising antibodies and receptor inhibitors were used 
against common heparin-binding chemokines previously reported to influence 
MSC migration [89]. The growth factors and cytokines tested were: FGF2 
antibody (5 μg/ml), CXCL12 antibody (3.6 μg/ml), CXCR4 antagonist 
(AMD3100; 6.29 μM), TGFβ3 antibody (0.3 μg/ml), CX3CL1 antibody (1.5 
μg/ml), CCR5 antagonist (7 μg/ml) and CCR3 antagonist (10 μg/ml). The 
concentrations were chosen based on (1) preliminary studies qualitatively 
assessing MSC migration in response to various concentrations of the cytokine 
inhibitors [used for antagonists against TGFβ3 (0.0003 – 0.3 µg/ml) and CXCL12 
(0.36 – 30.6 µg/ml)] or (2) the suggested value on the antibody data sheet (used 
for all other antibodies) or based on values suggested in the literature (AMD3100) 
[90].    
IJCM samples were pre-treated with the antibodies for 15 mins at ambient 
temperature prior to adding the IJCM to the scratch assays. Confluent monolayers 
of MSCs were pre-treated with the receptor antagonists for 30 mins at 37° C 
before creation of the wound and addition of IJCM. P2 purine receptors were 
blocked in scratch assays using P2 purine receptor antagonist suramin (1 mM; 
concentration chosen based on the suggestion in the data sheet). To assess if 
injury stimulates synthesis of the factors prior to release freshly harvested 
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cartilage was injured in serum free media in the presence of the protein synthesis 
inhibitor cycloheximide (10 μg/ml; Sigma-Aldrich, UK; concentration chosen 
based on qualitative preliminary studies) and injury conditioned media was 
collected following 24 h incubation as described above. To assess the requirement 
for matrix metalloproteinases (MMPs) for the release of factors following injury 
freshly harvested cartilage was injured in serum free media in the presence of 
broad spectrum metalloproteinase inhibitor marimastat (10 μg/ml; R&D Systems, 
UK; concentration chosen based on qualitative preliminary studies) and injury 
conditioned media was collected following 24 h incubation as described above. 
 
3.19 Measurement of ATP content 
ATP content was measured using ATP bioluminescence assay kit according to the 
manufacturer’s instructions. Luciferase reagent was prepared by dissolving the 
whole content of one vial (provided in the kit) in 10 ml of dilution buffer (also 
provided in the kit) and incubating in ice without stirring or shaking for 5 mins. 
This luciferase reagent was added to the samples in the 96 well plates (50 µl 
reagent to each well) and the luminescence from the samples was measured by 
microplate reader.  
ATP standard was prepared by dissolving the content of one vial (provided in the 
kit) in dilution buffer to give a final concentration of 10 mg/ml. This working 
solution was further serially diluted with the dilution buffer in the range of 10
-6 
M– 10-12 M ATP. Luciferae reagent was added to each dilution to produce a 
standard curve. The standard curve was used to quantify the concentration of ATP 
in the samples.  
 
3.20 Induction of chondrogenesis using IJCM  
For micromass cultures of MSCs, MSCs (5×10
5
 cells/ 50 µl) were placed as a 50 
µl droplet in the middle of the wells in 24 well culture plates and cells were 
allowed to attach over 24 h. Following incubation, the medium was replaced with 
either IJCM, IJCM with ATP (250 µM) and ascorbic acid (50 µg/ml) or ATP in 
serum free media (250 µM). Serum-free standard chondroinductive medium was 
used as positive control and 10% serum containing media was used as negative 
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control. Cultures were incubated at 37ᵒC in a humidified atmosphere of 5% CO2 
for 10 days and respective media was changed every 2 days.  
 
3.21 Statistical analysis  
In this study there were two separate variables to consider as biological variable. 
Number one was the cells including both mesenchymal stem cells (MSCs) and 
chondrocytes which were harvested from different animals. Number two was the 
injury conditioned media (IJCM) which was produced from the cartilage 
harvested from different animals. However, in order to produce enough media for 
each experiment IJCM was collected from five separate animals. Therefore, the 
variability between animals for IJCM was not quantified. Hence, where 
independent experiment is mentioned it represents only the biological replicates in 
terms of cells that were harvested from different animals.  
All experiments were performed in triplicate (technical replicate) and repeated 
three times (three independent experiments). Experiments using antibodies were 
repeated five times (five independent experiments). Where the data are 
represented as bar chart, graph shows the cumulative result from three 
independent experiments (n = 3). When the data are represented as scatter plot, 
graph shows individual results which include both technical replicate and 
biological replicate. Data were analysed using GraphPad Prism (version 6.0, 
Graphpad Software, Inc.,CA, USA). Data are presented as means ± SEM. SEM 
represents the spread among individual data points (including both technical and 
biological replicate) for individual conditions. One-way ANOVA followed by 
post-hoc test (Holm Sidak) was used to calculate the statistical significance of the 
difference in cell migration in response to different conditions. Differences were 
accepted as statistically significant at P <0.05 and are indicated by either asterisks 
(*) or plus (+). 
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Chapter 4 
Isolation and characterisation of mesenchymal stem cells  
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4.1 Introduction 
The objective of this study was to isolate mesenchymal stem cells (MSCs) from 
the synovial fluid and bone marrow of the bovine metacarpophalangeal joint and 
investigate the multipotency of the cells by determining if the MSCs can 
differentiate into chondrogenic, osteogenic and adipogenic lineages. The 
differentiation potential of the MSCs for chondrogenic, osteogenic and adipogenic 
lineage was determined using by standard differentiation assays and qualitative 
analysis.  
 
4.2 Results 
4.2.1 Establishment of bone marrow and synovial fluid mesenchymal stem 
cell culture   
Synovial fluid (SF) and bone marrow (BM) MSCs were isolated from the bovine 
metacarpophalangeal joints based on their capacity of plastic adherence under 
standard culture conditions using methodology described by Jones et al for SF 
MSCs [29]. BM MSCs appeared as adherent fibroblast-like cells with long 
projections and prominent nucleoli (Figure 4.1). SF MSCs were also adherent 
cells with similar fibroblast-like morphology but were smaller in size than the BM 
MSCs and were stellate shaped (Figure 4.2). Both MSCs have similar colony 
formation process, where they underwent several rounds of cell division following 
seeding into tissue culture flasks, with resulting fibroblastic colonies, each derived 
from a single cell (CFU-Fs) clearly detectable by day 7. Each colony, derived 
from a single cell, expanded in culture and merged to form monolayers of typical 
spindle-shaped fibroblasts (Figure 4.1 and 4.2).  
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Figure 4.1: Bovine BM-MSC in 10 day culture. Cells were isolated based on 
their plastic adherence capacity. Following 4 days of culture of the isolated 
cells, small rounded cells formed long projections with adherent fibroblast-like 
appearance. At day 7, cells merged to form individual colonies called colony-
forming units (CFU). These colonies then merged together to form a single 
monolayer. Scale bar represents 200 μm. 
Bone marrow MSC 
Day 4 Day 7 
Day 8 Day 10 
200 μm 
200 μm 200 μm 
200 μm 
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Figure 4.2: Bovine SF-MSC 7 day culture. Cells were isolated based on 
their plastic adherence capacity. Initially SF-MSCs appeared as small 
stellate shaped cells. Following 4 days of culture, these rounded cells 
formed small projections and appeared to have a polygonal morphology. 
By day 5, the single cells formed individual colonies which only lasted for 
one or two days. These colonies then merged together to form a single 
monolayer by day 7. Scale bar represents 200 μm.  
Synovial fluid MSC 
Day 4 Day 5 
Day 6 Day 7 
200 μm 
200 μm 200 μm 
200 μm 
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4.2.2 Determination of multilineage differentiation capacity of in vitro 
cultured bone marrow and synovial fluid mesenchymal stem cells  
BM MSCs and SF MSCs have been shown to differentiate into several types of 
mesenchymal lineages [29]. Monolayer cultures of BM and SF MSCs derived 
from the bovine joints were subjected to classic osteogenic, adipogenic and 
chondrogenic differentiation medium according to previously reported protocols. 
BM and SF MSCs cultured in complete MSC media were used as negative 
control.  
 
BM and SF MSC micromass cultures were used to qualitatively assess 
chondrogenic differentiation. Micromass cultures were subjected to standard 
chondroinductive media or MSC complete media (control) for 21 days. 
Metachromatic staining with alcian blue, indicative of cartilage matrix was used 
to detect chondrogenesis. The periphery of the micromass cultures in 
chondroinductive media consisted of elongated cells, while the centre region 
contained rounded cells. Alcian blue staining was detected across the micromass 
but was stronger in the centre of the micromass (Figure 4.3). Moreover, stronger 
staining was observed for BM MSC micromass cultures than SF MSC cultures 
suggesting that BM MSCs may have higher chondrogenic potential than SF 
MSCs. Both the morphology of the cells and metachromatic staining were 
suggestive of cartilaginous matrix synthesis by both BM and SF MSCs. In control 
micromass cultures, lacking chondroinductive media, MSCs formed uniform cell 
layer, where BM MSCs appeared as spindle shaped fibroblastic cells and SF 
MSCs appeared as polyglonal fibroblastic cells. No alcian blue staining was 
observed in any of the control cultures for both BM and SF MSCs (Figure 4.3). 
 
Micromass cultures of MSC were also assessed for immunohistochemical 
localisation of type II collagen. All micromass cultures stimulated with standard 
chondroinductive media showed positive staining with homogenous distribution 
of intense coloration indicative of high levels of collagen type II production. No 
staining was detected in negative controls where micromass cultures were 
maintained in low glucose DMEM supplemented with 10% MSC serum (Figure 
4.3). Only SF MSC pellet cultures were used to quantitatively assess the success 
of chondrogenic differentiation. Cells from the first passage were used for pellet 
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preparation by centrifugation where a single compact pellet was formed per 50000 
cells. Pellets were subjected to standard chondroinductive media for 21 days.  
SF MSC pellets cultured in complete MSC media were used as negative control. 
The extent of extracellular matrix accumulation was assessed by measuring the 
sulphated glycosaminoglycan (GAG) content of the pellets. Average sulphated 
GAG content was 14.75 ± 6.8 µg/pellet indicating chondrogenic differentiations. 
No sulphated GAG was produced in any pellets incubated in control media 
lacking chondrogenic factors. GAG content was not measured in BM MSC 
differentiation assays.  
 
Intracellular alkaline phosphatase is a key marker of osteogenic differentiation. 
SIGMA FAST
TM
 BCIP/NBT (5-Bromo-4-chloro-3-indolyl phosphate/Nitro blue 
tetrazolium) tablets were used as immunohistochemical stains for detection of 
alkaline phosphatase activity. Staining indicated that both BM MSCs and SF 
MSCs grown in osteogenic medium produced alkaline phosphatase activity 14 
days postinduction, consistent with successful progression toward an osteogenic 
lineage (Figure 4.4). 
 
Similar number of stained cells suggested that SF MSCs has an osteogenic 
differentiation capacity similar to that of cultured BM MSCs. In controls, lacking 
osteogenic supplements, no alkaline phosphatase stained cells were observed for 
both SF MSC and BM MSC cultures. Accumulation of lipid vacuoles following 
adipogenic induction was detected using 0.5% oil red O. Red fatty vacuoles 
indicating adipogenesis were detected in both SF MSC and BM MSC cultures 
grown in adipoinductive media 14 days post-induction (Figure 4.4). However, 
fewer numbers of SF MSCs stained with Oil red O compared to BM MSCs 
suggesting that SF-MSCs might have lower adipogenic capacity than BM MSCs. 
No red staining was detected in control MSC cultures lacking adipogenic 
supplements (Figure 4.4). 
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Figure 4.3: MSCs isolated from the BM and SF differentiated into 
chondrocytes. Control cultures were maintained in MSC complete media. 
Chondrogenesis was induced by stimulating 3D micromass cultures with 
standard chondroinductive media. Alcian blue was used to detect 
glycosaminoglycan deposition and collagen II immunohistochemistry was 
used for detecting collagen II formation in the micromass cultures.  
Images were taken at x10 magnification.  
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Figure 4.4: MSCs isolated from the BM and SF differentiated into 
osteoblasts and adipocytes. Control cultures were maintained in MSC 
complete media. Osteogenesis and adipogenesis was induced by 
stimulating monolayer MSC cultures with standard osteoinductive and 
adipoinductive media respectively. Differentiation was detected using, 
alkaline phosphatase for osteogenesis and oil red for Adipogenesis.  
Images were taken at x10 magnification. 
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4.4 Chapter discussion  
MSCs were isolated from the SF and BM of the abattoir-derived bovine 
metacarpophalangeal joints based on their plastic adherence under monolayer 
culture conditions. Initially, until passage 2, MSC from each bovine joint were 
cultured in separate flasks to minimise the risk of infection. This also allowed 
observation of rate of SF MSC proliferation between different colonies (cells from 
different animals) and with their matched BM counterparts. Following plating 
both SF and BM MSC appeared as small round cells. SF MSCs consistently 
attached to the flask surface by day 2 whereas BM MSC attached between day 2 
and day 4. SF and BM MSCs also differed in their morphology. For example, SF 
MSCs were small and less prominent nucleus whereas BM MSCs had long 
projections and prominent nucleoli (Figure 4.1 and 4.2).  Longer proliferation 
time observed in our study is consistent with previous findings which showed that 
bovine SF MSC colonies had shorter population doubling times compared to BM 
MSC colonies [30].  
 
Previous studies have reported that use of plastic adherence to isolate MSC from 
various animal models including rodents, pigs, cattle and sheep. In this study we 
used a skeletally matured bovine model due to its similarities in physiology and 
organ size with the humans [89]. Moreover, due to their longer life span compared 
to the laboratory animal models, bovine experimental model is considered to be 
good for long term experiments in regenerative medicine. It has been suggested 
that cells isolated by this method contains a heterogeneous population of 
progenitor cells that have various degrees of commitment. For example, at 
passage 0, we observed a mixture of elongated spindle-shaped fibroblast-like BM 
MSCs along with small round hematopoietic cells. This is similar to previous 
reports where flow cytometry analysis showed the presence of both CD271+ 
colonies which were multipotent and entirely mesenchymal along with CD45+ 
hematopoietic lineage cells [29]. However, in contrast to BM MSC cultures, we 
did not observe any phenotypic heterogeneity in SF MSC cultures at passage 0.  
 
The source of the SF MSC is still unknown. A study by Jones et al suggested that 
SF MSC may be derived through break down of synovium [29]. Their suggestion 
is based on the finding that there was a positive correlation between the number of 
synovial microfragments and number of SF MSC. We have also observed 
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synovial microfragments in our undiluted synovial fluid samples from the bovine 
joint. However, since these fragments could also be a source for synoviocytes, 
they were removed from the diluted synovial fluid through filtration before 
centrifugation to isolate the MSCs. This reduced the number of MSCs isolated but 
allowed a homogenous population of SF MSC to be cultured.  
 
Multipotent differentiation potential of both SF and BM MSC was evaluated 
using standard inductive media as described in the methods. Previous studies have 
suggested a dose-dependent effect of ascorbic acid and FCS on osteogenic 
differentiation of BM MSC [69, 73]. Using a bovine foetal model as a source of 
BM MSC, they showed that increasing concentration of ascorbic acid led to 
higher alkaline phosphatase activity and stronger mineralisation. Similarly, 
increasing FCS concentration also led to stronger mineralisation but did not affect 
the alkaline phosphatase activity. These results suggested that osteogenic 
differentiation could be enhanced by a higher ascorbic acid concentration and 
reduction of FCS to 2% or 5% may affect the differentiation process. However, 
since we only used differentiation as a measure for validating that our isolated 
cells were MSCs, we only analysed MSC differentiation under standard condition 
of 50 µg/ml ascorbic acid and 2% FCS. At these concentrations we observed 
osteogenic differentiation of both SF and BM MSC. Our chondroinductive media 
was supplemented with TGFβ1 which resulted in the production of GAG as 
confirmed both qualitatively using alcian blue staining and quantitatively using 
DMB assay. Similar results were previously reported by other studies using the 
same concentration of TGFβ. However, these studies also reported spontaneous 
MSC differentiation in the absence of TGFβ. However, results from the 
micromass assays for both SF and BM MSCs cultured in control media (high 
glucose DMEM supplemented with 10% FCS) where no GAG formation was 
observed suggested that supplementation of chondrogenic factors was required to 
stimulate MSC differentiation.  
 
Using the standard inductive media, cultured SF and BM MSCs differentiated into 
chondrogenic, osteogenic and adipogenic lineages (Figure 4.3 and 4.4). However, 
SF MSC had lower adipogenic capacity than BM MSC. This is in agreement with 
results reported by Jones et al [29] which suggested that even though both SF and 
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BM MSCs had the potential to differentiate into bone, cartilage and fat, normal SF 
MSCs are considerably different in their phenotype from their BM counterparts.   
Methods for studying MSC migration 
 
90 
 
 
Chapter 5 
Methods for studying MSC migration  
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5.1 Objective  
To assess MSC migration using the commonly used migration assays such as 
transwell assay, scratch assay and cell exclusion zone assay.  
 
5.2 Chapter Introduction  
Even though the commonly used migration assays are widely used and can 
reliably detect differences in cell migration in response to various stimuli, there 
are insufficient reports in the literature on assessment of bovine and human SF 
and BM MSC chemotactic migration using these techniques. The aim of this 
study was to optimise the conditions of the common migration assays to study 
bovine and human MSC migration in response to various stimuli. The three assays 
optimised in this study were Transwell assay, Scratch assay and Cell exclusion 
zone assay.    
 
5.3 Results  
5.3.1 Imaging membranes following Transwell migration assay  
Transwell assays were carried out according to the protocol described in the 
methods (Section 3.16.1). Initially, fixed membranes were imaged under a light 
microscope using x4, x10, x20 and x40 lens (Figure 5.1a). Even though at x4 and 
x10 it was possible to identify the migrated cells, only using x20 and x40 it was 
possible to distinguish the lower openings of the membrane pores from the upper 
openings (Figure 5.1b). Between x20 and x40, x20 was chosen as the 
magnification for all subsequent experiments because it allowed imaging of 
greater membrane area. 5 different microscopic fields were imaged per membrane 
at x20 magnification for all subsequent experiments. Once, the membrane was cut 
out of the well, it’s orientation with shiny side on the top also allowed to 
positively identify the location of the cells on the lower side of the membrane.  
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Figure 5.1: (a) Bovine SF-MSC migration in response to serum-free 
media and media supplemented with 5% serum. Same membrane was 
imaged at various magnifications to identify the optimal magnification for 
digital imaging which will then be used to quantify the number of migrated 
cells. x4 magnification allowed visualisation of greater membrane area 
however, it was more difficult to distinguish between cells which might lead 
to inaccurate quantification of the number of migrated cells. Only at x20 and 
x40 could individual cells be reliably identified.   (b) Migration of BM and 
SF MSC to 5% serum imaged at x20 magnification. Cells were stained 
with crystal violet and the clear holes are the pores in the membrane through 
which the cells migrate (red arrows). BM MSCs had wider cytoplasmic 
projections compared to SF MSCs. The cell morphology of the migrating 
cells was similar for both MSCs.   
(b) 
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5.3.2 Influence of collagen and fibronectin pre-coating on MSC migration in 
Transwell assay  
Influence of pre-coating the lower side of the membrane on chemotactic migration 
was tested using SF MSCs [88]. Membrane was either pre-coated with collagen or 
fibronectin by incubating the lower side of the membrane with the ECM solution 
for an hour. ECM solution did not touch the upper side of the membrane. A 
significant increase in SF MSC migration was observed when the membrane was 
pre-coated with fibronectin compared to control with all serum concentrations. 
For example, 0.5 fold increase in migration (p<0.05) at 0% serum concentration, 
0.9 fold increase (p<0.05) at 1% serum concentration and 1.4 fold increase at 10% 
serum concentration (p<0.05) was observed with fibronectin coating compared to 
collagen coating. Moreover, a serum concentration dependent significant increase 
in migration was observed with fibronectin coating which was not seen with 
collagen coating (Figure 5.2).  Hence, lower side of the membrane was coated 
with fibronectin for all further experiments to increase the sensitivity of the 
migration assay.  
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5.3.3 Assessment of MSC migration in response to varying concentration of 
serum in Transwell assay  
Both SF and BM MSCs migrated in the absence of serum in the media 
(DMEM+0.1% BSA). Presence of serum significantly increased SF MSC 
migration such that at SF MSC demonstrated a 0.8 fold increase (p<0.001) in 
response to 1% serum and 0.5 fold (p<0.0001) to 5% serum compared to 0% 
serum (Figure 5.3 and 5.5). Significant increase in BM MSC migration was 
observed only in response to 5% serum (3 fold increase (p<0.0001) compared to 
0% serum) (Figure 5.4 and 5.5).  Since significant migration was observed in 
response to 5% serum with both SF and BM MSCs but not with 1% serum with 
BM MSCs, 0% serum concentration was chosen as negative control and 5% 
serum concentration was chosen as positive control for all subsequent transwell 
migration assays. These results also suggested that the optimised protocol allowed 
reliable induction and determination of MSC migration in response to a 
chemoattractant stimulus.   
 
Figure 5.2: Influence of membrane pre-coating on number of 
migrated cells. Graphs showing mean number of migrated cells ± SEM. 
Membranes were either pre-coated with collagen or fibronectin and SF-
MSC migration were assessed at various serum concentrations. 
Fibronectin pre-coating significantly increased MSC migration in 
response to all serum concentrations compared to fibronectin. * and ** 
p<0.05.   
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Figure 5.3:  Migration of bovine SF MSCs over 24 h in response 
to various serum concentrations. Representative image of one 
microscopic field at x20 magnification is shown here. Membranes 
were stained with crystal violet. Visually, an increase in migration 
with increase in serum concentration was seen. However, no such 
linear relationship was observed when the number of migrated cells 
was quantified. 
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Figure 5.4: Migration of bovine BM MSCs over 24h in response to 
various serum concentrations. Representative image of one 
microscopic field at x20 magnification is shown here. Membranes were 
stained with crystal violet. Visually, an increase in migration with 
increase in serum concentration was seen. However, no such linear 
relationship was observed when the number of migrated cells was 
quantified. 
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(a) 
(b) 
Figure 5.5: Migration of bovine (a) SF and (b) BM MSCs over 24h in 
response to various serum concentrations. Graphs showing mean 
number of migrated cells ± SEM. (a) Presence of serum significantly 
increased the number of migrated SF MSCs. However, no significant 
increase was observed when the serum concentration was increased from 
1% to 5%. (b) In contrast, no significant increase in migration was 
observed in response to 1% serum compared to serum free media with 
BM MSCs. Significant increase was only observed with 5% serum. *** 
p<0.001 and **** p<0.0001 compared to 0% serum concentration.  
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5.3.4 Assessment of MSC migration at multiple time points in Transwell 
assay 
Migratory potential of MSCs was evaluated at multiple time points to optimise the 
time of the migration assay. Migration assay was terminated at 4 h, 8 h and 24 h. 
Our MSC cultures suggested that neither SF- nor BM MSCs proliferated within 
any of these time points which are in agreement with previous findings [91, 92].  
Number of migrated cells was quantified following termination of assay at each 
time point. Significant increase in SF MSC migration in response to 5% serum 
concentration (positive control) compared to 0% serum concentration (negative 
control) was only observed following 8 h migration (p<0.05) and maintained at 24 
h migration (p<0.05) but not after 4 h migration (Figure 5.6 and 5.8). In contrast, 
5% serum concentration significantly increased BM MSC migration compared to 
0% serum concentration at all three time points (p<0.05) (Figure 5.7 and 5.8). 
Since, significant increase in migration was observed at both 8 h and 24 h for SF 
and BM MSCs, 24 h was chosen as the duration of the assay in order to allow 
maximum time for MSC migration.  
 
Post-hoc (Holm Sidak) analysis followed by one-way ANOVA suggested a 
significant increase in SF MSC migration with time in response to 5% serum 
concentration (p<0.05). For example, 2.1 fold increase (p<0.05) in migration at 8 
h and 1.9 fold increase (p<0.05) in migration at 24 h was observed compared to 4 
h. Significant increase in migration in response to 0% serum concentration was 
only observed following 24 h migration. 0.6 fold increase in migration at 8 h and 
1.6 fold increase (p<0.05) in migration at 24 h was observed compared to 4 h. In 
contrast, significant increase in migration was observed with time for both 0% and 
5% serum concentration with BM MSC. For example, 2 fold increase (p<0.01) 
and 2.4 fold increase in migration (p<0.05) was observed compared to 4h for 0% 
serum concentration. Similarly, 2.8 fold increase in migration (p<0.05) was 
observed at both 8 h and 24 h compared to 4 h with 5% serum concentration.       
 
Pearson product-moment correlation suggested that there was a strong correlation 
between number of migrated cells over time for SF MSC with 0% serum 
concentration (R
2
 = 0.98) and for BM MSC with 5% serum concentration (R
2
 = 
0.87). Only a weak correlation was observed for SF MSC with 5% serum 
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concentration (R
2
 = 0.36) and for BM MSC with 0% serum concentration (R
2
 = 
0.58). ANOVA analysis of the correlations suggested that the regressions were 
not statistically significant indicating that migration assay time cannot be used to 
predict the number of migrated cells.   
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Figure 5.6: Bovine SF-MSC migration in response to serum 
free media and media containing 5% serum over time. 
Membranes were stained with crystal violet. Representative image 
of one microscopic field at x20 magnification is shown here. 
4 h 
8 h 
24 h 
SF MSC 
Negative control Positive control  
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Figure 5.7: Bovine BM-MSC migration in response to serum 
free media and media containing 5% serum over time. 
Membranes were stained with crystal violet. Representative image 
of one microscopic field at x20 magnification is shown here. 
4 h 
8 h 
24 h 
BM MSC 
Negative control Positive control  
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(a) 
(b) 
Figure 5.8: Graph showing the mean number of migrated cells ± SEM 
over time. Assays were terminated at 4 h, 8 h and 24 h and number of 
cells was quantified at each time point. * p<0.05 and ** p<0.01 compared 
to 4 h for respective controls. 
(a) 
(b) 
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5.3.5 Assessment of human bone marrow mesenchymal stem cell migration in 
Transwell assay   
Following establishing that chemotactic migration of bovine MSCs can be studied 
using the Transwell assay system, we assessed human bone marrow mesenchymal 
stem cell (hBM MSC) migration in the Transwell assay. The lower side of the 
membrane was coated with fibronectin and the assay was set up as described 
previously for bovine MSCs. Following assay termination, cells were stained with 
crystal violet and imaged using light microscopy. Migrated cells could be reliably 
identified at x20 magnification. Number of migrated cell was counted in 5 
different microscopic fields as described before for bovine MSCs [93] (Figure 
5.9). 
 
Similarly to bovine BM MSCs, hBM MSCs migrated in the absence of serum. No 
significant difference in migration was observed in the presence of 0.1% serum in 
the media. However, a serum concentration dependent significant increase in 
migration was observed between 1% serum concentration and 10% serum 
concentration. For example, 0.6 fold increase (p<0.001) in migration was 
observed in response to 1% serum compared to 0% serum and 0.4 fold increase 
(p<0.001) in migration was observed at 10% serum compared to 1% serum 
(Figure 5.10). These results suggested that Transwell assays could be used to 
study MSC migration in response to a chemoattract.   
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Figure 5.9: Human BM MSC migration over 24 h in response to 
various serum concentrations. Membranes were stained with crystal 
violet.  Representative image of one microscopic field at x20 
magnification is shown here.  
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5.3.6 Quantifying cell migration using calcien AM: comparison between 
calcein AM and crystal violet staining method 
Two different cell types were used to compare calcein-AM and crystal violet 
staining as methods for quantifying the number of migrated cells. With crystal 
violet staining, cells need to be manually counted which is time consuming. In 
contrast, calcein-AM allows rapid analysis of cell migration as the fluorescence 
can be read immediately using the microplate reader within 7 mins. However, 
crystal violet allowed direct measurement of the number of migrated cells whereas 
calcein-AM provides a comparative value in relative fluorescence unit (RFU) 
among different stimuli. The RFU can be converted to number of migrated cells, 
Figure 5.10: Migration human BM MSCs over 24 h in response to 
various serum concentrations. Graphs showing mean number of migrated 
cells ± SEM. Presence of 0.1% serum did not significantly increase MSC 
migration compared to serum free media. However, 1% serum significantly 
increased migration compared to both serum free media (p<0.001) and 0.1% 
serum (p<0.001). Similarly, 10% serum significantly increased migration 
compared to serum free media (p<0.0001), 0.1% serum (p<0.0001) and 1% 
serum (p<0.001).  *** p<0.001 and **** p<0.0001  
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but this requires a standard curve. Moreover, the results suggested that there was a 
difference in the fluorescence reading depending on if the plate was read from the 
top or from the bottom on the plate reader.  
 
Using top reading, no significant difference in migration with increasing serum 
concentration was observed with bovine SF MSCs (bSF MSCs) and only a 
significant increase was observed at 10% serum concentration with human BM 
MSCs (hBM MSCs) (Figure 5.11). In contrast, when the same reading was taken 
from the bottom a significant increase was observed with 10% serum 
concentration in bSF MSCs and with 1% and 10% serum concentration in hBM 
MSCs. This suggested that bottom reading was more reliable at discriminating 
between the numbers of migrated cells at different serum concentrations and 
caused by the migrated cells settling on the bottom of the lower collecting well.  
 
When crystal violet was used to quantify the number of migrated cells in the same 
experiments, a serum concentrated dependent increase in migration was observed 
with hBM MSC over a range of 1-10% FCS. Although this serum concentration 
dependence was not observed with bSF MSC 1 and 10% FCS, a significant 
difference in migration was observed between presence and addition of 1% serum 
in the media (Figure 5.11). This suggested that even though the crystal violet 
method was more time consuming, it was more sensitive and reliable in detecting 
a difference in migration between different chemoattractants. Hence, we used 
crystal violet as out method of staining to quantify the number of migrated cells 
unless a rapid analysis was required.  
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Figure 5.11: Migration of bovine SF MSC (left column) and human BM 
MSC (right column) in response to various serum concentrations 
quantified either using calcein-AM (a-d) or crystal violet (e-f). 
Fluorescence reading from the bottom of the plate was more sensitive at 
detecting differences in migration in response to different serum 
concentrations compared to reading taken from the top of the plate. Further, 
crystal violet was more sensitive at detecting differences in migration in 
response to different serum concentrations compared to calcein-AM.  
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5.3.7 Assessment of MSC migration using scratch assays 
Scratch assays were carried out according to the protocol described in the methods 
(Section 3.16.3) in response to serum free media to establish cell seeding density 
and duration of migration assay. Since little migration was observed over 30 h 
(Figure 5.12), and the Transwell assays were carried out for 24 h, 24 h was chosen 
to be the duration of the SF MSC scratch assay. All further experiments involving 
SF MSCs were terminated following 24 h and serum free media was used as 
negative control. Reduction in wound width over 24 h was calculated using the 
formula below to quantify MSC migration in scratch assays (Figure 5.13).  
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Figure 5.12: Migration of bovine SF MSCs in response to serum 
free media (DMEM+0.1% BSA) was evaluated using the 
monolayer scratch assay. Migration was monitored microscopically 
at a regular interval and imaged at 0 h (immediately following 
creation of the wound), 6 h, 24 h and 30 h. Please scan the QR code 
to watch the time-lapse video of SF MSC migration in scratch assay. 
SF MSC 
0 h 6 h 
24 h 30 h 200 μm 
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Figure 5.13: Reduction in wound width was measured to quantify MSC 
migration over 24 h. Width was measured as described in the methods and 
averaged to get the wound width at 0 h (immediately following creation of 
the wound) and 24 h following creation of the wound. Reduction in wound 
width was measured by subtracting wound width at 0h from wound width at 
24 h. Migration was quantified as percentage reduction in wound width using 
the formula: . Please scan the QR code to watch 
how this analysis was done used Image-j.  
0 h 24 h 
200 μm 
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When the same protocol was followed to carry out scratch assays using bovine 
BM MSCs, using serum free media as negative control, cells detached from the 
plate over 24 h (Figure 5.14). 
 
 
 
 
 
 
 
 
 
 
 
In order to avoid this problem, plates were fibronectin-coated by incubation in 6.5 
µg/ml of fibronectin for 1 h at 37°C. Migration was followed over 24 h with 
images taken at T0 (time of creation of wound), T6 (6 h after creation of wound), 
T17 (17 h after creation of wound) and T 24 (24 h after creation of wound). MSCs 
maintained their plastic adherence till T17 but lost this attachment at T 24 (Figure 
5.15). Hence, all further scratch assays involving BM MSCs were carried out in 
fibronectin pre-coated plates and terminated after 17 h (T17) from the creation of 
the wound.   
Figure 5.14: Migration of bovine BM MSCs was evaluated using the 
monolayer scratch assay. BM MSCs lost their plastic adherence 
following 24 h migration in serum free media (DMEM+0.1% BSA).  
0 h 24 h 
200 μm 
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In the scratch assays, migrating SF MSCs formed elongated spindle-like cell 
bodies, displaying two directional-polarities, with two elongated leading edge one 
in the direction of the gap and the second to maintain contact with the cells in the 
monolayer. Migrating cells make multiple contacts either with the same cells or 
with several different cells in the monolayer to preserve the functional cell-cell 
junctions (Figure 5.16 a). BM MSCs exhibit a different mode of migration 
compared to SF MSCs and migrate collectively as sheets of cells (Figure 5.16b).  
 
 
 
 
Figure 5.15: Migration of bovine BM MSCs evaluated in monolayer 
scratch assays. Plate wells were pre-coated with fibronectin prior to cell 
seeding. BM MSCs retained their plastic adherence in fibronectin coated 
plates for 17 h but this adherence following 24 h migration. Hence, all 
scratch assays were performed over 17 h in fibronectin pre-coated plates.   
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5.3.8 Assessment of MSC migration using cell exclusion zone assays 
Cell exclusion zone assays were used to assess the requirement for cell activation 
or cell injury for MSC migration. We tested two different inserts available 
commercially from Ibidi (Figure 5.17) and Platypus Technologies Inc (Oris-FLEX 
inserts) (Figure 5.18).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.16: Mode of bovine SF MSC (a) and BM MSC (b) 
migration in scratch assays. SF MSCs form elongated spindle-like 
projections with bi-directional polarities. BM MSCs in contrast 
migrate collectively as sheets of cells.  
(a) 
(b) SF MSC BM MSC 
40 μm 
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Figure 5.17: Bovine SF MSC migration was evaluated in cell 
exclusion zone assay using Ibidi inserts. Images were taken at x4 
magnification and x10 magnification at 0 h (immediately following 
creation of wound) and 24 h after creation of wound. Image taken at x10 
magnification was optimal for image analysis and measurement of 
wound width.    
0 h 24 h 
x4 
x10  
500 μm 
200 μm 
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Figure 5.18: Bovine SF MSC migration was evaluated cell exclusion zone 
assay using Oris-FLEX inserts. Images were taken at x4 magnification at (a) 
0 h immediately following creation of wound) and (b) 24 h after creation of 
wound. Only at this magnification it was possible to visualise the entire wound 
area. Wound area was calculated from the diameter of the wound. Reduction in 
wound area was used to quantify cell migration. (c, d) However, problems 
involved calculating wound closure using this method since not all wounds 
closed in perfect circles.  
 
500 μm 
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5.4 Chapter Discussion  
In this study the conditions were optimised for three different assays to assess in 
vitro migration of bovine and human MSC. Three different tissue sources of 
MSCs were tested. These were were bovine SF MSC, bovine BM MSC and 
human bone marrow MSC (hBM MSC). Previous studies have reported the use of 
Transwell assays to investigate hBM MSC [88]. However, it was still important to 
establish the protocols and conditions for the analysis of bovine MSC migration in 
response to the serum stimulus and reliably detect the migrated cells for this 
study. Five conditions were investigated to optimise the Transwell assays. These 
included identifying the positive and negative controls, point of assay termination, 
influence of pre-coating the membrane with ECM protein, magnification at which 
to image the membrane and method for quantifying the number of migrated cells.  
 
Serum has previously been reported to be a potent inducer of MSC migration [88]. 
In this study, it was found that both bovine and human MSCs can migrate in the 
absence of serum but presence of serum significantly enhanced this migration. A 
serum concentration-dependent increase in migration with bovine MSCs was not 
observed in that a higher migration was observed with 1% serum compared to 5% 
with bovine SF MSCs (Figure 5.5a), suggesting that 1% serum gave a maximal 
response. Similarly, a higher migration was observed in response to 5% serum 
compared to 10% serum concentration with bovine BM MSCs which suggested 
that 5% FCS may have been optimal for these MSCs (Figure 5.5b). In contrast, a 
serum concentration dependent level of migration was observed with hBM MSCs 
in  (serum concentrations ranging from 1-10%) (Figure 5.10). 
 
It is possible that the difference observed between human and bovine MSCs was 
most likely due to a species difference.  Alternatively, there are reports [69] of 
rapid decrease in MSC migratory capacity following brief period of in vitro 
culture. One in vivo study observed a 10% reduction in migration of culture-
expanded murine BM MSCs to the BM compared to freshly isolated BM MSCs. 
They suggested that the most likely reason for this loss of migration capacity was 
the alteration of the migration molecules present on the surface of the cells during 
their in vitro incubation. These include cytokine receptors and adhesion molecules 
and indeed loss of integrin β1, SH3 and ICAM-1 and reduction in production of 
extracellular molecules have been previously reported following in vitro culture of 
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human MSCs [94]. It may be possible that the human MSCs were more sensitive 
to these effects of in vitro culture than the bovine MSCs and this accounted for the 
difference between the cell types.  
 
Moreover, since extended period of culture and repeated passaging affects the 
MSC phenotype, the bovine MSCs were used within passage 1-3 for these 
experiments. In combination with avoiding cross contamination between animals 
and using the MSCs at low passage number, these experiments were performed 
such that each serum concentration was tested on MSCs from different animals. 
Therefore, it was also possible that the apparent lack of serum concentration 
dependent migration for the bovine MSCs was due to intra-animal variation in 
migration capacity. Further, it is also possible that the expression of receptors on 
the surface of the MSCs isolated from bovine and human sources are different by 
their natural physiology. Hence, the differences observed were simply due to 
differential expression of surface molecules between the two species.  
 
In order to minimise the variabilities in the succeeding migration experiments, 
bovine SF and BM MSCs were isolated from several animals and they were 
cultured  separately until P1 (passage one) to avoid cross contamination if one 
sample became infected with microbial or fungal contamination. From P2-P3  
MSCs from the different animals were pooled for each type of MSCs. Samples of 
the pooled MSCs at P1 were stored in liquid nitrogen so that all repeats of the 
experiment were carried out using the same cells to ensure consistency in the 
results. Further, all MSCs were cultured in serum which had been specially tested 
and validated to support the clonal enumeration and expansion of MSCs by the 
manufacturer. All repeats of the same experiment or comparative experiments 
were performed using the same lot of serum to avoid variations in culture that 
may arise from the lot to lot variation of the serum.  
 
These experiments also demonstrated the importance of fibronectin in MSC 
survival. For example, it was observed that pre-coating the Transwell membranes 
with fibronectin induced higher MSC migration compared to collagen coating. 
Furthermore, the BM MSCs did not survive in 24-well tissue culture plates in the 
absence of serum and cell survival in serum-free medium was only promoted 
following pre-coating of the well plates with fibronectin. Fibronectin is a dimeric 
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glycoprotein organised into fibrils to form the insoluble ECM. Many studies have 
reported the importance of fibronectin interaction with the cell surface receptors in 
regulating various cell functions such as growth, adhesion, differentiation and 
migration. One study has suggested that fibronectin regulates MSC migration 
through α5β1-integrin mediated activation of platelet-derived growth factor 
receptor (PDGFR)-β [95]. The report showed that binding of integrin present on 
the MSC surface to fibronectin promoted PDGFR- β receptor clustering and 
association which in turn led to autophosphorylation of the PDGFR-β and 
provided the docking sites for the downstream signal transduction molecules. 
These molecules included phosphoinositide 3-kinase (PI3K) which stimulated 
actin reorganisation and mediated MSC migration, phospholipase Cγ (PLCγ) 
which promoted cell motility and growth and Src family tyrosine kinase which 
affected cell proliferation. They also found that PDGFR-β mediated cell migration 
was specifically regulated by binding to specific ECM ligands such that binding to 
fibronectin and not to laminin induced autophosphorylation of the receptor. 
Therefore, it was possible that the increased migration observed with fibronectin 
pre-coating of the Transwell membranes compared to collagen pre-coating; might 
be regulated in the same manner such that fibronectin and not collagen was more 
potent at inducing receptor autophosphorylation. Also, since the 
autophosphorylation of the receptor occurred in the absence of growth factors, it 
was possible that fibronectin pre-coating of the tissue culture plates promoted BM 
MSC survival in the similar manner in the absence of serum in the media.   
 
In the experiments presented in this thesis we used both Transwell and scratch 
assays to validate MSC migration in response to various stimuli. Using two 
different assays allowed validation of MSC migration both at the single cell level 
in the absence of cell-cell contact Transwell assay) and as sheet of cells with 
intact cell-cell contact (scratch assay). However, compared to Transwell assays, 
scratch assays were easier to set up and maintain to monitor MSC migration for a 
longer period of time. Moreover, the ability to monitor cell migration at a regular 
interval without needing to terminate the assay meant that cultures could be 
monitored until migration was complete or no longer progressing.  
 
Cell exclusion zone -based migration assays using two different commercially 
available silicon inserts were also investigated for the bovine SF and BM MSCs. 
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The rationale for using this approach is that in the migration assay no stimulation 
of the MSCs occurs immediately prior to the addition of media containing 
migratory factors). Both in the Transwell system and scratch assay the cells are 
subjected to physical and or chemical stimulation of the MSCs immediately prior 
to addition of the media samples. i.e. in the Transwell system the MSCs are 
subjected to trypsinisation and centrifugal forces and in the scratch assay the cell 
layer was wounded . 
 
In the exclusion zone assay it was observed that Oris-FLEX stoppers provided by 
Platypus Technology were more durable such that it retained its adhesion capacity 
with multiple uses. In contrast, Ibidi inserts lost their plastic adherence following 
one-time use. This meant new inserts needed to be purchased frequently which 
was not economical. However, Ibidi inserts allowed easier comparison of data 
between scratch assays and cell exclusion zone assays since both allowed 
measured of % reduction in wound width compared to % reduction in wound area 
(Oris-FLEX).  
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Chapter 6 
Migration of mesenchymal stem cells to injured cartilage  
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6.1 Objective 
The objective of the following experiments were 1) to determine the level of cell 
death after cartilage injury by sharp and blunt trauma and 2) to determine if 
Mesenchymal stem cells (MSCs) isolated from the SF and BM of the bovine 
metacarpophalangeal joint migrate towards injured cartilage in response to the 
injury.  
6.2 Chapter introduction  
It is essential to understand the natural healing mechanism following cartilage 
damage to develop treatments designed to augment that repair. Increasing 
evidence suggests the importance of MSCs as repair cells in wound healing and 
inflammatory diseases. Microfracture technique where the repair is mediated 
completely by the proliferation and differentiation of BM MSCs [27] 
demonstrates the importance of BM MSCs as a source of repair cells for cartilage 
injury. More recently, MSCs have been identified in synovial fluid (SF) [28-30] 
which increased 7-fold in arthritic patients compared to normal patients. This 
suggested that SF MSCs may also play a role in homeostatic repair during 
cartilage diseases. 
Previous studies have also reported the migration capacity of MSCs to the injury 
site in other tissues such as fractured bone, traumatic brain injury, lung injury, 
liver injury, acute renal failure, acute burns and radiation-induced injuries [89]. 
For example, MSC recruitment to the site of the fracture occurred within 1 day of 
the injury although the exact mechanism and source of MSC is still unknown [96]. 
Studies have suggested a combined source of BM, adjacent soft tissues, 
periosteum, peripheral blood vessel walls and peripheral blood [89]. An increase 
in circulating MSC-like cells in peripheral blood of acute burn patients have also 
been reported, with higher number of cells found in young patients with more 
extensive burns [97]. The study suggested that MSCs were mobilised into the 
bloodstream through acute burn signals although this hypothesis has not yet been 
confirmed. Bone sarcoma and obstructive apnoea studies have also suggested a 
similar MSC mobilisation where an increase in circulating MSC was reported 
compared to healthy individuals [89]. Therefore, MSC recruitment to the injured 
tissue and their consequent participation in the reparative process may be part of 
the natural healing process. 
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The aim of this study was to develop an in vitro model to investigate SF and BM 
MSCs migration in response to injured cartilage. We also compared the migration 
of MSCs towards injured cartilage with non-injured and dead cartilage.  
 
6.3 Results 
6.3.1 Cartilage injury assessed through live/dead staining 
Prior to mechanically injuring the cartilage it was important to establish that non 
injured cartilage i.e. freshly isolated cartilages had recovered from any injury 
caused by harvesting using a scalpel. Hence, freshly isolated cartilage pieces were 
rested in media (as described in section 3.4.1) with 10
-7
M dexamethasone. The 
rested cartilages were stained (CMFDA and PI), fixed and imaged using confocal 
laser scanning microscopy. No obvious region of cartilage damage was observed. 
However, some dead chondrocytes could still be seen (Figure 6.1b). The rested 
discs were then injured using a no.11 scalpel blade with a single, linear cut, 
caused by passing the blade once through the middle of the discs in a straight line 
(Figure 6.1a). Sharp injury led to splitting of the matrix and chondrocyte death 
along the edges of the injury (Figure 6.1c). Even though the number of dead cells 
was not quantified, a greater area of chondrocyte death was observed following 
injury compared to the rested cartilage control.  
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Figure 6.1: Assessment of cartilage injury. (a) In order to obtain injured 
cartilage, each cartilage disk was subjected to several cuts using a no.11 
scalpel blade. Red arrow showing the direction of the cuts, with the cartilage 
cut in push-through mode passing the scalpel blade perpendicular to the long 
axis of the discs in straight lines. Each scalpel injury was made in the same 
direction and next to each other for standardisation of the injury. Cartilage 
remained submerged in media during creation of injury to prevent cartilage 
drying. Cartilage disks (imaged at ×10 magnification). Green cells (cells 
stained with CMFDA) represent live cells and red cells (cells stained with PI) 
represent dead cells. Cartilage disks were placed in DMEM supplemented 
with 10
-7
 M dexamethasone immediately following collection and maintained 
in the media for 72h. (b) Control disks with no protocol based cuts had no 
obvious region of injury but few cell deaths were still observed. (c) Following 
creation of sharp injury, localised chondrocyte death was observed along the 
edges of the injury.  
Control  Sharp injury   
(a) 
(b) (c) 
200 μm 
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6.3.2 Assessment of cartilage damage following sharp and blunt injury 
Chondrocyte viability following sharp and blunt injury was assessed using 
CMFDA and PI and imaged using CLSM. Sharp injury was induced by No. 22 
scalpel blade attached to a No. 4 scalpel handle and a metal biopsy punch. The cut 
was made by passing the blade once through the cartilage surface from the top of 
the cartilage to the bottom of the cartilage in a straight line. Blunt injury was 
produced using a Swiss style hammer. Injury was induced once with the specified 
tool with no additional sliding or rotational movement. Following injury, each 
explant was immediately stained with CMFDA and PI and fixed for microscopy.  
 
Both No. 22 scalpel blade and the metal punch produced a fine linear injury with 
chondrocyte death confined to the edges of the injury (Figure 6.2a and b). 
Chondrocyte death from the hammer impact was more diffused and spread out 
from the region of impact (Figure 6.2c).  
 
 
 
 
 
 
 
 
 
Migration of mesenchymal stem cells to injured cartilage 
 
126 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2: Both sharp and blunt injury causes chondrocyte death 
around the edges of the injury. Yellow arrow points to the region of 
injury. All images were taken at ×5 magnification. (a) No.22 scalpel 
blade (sharp injury) (b) biopsy punch (sharp injury) (c) hammer (blunt 
injury). Immediately following injury, chondrocyte death was localised 
around the cut or region of impact.  
(a)  (b)  
(c)  
No. 22 Scalpel blade    Metal biopsy punch    
Hammer     
200 μm 
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6.3.3. Assessment of chondrocyte viability 2 h following sharp and blunt 
injury  
Chondrocyte viability was also assessed 2 h after mechanical injury of the 
cartilage discs. Following injury explants were incubated in high glucose DMEM 
for 2 h before being processed for CLSM imaging. There was increase in 
chondrocyte death for both blunt and sharp injury. However, chondrocyte death 
seemed to spread at a higher rate from the region of impact with blunt injury 
compared to sharp injury.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Following injury chondrocyte death increases with 
time. This increase is greatly enhanced in blunt injuries 
compared to sharp injuries. Arrows point to the region of wound 
creation and impact. All images were taken at ×5 magnification. 
Note: The 0 h images shown here are same as those shown above 
in figure 6.2.  
0h  
2h  
Puncher   Hammer    No. 22 Scalpel blade    
Sharp injury  Blunt injury  
200 μm 
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6.3.4 MSCs migrate specifically to the site of the cartilage injury 
To investigate if the MSCs can respond to injured cartilage, SF MSCs were 
labelled with PKH67 and incubated with injured cartilage for 24 h (Figure 6.4a). 
Cartilage injury was created by cutting the cartilage surface multiple times with a 
scalpel blade (Figure 6.4b, c and d). Following 24 h, injured cartilage explants 
were imaged using fluorescence microscopy. SF MSCs specifically aligned along 
the edges of the injury (Figure 6.4e, f and g) suggesting that MSCs can respond to 
cartilage injury and can migrate specifically to the injury site where they might be 
involved in repairing the injury.  
Migration of mesenchymal stem cells to injured cartilage 
 
129 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4: Migration of fluorescently labelled SF MSCs in response to 
injured cartilage. Freshly harvested articular cartilages were ‘rested’ by 
incubating in chondrocyte culture media for 72 h. cartilages were then 
washed with PBS and injured by cutting the surface several times with no.11 
scalpel blades. Injured cartilage was incubated for 4 h with the PKH67 
labelled SF MSCs. (a) Fluorescently labelled SF MSCs prepared by 
incubating the cells with PKH67. (b) (c) (d) Phase contrast microscopy 
showing the edges of the scalpel cut injury indicated by the white arrows. (e) 
(f) (g) Fluorescent microscopy showing SF MSCs aligned along the edge of 
the injury.  
(a) 
200 μm 
(b) (c) (d) 
(e) (f) (g) 
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6.3.5 Migration potential of SF MSC to injured cartilage  
Migration potential of SF MSC to injured cartilage was evaluated using the 
Transwell migration assay. Serum free media supplemented with 0.1% BSA was 
used as negative control and media with 0.1% BSA and 5% serum was used as 
positive migration control. Devitalised cartilage was produced by the freeze-
thawing technique described in section 3.4 and non injured cartilage produced by 
resting in medium for 72 h. On completion of the assay, a significant 0.6 fold 
increases (P<0.05) in migration was observed with MSCs inresponse to injured 
cartilage compared to control. Even though no increase in migration was observed 
in response to dead cartilage compared to control, 1.8 fold increases (P<0.05) in 
SF-MSC migration was observed in response to non injured cartilage (Figure 6.5). 
Following termination of the migration assay, the viability of each cartilage disk 
was assessed using PrestoBlue assay. All non injured cartilages and injured 
cartilages were found to be viable and dead cartilages were non-viable at the time 
of the experiment.  
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6.3.6 Migration potential of BM MSC to injured cartilage  
The experiment was repeated using BM MSCs and the number of migrated cells 
was quantified using crystal violet. DMEM/0.1% BSA was used as negative 
control and DMEM/0.1% BSA+ 5% FCS were used as positive control. Again 
devitalisation of the dead cartilage was achieved using freeze-thawing and the 
cartilage was rested for 72 h in culture medium to give non injured cartilage. 
Following 24 h migration assay BM MSCs showed an increase in migratory 
capacity to the positive control (1.2 fold) (P<0.05), injured cartilage (1 fold) 
(P<0.05), dead cartilage (1.4 fold) (P<0.05)  and living cartilage (0.9 fold) 
(P<0.05)  compared to control (Figure 6.6).  Therefore, in these experiments 
MSCs not only migrated to living cartilage but they also migrated to dead 
cartilage.  
 
 
 
Figure 6.5: Migration of SF-MSCs in response to injured, non-injured 
and dead cartilage. Cells were stained with calcein-AM.  Preliminary data 
suggested that SF-MSCs have the capacity to migrate in response to both 
injured and non-injured cartilage but not dead cartilage. Following staining 
with calcein-AM, cells where detached from the insert membranes and the 
fluorescence was read at an excitation >485 nm and emission at 520 nm. 
*P<0.05. 
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Figure 6.6: Migration of BM MSCs in response to injured, non-injured 
and  dead cartilage. (a). Membranes were stained with crystal violet. (b). 
Number of migrated cells in 5 microscopic fields were counted and data 
expressed as mean number of migrated cells per 5 fields in 3 membranes ± 
SEM. (c). Normalised mean was calculated by subtracting the mean of each 
variable from the mean of DMEM+0.1% BSA (negative control). Data 
suggests that MSCs can migrate in response to injured, non-injured and dead 
cartilage.* P<0.05.  
(a) 
(b) 
Negative Control Positive Control 
Non-injured cartilage  Injured cartilage  Dead cartilage  
* 
* 
* 
* 
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6.3.7 Assessment of cartilage discs viability following optimisation of protocol 
to produce non injured and dead cartilage  
In these experiments, non-injured cartilage was produced by incubating the 
freshly isolated cartilage pieces in culture medium containing 10
-7
M 
dexamethasone (section 3.4.2).  The dead cartilage was devitalised by microwave 
irradiation as described in section 3.4.3.  The PrestoBlue assay was used to assess 
cartilage viablity following treatment of cartilage with microwave irradiation and 
compared with the viablity of non injured and injured cartilage. Following 2 h 
incubation of cartilage discs with PrestoBlue no significant difference in 
fluorescence (RFU) was observed between control media (DMEM+10% 
serum+10% PrestoBlue, in absence of cartilage) and cartilage discs killed by 
microwave irradiation. In contrast, significant difference in fluorescence was 
observed between living discs (non injured cartilage discs and injured cartilage 
discs) and control media (Figure 6.7).  
 
 
 
 
 
 
 
 
 
Figure 6.7: Assessment of cartilage viability using PrestoBlue assay. 
Cartilage viability was tested using PrestoBlue assay. All uninjured 
living and injured cartilages were viable and dead cartilages were non-
viable at the time of the experiment. 
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6.3.8 Migration potential of SF and BM MSCs to injured, non-injured and 
dead cartilage following optimisation of protocol to produce non injured and 
dead cartilage 
To test if there was higher MSC migration towards injured cartilage compared to 
non injured and dead cartilage, migration potential of SF MSCs to injured 
cartilage was evaluated using cartilage discs in transwell migration assay. 
Following 24 h migration assay, significant migration were observed with both SF 
and BM MSCs in response to injured cartilage compared to non-injured and dead 
cartilage. In response to injured cartilage following 24 h, SF MSC migration was 
35% higher (p<0.05) compared to non-injured cartilage and 52% higher (p<0.05) 
compared to dead cartilage. In response to injured cartilage following 24 h, BM 
MSC migration was 62% higher (p<0.01) compared to non-injured cartilage and 
48% higher (p<0.01) compared to dead cartilage  (Figure 6.8 and 6.9).  
 
Figure 6.8:  SF and BM MSC migration (24 h) in response to injured, non-
injured and dead cartilage.Membranes stained with crystal violet and imaged 
at x20 magnification.  
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Figure 6.9:  SF and BM MSC migration (24 h) in response to injured, non-
injured and dead cartilage.(a) and (b): Graph showing mean number of 
migrated cells per 5 microscopic fields in 3 membranes (mean ± SEM). 
*p<0.01 **p<0.001 ****p<0.0001 compared to negative control and as 
indicated by bars.  
(b) 
(c) 
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6.4 Chapter Discussion  
Using an in vitro model of cartilage injury and Transwell migration assay it was 
demonstrated that both BM and SF MSC migrate significantly more in response to 
injured cartilage compared to non injured cartilage. In our preliminary 
experiments we began by developing a chondral model to study the effect of blunt 
and sharp injury on cartilage. Using a hammer and chisel produced inconsistent 
chondral blocks and this issue was overcome by using a dremel. However, this 
had two main disadvantages: it required prolong exposure of cartilage to airflow 
and it produced an increased temperature at the cutting edge. Previous 
experiments using the bovine metatarsophalangeal joint have reported that airflow 
caused altered cartilage appearance, enhanced cartilage drying and increased 
chondrocyte death [98]. Moreover, even though rehydrating the cartilage using a 
saline-soaked gauge reversed the macroscopic appearance of the cartilage related 
to dehydration, it did not decrease the level of chondrocyte death associated with 
cartilage drying. The same group have also reported chondrocyte death associated 
with increased temperature due to drilling [99]. Hence, production of chondral 
explants using a dremel was not an effective method the method was further 
modified to use a 6 mm biopsy punch to collect 1.5 mm thick and 6 mm diameter 
cartilage discs.  
Using these discs, the effect of sharp and blunt injury on chondrocyte survival in 
the injury areas immediately following injury and 2 h after injury was studied.  
Immediately following sharp injury, chondrocyte death was observed around the 
edges of the injury which remained confined to the edges of the injury at 2 h after 
injury. In contrast, with blunt injury, localised cell death spread outwards from the 
point of impact and increased chondrocyte death was observed at 2 h after impact 
compared to that seen immediately after impact. We also observed the spread of 
cell death outward from the cut cartilage surface following 2 h incubation when 
the injury was created using biopsy punch. This could be due to the pressure 
applied to the cartilage with the biopsy punch during creation of the injury.   
These results were in agreement with previous reports comparing blunt injury 
with sharp injury where they found that injury by sharp scalpel caused less 
chondrocyte death compared to blunt impact produced by a trephine [47, 100]. 
Since blunt injury affected greater area of the cartilage matrix, time dependent 
increase in cell death with blunt injury compared to sharp injury is suggestive of a 
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relationship between matrix disruption and cell viability. This view is also 
supported by previous findings where localised cell death was observed around 
the impact-induced cracks but not around the impacted region without cracks 
[101].  
Matrix disruption- induced cell death may occur by various mechanisms including 
cell death due to changes in cell morphology and interruption of cell-matrix 
interaction. For example, using integrin antibody it was found that collagen-
chondrocyte interaction was crucial for chondrocyte survival where chondrocytes 
deprived of matrix molecules underwent apoptosis [102]. It is also important to 
note that some cell death may have been through direct injury without matrix 
damage simply by cutting through the cells.  
Due to its ease of reproducibility and induction of a highly localised region of 
damage and we chose to investigate the model of using sharp injury on articular 
cartilage in which to study MSC migration towards injured cartilage. Using this 
model and fluorescently labelled SF MSC we found that, following injury, MSCs 
specifically migrated to the site of the injury where they aligned at the edges of 
the cut. The Transwell assay was the used to compare and quantify the number of 
MSCs that migrated towards the injured cartilage compared to migration to non 
injured and dead cartilage. Several difficulties were faced carrying out the 
experiments because it is difficult to obtain cartilage which has not already been 
injured due to the collection process.  
One way to minimise the cartilage injury was to use osteochondral explants 
however it is difficult to make firm conclusions about the effect of MSC 
migration in response to injured cartilage. This was because there will be no clear 
indication whether MSC migration was in response to injured cartilage or the 
injured underlying subchondral bone or both. Hence, it was important to excise 
the cartilage from the osteochondral explants. Using this process, it was difficult 
to reproducibly collect cartilage explants of the same depth and further injury was 
exerted on the cartilage during the processing. Using a 6 mm biopsy punch to 
collect 1.5 mm × 6 mm (depth × diameter) discs overcame these issues of 
inconsistency, reproducibility and also minimised the amount of injury exerted 
through the collection process. During the initial preliminary experiments 
significant MSC migration to both non-injured and injured cartilage was observed  
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Migration to non-injured cartilage could either be in response to cartilage itself or 
as a result of the existing injury exerted on the cartilage during the collection 
process. To investigate the second possibility, media was supplemented with 100
 
nM dexamethasone. Dexamethasone is a potent synthetic glucocorticoid with a 
high receptor binding affinity. It is a common reagent used in standard 
chondroinductive and osteoinductive media and is also known to potentiate 
cartilage proteoglycan synthesis. One study investigating the effect of 
dexamethasone on cartilage matrix degradation reported that administration of 
dexamethasone could restore proteoglycan biosynthesis and loss of GAG in TNFα 
treated mechanically injured cartilage [103]. It was suggested that the inhibition of 
matrix degradation by dexamethasone may involve modulation of proteolytic 
activity of aggrecanases. Therefore, following collection, we treated the cartilage 
discs with 10
-7
 M dexamethasone for 72 h to reduce the cartilage damage caused 
by the collection process. CLSM images of the ‘rested’ discs showed no obvious 
region of injury as indicated by the lack of split matrix but a very low level of 
chondrocyte death was still observed. When the migration assay was repeated 
using these discs, no significant MSC migration was observed in response to the 
‘rested’ cartilage compared to negative control (serum free media). This suggested 
that MSC migration observed in previous experiments to the ‘non-injured control 
cartilage’ was due to prior injury of the cartilage exerted from the collection 
process. Further, the low level of migration observed in response to the ‘rested’ 
cartilage could be due to the little remaining injury as indicated by the 
chondrocyte death.  
Further investigation into the migration of MSC to devitalised cartilage was 
carried out to investigate whether migration of MSCs to the dead cartilage was  a 
true response or due to leakage of cell contents during the freeze thawing process, 
causing release of intracellular proteolytic enzymes which in turn stimulated 
release of matrix proteins and promoted MSC migration. No significant SF MSC 
migration was observed when the dead cartilage was irradiated using microwave 
to kill the cartilage almost instantaneously by denaturing and precipitating out 
cartilage proteins. However, still significant migration of BM MSC to dead 
cartilage was observed suggesting that unlike SF MSC which migrated only to 
injured cartilage, BM MSC may migrate in response to both dead and injured 
cartilage. Such differential regulation of SF and BM MSC migration is suggestive 
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that during the natural healing process SF MSC might be the first to respond to 
the cartilage injury whereas BM MSC only migrate following severe damage. 
This is a possibility since SF MSC have direct access to the cartilage whereas BM 
MSC can only detect the injury if the injury extends to the underlying subchondral 
bone.  
 
6.5 Chapter summary  
In this chapter an in vitro model of cartilage injury was developed and using 
Transwell migration assay the migration potential of bovine BM and SF MSCs to 
injured cartilage was assessed. It was found that both BM and SF MSCs migrated 
significantly more towards injured cartilage compared to non injured cartilage. 
Furthermore, in contrast to SF MSCs, BM MSCs also migrated significantly more 
towards dead cartilage compared to non injured cartilage. 
 Chapter 7 
Assessment of MSC migration and characterisation of 
injury conditioned medium (IJCM)  
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7.1 Objective 
The objectives of these experiments were to 1) investigate whether in vitro injured 
articular cartilage released agents (‘injury factors’) which can promote migration 
of SF and BM MSCs and 2) characterise any ‘injury factors’ which are released 
by the articular cartilage injured in vitro.   
 
7.2 Chapter Introduction  
The ability of the MSCs to migrate specifically to the site of the cartilage injury 
suggested that injured cartilage may release stress and biochemical signals which 
can stimulate distant stem cells to migrate to the site of the injury. To our 
knowledge two other groups are investigating the signalling response of the 
articular cartilage to traumatic injury. The Vincent laboratory has shown that 
damaged articular cartilage releases a number of regulatory factors from heparan 
sulphate-bound stores within the pericellular matrix [104] They have shown that 
FGF2 [46], hepatoma-derived growth factor (HGF) and CTGF [105] were 
released following cartilage injury. FGF2 was shown to be associated with 
chondroprotective in vivo such that mice deficient of FGF2 developed 
significantly accelerated OA spontaneously and upon surgical joint destabilisation 
[106]. The role of HGF is still unknown. Similarly, Dell’Accio’s group have 
shown that the WNT signalling and bone morphogenetic protein (BMP) pathway 
is activated following mechanical injury of cartilage [107]. They are currently 
investigating if these pathways play a role in stimulating mesenchymal stem cell 
involvement in the cartilage repair.  
 
Several studies have also reported the importance of chemokines and cytokines as 
regulators of MSC migration. Chemokines are molecules that can induce 
directional cell migration by establishing chemical gradients along which cells can 
migrate. They are small molecules, 8-14 kDa in size containing four conserved 
residues of cysteine and subdivided into four families based on the two cysteine 
residues at the N terminal. The subfamilies are CXC, CC, (X)C and CX3C. The 
chemokine receptors are G-protein coupled receptors which are subdivided into 
the same four families as their ligands [108].  
 
Therefore, the objective of these experiments was to investigate whether in vitro 
injured articular cartilage released agents (‘injury factors’) which can promote 
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migration of SF and BM MSCs and characterise ‘injury factors’ which are 
released by the articular cartilage injured in vitro.   
 
7.3 Results  
7.3.1 Assessment of mesenchymal stem cell migration in response to IJCM in 
Transwell assays  
To investigate the possibility that migratory factor(s) released from the cartilage 
upon sharp injury stimulated MSC migration towards injured cartilage, culture 
medium was conditioned by incubating finely cut cartilage pieces for 24 h (refer 
section 3.14). The injury conditioned medium (IJCM) samples were put in the 
lower well of the Transwell chambers and assayed for stimulation of MSC 
migration. Serum free media (DMEM + 0.1% BSA) was used as negative control 
and media supplemented with 5% serum (DMEM+5% serum+0.1% BSA) was 
used as positive control.  IJCM induced a high degree of MSC chemotactic 
migration such that the number of migrated cells was significantly higher when 
IJCM was present on the lower wells compared to serum-free control media 
(Figure 7.1). SF-MSCs demonstrated a 0.6 fold increase (p<0.001) (Figure 7.2a) 
and BM MSCs a 1.5 fold increase (p<0.01) (Figure 7.2b) in migration to IJCM 
compared to control. In comparison, SF-MSCs demonstrated a 0.5 fold increase 
(p<0.01) and BM MSCs a 3 fold increase in migration (p<0.01) in response to 5% 
serum compared to control. These results suggested that MSC migration 
stimulating soluble factors present in the cartilage were released upon cutting 
injury.    
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Figure 7.1: Migration of bovine SF-MSCs (a, b and c) and BM MSCs (d, 
e and f) in response to IJCM were studied using transwell assays over 24 
h. Membranes were stained with crystal violet. Representative image of one 
microscopic field at x20 magnification is shown here. Presence of serum (5% 
serum; positive control) increased the number of migrated cells compared to 
serum free media (negative control) for both SF and BM MSCs. Similarly, 
IJCM also induced greater MSC migration for both MSCs. 
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Figure 7.2: Migration of bovine (a) SF MSC and (b) BM MSC in 
response to IJCM over 24h assessed using transwell assays. Graph 
showing mean number of migrated cells ± SEM. (a) Both presence of 
serum and IJCM significantly increased the number of migrated SF 
MSCs compared to serum free media (DMEM+0.1% BSA).  No 
significant difference in migration was observed between 5% serum 
and IJCM. (b) Both presence of serum and IJCM significantly 
increased the number of migrated BM MSC compared to serum free 
media. Further, 5% serum induced significantly higher number of 
migrated cells compared to IJCM. ** p<0.01, *** p<0.001 and **** 
p<0.0001.   
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7.3.2 Assessment of mesenchymal stem cell migration in response to IJCM in 
scratch assays  
The effect of IJCM was validated using scratch assays. IJCM induced rapid 
wound closure of SF MSC scratch assays such that complete wound closure was 
observed consistently between 24 h and 36 h (Figure 7.3b). In contrast, slow 
wound closure was observed with serum free media and completion of wound 
closure was not achieved within 36 h (Figure 7.3a).  
Wound closure was quantified for both SF MSCs (over 24 h) and BM MSCs (over 
17 h) in response to IJCM by measuring the percentage reduction in wound width. 
In SF MSC scratch assays, IJCM which was generated under serum free 
conditions, affected wound closure more rapidly than serum free control (Figure 
7.4a). At 24 h, when the extent of wound closure was approximately 75% ± (6%) 
(p<0.0001) for IJCM stimulated assays, the extent of closure for serum free 
control assays was only 14% ± (1%) (Figure 7.5a). Similarly, IJCM also induced 
significant BM MSC migration (approximately 87% ± (4%))(p<0.0001)  into the 
wound compared to serum free negative control (48% ± (7%)) (Figure 7.4b and 
7.5b).  
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Figure 7.3: Migration of bovine SF MSCs in response to IJCM 
and serum free media (DMEM+0.1% BSA) was evaluated 
using the monolayer scratch assay. Migration was monitored 
microscopically at a regular interval and imaged at 0 h 
(immediately following creation of the wound), 6 h, 24 h and 36 h. 
IJCM induced rapid MSC migration into the wound compared to 
control. Images were taken at x10 magnification. Complete wound 
closure was observed consistently between 24 h and 36 h with 
IJCM whereas no wound closure was observed with control even 
after 36 h. Bar represents 200 μm.  Please scan this image to 
watch the time-lapse video of SF MSC migration in scratch 
assay. 
0 h 
6 h 
24 h 
IJCM Control 
36 h 
 (DMEM +0.1% BSA) 
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Figure 7.4: Assessment of MSC migration in response to 
injury conditioned media (IJCM) using scratch assay. 
Images were taken at x10 magnification. IJCM induced 
rapid wound closure in both (a) SF MSC and (b) BM MSC 
scratch assays compared to control. 
bBM MSC 
(b) 
(a) IJCM 
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24 h 
IJCM 
0 h 
17 h 
200 μm 
200 μm 
Assessment of MSC migration and characterisation of injury conditioned medium (IJCM) 
 
148 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.5: Assessment of MSC migration in response to injury 
conditioned media (IJCM) using scratch assay.Graph showing 
percentage reduction in wound width over 24 h (%) ± SEM for SF 
MSCs and over 17 h (%) ± SEM for BM MSCs. Significant 
reduction in wound width was observed with IJCM compared to 
control for both (c) SF MSC and (d) BM MSC. For SF MSCs, 75% 
± (6%) reduction in wound width was observed with IJCM 
(p<0.0001) compared to only 14% ± (1%) with serum free media. 
Similarly, for BM MSC, 87 % ± (4%) reduction in wound width 
was observed with IJCM (p<0.0001) compared to 48% ± (7%) with 
control. Further, BM MSCs were more migratory than SF MSCs 
such that higher degree of wound closure was observed with serum 
free media for BM MSCs compared to control. 
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7.3.3 Assessment of migration of other skeletal cell types in scratch assays in 
response to IJCM  
The specificity of IJCM to induce MSC migration was investigated using articular 
chondrocytes and the MG-63 (osteoblastic cell line) using scratch assay 
methodology and adding IJCM to the cell layers. Chondrocytes and MG-63 cells 
were grown to confluence and ‘scratch’ wounds were created using the same 
method used for MSCs (section 3.16.3). Serum free media (DMEM+0.1% BSA) 
was used as negative control and assay was monitored microscopically over 24 h. 
In chondrocyte scratch assays, serum free media did not induce rapid wound 
closure similar to MSCs (Figure 7.6a). However, in contrast to MSCs, IJCM also 
did not induce significant wound closure compared to the control (Figure 7.6b). 
For example, when approximately 31% ± (3%) reduction in wound width was 
observed with serum free media, 31% ± (3%) reduction in wound width was 
observed with IJCM (Figure 7.8a). Similarly, IJCM did not induce significant 
wound closure in MG-63 scratch assays compared to control (Figure 7.7). For 
example, when 85% ± (4%) wound closure was observed with serum free media, 
77% ± (7%) wound closure was observed with IJCM (Figure 7.8b). These results 
suggested that IJCM may specifically induce migration in MSCs and may not 
stimulate migration of other skeletal cell types. 
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Figure 7.6: Migration of bovine articular chondrocytes in response to 
IJCM and serum free media (DMEM+0.1% BSA) was evaluated 
using the monolayer scratch assay. Migration was monitored 
microscopically at a regular interval and imaged at 0 h (immediately 
following creation of the wound), 6 h, 24 h and 36 h. IJCM did not 
induce rapid MSC migration into the wound compared to control. 
Complete wound closure was not observed for either negative control or 
IJCM following 36 h of wound creation.  
Chondrocytes  
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Figure 7.7: Migration of MG-63 cell lines (osteoblastic cells) in response to 
IJCM and serum free media (DMEM+0.1% BSA) was evaluated using the 
monolayer scratch assay. Migration was monitored microscopically at a 
regular interval and imaged at 0h (immediately following creation of the 
wound), 6 h and 24 h. Initially, wound closure was slow and no cell movement 
was observed in the first 6 h. However, rapid wound closure was observed with 
both serum free media and IJCM following 24 h assay.  
MG-63 cell line (pre-osteoblastic cells) 
0 h 
6 h 
24 h 
IJCM Control 
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Figure 7.8: Migration of (a) bovine articular chondrocytes and 
(b) MG-63 cell lines (pre-osteblastic cells) in response to IJCM 
and serum free media (DMEM+0.1% BSA) were evaluated 
using the monolayer scratch assay. Graph showing percentage 
reduction in wound width (%) ± SEM over 24h. No significant 
difference in wound width reduction was observed between IJCM 
and serum free media (negative control) for both chondrocyte and 
MG-63 cell line scratch assays.  
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7.3.4 Histological assessment of injured cartilage to evaluate MSC migration 
in response to injury conditioned media (IJCM)  
Cartilage discs were collected using a 6mm biopsy punch. Discs were injured 
using a no.11 scalpel blade attached to a no.3 scalpel holder. A single cut was 
made in the push-through mode by passing the scalpel blade perpendicular to the 
long axis of the discs in a straight line. Each disc was placed in individual wells in 
a 24 well plate and 1×10
6
 MSCs were seeded into each well re-suspended in either 
serum free media (DMEM+0.1% BSA) or IJCM and incubated for 7 days at 37°C 
and 5% CO2. Following this, the discs were fixed for 30 min in 4% formaldehyde 
in ambient temperature, washed once with PBS and mounted in optimal cutting 
temperature (OCT) prior to cryosectioning. Cryosections were mounted onto the 
microscopic slides and stained with haematoxylin and eosin (H&E). MSCs were 
found to be present at the cut edge of the cartilage discs for both serum free media 
and IJCM. However, higher numbers of MSC were present in cartilage discs 
incubated in IJCM compared to control (Figure 7.9). 
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Figure 7.9: IJCM enhances SF MSC migration to the injured cartilage. 
Representative H&E stained sections of injured cartilage discs cultured 
with SF MSC for 7 days. (a) Control cultures were maintained in serum 
free media (DMEM+0.1% BSA). (b) Injured cartilage maintained in IJCM. 
Attached MSCs to the cut edge of the cartilage was seen for both control 
and IJCM. However, higher numbers of MSCs were seen with IJCM 
compared to control. Arrow indicates SF MSCs  
 
 
Control  IJCM (a) (b) 
 (DMEM +0.1% BSA) 
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7.3.5 Primary characterisation of injury conditioned media (IJCM) using 
immobilised heparin to remove heparin-binding factors from IJCM (hIJCM) 
It was important to understand to what extent the migration stimulatory factors 
were being released from injured cartilage either by release/secretion from the 
chondrocytes or from an extracellular reservoir. Extracellularly, these factors are 
likely to be sequestered in the matrix bound to heparan sulphate containing 
proteoglycans. IJCM was added to microwell plates containing immobilised 
heparin and incubated for 24h at 4°C. The heparin-treated IJCM samples were 
then removed from the microplate wells, pooled and tested for their ability to 
stimulate MSC migration using scratch migration assays. Serum free media 
(DMEM+0.1% BSA) was used as control. 
 IJCM induced significant migration of SF MSC into the wound. Heparin-
treatment of IJCM reduced the migratory stimulation of IJCM such that the extent 
of wound closure by SF MSCs was only  approximately 49% ± (8%) compared to 
75% ± (6%) by IJCM (p<0.001) over 24h (Figure 7.10a and 7.11a). However, 
migration in response to heparin treated IJCM was still significantly more 
compared to control (27% ± (2%)) (p<0.001). Similarly, heparin-treatment of 
IJCM also reduced the migratory stimulation of IJCM in BM MSC scratch assays 
(Figure 7.10b). At 17 h, when the extent of wound closure was approximately 
87% ± (4%) with IJCM, it was only 57% ± (3%) with heparin-treated IJCM 
(p<0.001). But in contrast to SF MSCs, there was no significant difference in 
migration between heparin treated IJCM and control (48% ± (7%)) (Figure 7.11b).  
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Figure 7.10: Assessment of MSC migration in response to heparin-
treated injury conditioned media (IJCM) using scratch assay. Images 
were taken at x10 magnification. IJCM induced rapid wound closure in both 
(a) SF MSC and (b) BM MSC scratch assays compared to control. Pre-
treatment of IJCM with heparin reduced the migration stimulatory capacity 
of IJCM such that reduction in wound closure was decreased compared to 
untreated IJCM for both (a) SF and (b) BM MSCs.   
200 μm 
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Figure 7.11: Migration of bovine (a) SF MSCs and (b) BM MSCs in 
response to heparin treated IJCM was evaluated using monolayer scratch 
assays. Graph showing percentage reduction in wound width over 24h (%) ± 
SEM. Significant reduction in wound width was observed with IJCM 
compared to control for both (a) SF MSC and (b) BM MSC. Pre-treatment of 
IJCM with heparin significantly reduced the migration stimulatory capacity of 
IJCM for both SF and BM MSCs. For example, the extent of wound closure 
by SF MSCs was only approximately 49% ± (8%) compared to 75% ± (6%) 
by untreated IJCM over 24h. And for BM MSCs it was only approximately 
56% ± (3%) compared to 87% ± (4%) by untreated IJCM over 17h. However, 
SF MSC migration in response to treated IJCM was still significantly more 
compared to control (27% ± (2%)). In contrast, heparin-treatment reduced BM 
MSC migration to level seen with serum free negative control.  *** p< 0.001 
and **** p<0.0001.  
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7.3.6 Assessment of SF MSC migration in response to common migration 
stimulatory factors 
We conducted scratch assays for bovine SF MSCs using seven chemokines and 
growth factors (CXCL12, TGFβ3, FGF2, CCL2, CCL3, CCL5 and TNFα) and 
compared their migration stimulatory capacity with control and IJCM. IJCM had 
the most potent chemotactic effect compared to both control and all 7 
chemoattractants tested (p<0.0001) (Figure 7.12 and 7.13). Approximately, 
percentage reduction in wound width with IJCM was 90% ± (2%) (p<0.0001) 
compared to approximately 27% ± (2%) with control (DMEM+0.1% BSA). 
Among the 7 chemoattractants tested, CXCL12 (52% ± (5%); p<0.0001), TGFβ3 
(54% ± (3%); p<0.001), CCL2 (48% ± (6%); p<0.01) and CCL5 (61% ± (4%); 
p<0.0001) showed significant reduction in wound width compared to control. No 
significant reduction in wound width was observed with FGF2 (47% ± (6%); NS), 
CCL3 (35% ± (4%); NS) and TNFα (42% ± (8%); NS) compared to control 
(Figure 7.14).  
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Figure 7.12: Assessment of SF MSC migration in response to 
CXCL12, TGFβ3 and FGF2 compared to conditioned media 
(IJCM) using scratch assay over 24 h. Images were taken at x10 
magnification. Serum free media was used as control. All three 
growth factors induced MSC migration but complete wound 
closure was only observed with IJCM.   
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Figure 7.13: Assessment of SF MSC migration in response to 
CCL2, CCL3, CCL5 and TNFα compared to conditioned media 
(IJCM) using scratch assay over 24h. Images were taken at x10 
magnification. Serum free media was used as control. All four 
cytokines induced MSC migration but complete wound closure was 
only observed with IJCM.   
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Figure 7.14: Assessment of bovine SF MSCs migration in 
response to seven chemokines and growth factors (CXCL12, 
TGFβ3, FGF2, CCL2, CCL3, CCL5 and TNFα) compared to 
IJCM. Graph showing percentage reduction in wound width (%) 
over 24h ± SEM. IJCM was the most potent inducer of SF MSC 
migration and induced significant MSC migration compared to both 
control and all chemoattractants tested. Among the 7 
chemoattractants tested, CXCL12 (52% ± (5%)), TGFβ3 (54% ± 
(3%)), CCL2 (48% ± (6%)) and CCL5 (61% ± (4%)) showed 
significant reduction in wound width compared to control. No 
significant reduction in wound width was observed with FGF2 (47% 
± (6%)), CCL3 (35% ± (4%)) and TNFα (42% ± (8%)) compared to 
control. * p<0.01, *** p<0.001, **** p<0.0001 compared to control 
and ++++ p<0.0001 to IJCM.  
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7.3.7 Characterisation of injury conditioned media (IJCM) using antibody 
and receptor antagonists against common heparin interactome members 
To identify migration stimulatory factors, present in the IJCM, neutralising 
antibodies and receptor inhibitors were used against common heparin-binding 
chemokines and growth factors previously reported to influence BM MSC 
migration. Both CXCL12 and TGFβ3 antibody and the CXCL12 receptor, 
(CXCR4) antagonist (AMD3100) significantly reduced the stimulatory migration 
effect of IJCM in SF MSC scratch assays (Figure 7.15). In contrast, a neutralising 
FGF2 antibody did not affect the migration stimulatory effect of IJCM in SF MSC 
scratch assays. Hence, when the extent of wound closure was 91% ± (3%) in the 
presence of untreated IJCM, it was 52% ± (4%) (P<0.0001 compared to IJCM) in 
the presence of CXCL12 antibody in the IJCM, 50% ± (3%) (P<0.0001 compared 
to IJCM) when cells were pre-treated with AMD3100, 45% ± (5%) (P<0.0001 
compared to IJCM) in the presence of TGFβ3 antibody in the IJCM and 89% ± 
(4%) (compared to IJCM) in the presence of FGF2 antibody in the IJCM (Figure 
7.17). . Controls of serum-free medium (DMEM + 0.1% BSA) and the antibodies 
and receptor antagonists were also tested on basal migration levels. No significant 
difference in wound closure was observed between the presence and absence of 
antibodies in the basal media.  
Since, both CCL2 and CCL5 elicited significant MSC migration compared to 
serum free media (Figure 7.14), the effect of receptor inhibitors against CCL2 
(also known as MCP-1) and CCL5 were also tested. Blocking either of the 
receptors did not have any significant effect on the stimulatory migratory effect of 
IJCM such that with CCL2 receptor antagonists approximately 92% ± (8%) and 
CCL5 receptor antagonists approximately almost 100% ± (1%) reductions in 
wound width were observed (Figure 7.16 and 7.17). Furthermore, the effect of a 
neutralising antibody against CX3CL1 was investigated since previous studies 
have reported CX3CL1 to be potent inducer of human BM MSC migration. 
However, no significant difference in MSC migration was observed 
(approximately 91% ± (5%)) was observed in the presence of the CX3CL1 
neutralising antibody compared to IJCM (Figure 7.16 and 7.17). 
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Figure 7.15: Release of migration stimulatory factors from injured 
cartilage following sharp injury was studied using antibody and receptor 
antagonists. SF MSC migration was studied using scratch assays. 
Representative image of one experiment. Images were taken at x10 
magnification. Serum free media (DMEM+ 0.1% BSA) was used as negative 
control. Almost complete wound closure was observed with IJCM. Both 
treatment of IJCM with CXCL12 antibody and pre-treatment of MSCs with 
CXCL12 receptor (CXCR4) antagonists (AMD3100) reduced the migration 
stimulatory capacity of IJCM. Treatment of IJCM with FGF2 antibody had no 
effect on IJCM’s ability to induce MSC migration and almost complete closure 
of wound was observed.  
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Figure 7.16: Release of migration stimulatory factors from injured 
cartilage following sharp injury was studied using antibody and receptor 
antagonists. SF MSC migration was studied using scratch assays. 
Representative image of one experiment. Images were taken at x10 
magnification. Serum free media (DMEM+ 0.1% BSA) was used as negative 
control. Almost complete wound closure was observed with IJCM. Treatment 
of IJCM with CX3CL1 antibody, CCL2 receptor (CCR2) antagonists or 
CCL5 receptor (CCR5) antagonists had no effect on IJCM’s ability to induce 
MSC migration and almost complete closure of wound was observed 
following 24h.  
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Figure 7.17: Release of migration stimulatory factors from injured 
cartilage following sharp injury was studied using antibody and 
receptor antagonists. Graph showing percentage reduction in wound 
width (%) over 24h ± SEM. Both pre-treatment of IJCM with CXCL12 
antibody and pre-treatment of MSCs with CXCL12 receptor (CXCR4) 
antagonist (AMD3100) significantly reduced the migration stimulatory 
capacity of IJCM. The neutralising antibody significantly reduced MSC 
migration by approximately 39% ± (4%) and CXCR4 antagonist 
AMD3100 significantly reduced MSC migration by approximately 40% ± 
(3%).  Other antibodies and receptor antagonists had no significant effect 
on the migration stimulatory capacity of IJCM. **** p<0.0001 compared 
to control and ++++ p<0.0001 to IJCM. 
Assessment of MSC migration and characterisation of injury conditioned medium (IJCM) 
 
166 
 
7.3.8 Assessment of pre-treated of SF MSC (pre-treated with AMD3100) 
migration in response to IJCM in transwell assay  
In order to validate the results from scratch assays, SF MSCs were pre-treated 
with CXCL12 receptor inhibitor (AMD3100) before seeding into the upper wells 
of the Transwell chambers. We also tested the presence of FGF2 by blocking the 
growth factor activity using FGF2 antibody in the IJCM. Serum free media 
(DMEM+0.1% BSA) was used as negative control and 5% serum (DMEM+5% 
serum + 0.1% BSA) was used as positive control Similarly to the previous results 
from scratch assays, pre-treatment of MSCs with ADM3100 significantly reduced 
MSC migration in response to IJCM by approximately 0.4 fold (p<0.01) 
compared to non-treated MSCs (Figure 7.18d and 7.19). Further, no significant 
difference in migration was observed between ADM3100 treated-MSCs in 
response to IJCM and untreated MSCs in response to negative control. Moreover, 
no significant difference in migration was observed when IJCM was treated with 
FGF2 antibody compared to untreated IJCM (IJCM: 1.2 fold increase in migration 
compared to negative control (p<0.0001); FGF2 antibody treated IJCM: 1.1 fold 
increase in migration compared to negative control (p<0.0001)) (Figure 7.18e and 
7.19). 
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Figure 7.18: Release of migration stimulatory factors from injured 
cartilage following sharp injury was studied using antibody and receptor 
antagonists.SF MSC migration was studied using transwell assay. Membranes 
were stained with crystal violet. Representative image of one microscopic field 
at x20 magnification is shown here. Serum free media (DMEM+0.1% BSA) 
was used as negative control and 5% serum (DMEM+5% serum+0.1% BSA) 
was used as positive control. Effect of CXCL12 studied using CXCL12 
receptor (CXCR4) antagonist (AMD3100). Effect of FGF2 was studied using 
FGF2 antibody. Pre-treatment of MSCs with AMD3100 reduced MSC 
migration in response to IJCM compared to untreated MSCs. Pre-treatment of 
IJCM with FGF2 antibody did not affect MSC migration compared to untreated 
IJCM. 
DMEM+0.1% BSA 
DMEM+5% serum+0.1% 
BSA 
IJCM 
IJCM + CXCL12 
receptor inhibitor 
IJCM + FGF2 antibody  
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Figure 7.19: Release of migration stimulatory factors from injured 
cartilage following sharp injury was studied using antibody and 
receptor antagonists. SF MSC migration was studied using transwell 
assay. Graph showing mean number of migrated cells ± SEM. Serum free 
media (DMEM+0.1% BSA) was used as negative control and 5% serum 
(DMEM+5% serum+0.1% BSA) was used as positive control. ADM3100 
(CXCL12 receptor inhibitor) significantly reduced MSC migration in 
response to IJCM by approximately 0.4 fold compared to non-treated 
MSCs. Further, no significant difference in migration was observed 
between pre-treated MSCs in response to IJCM and untreated MSCs in 
response to negative control. No significant difference in migration was 
observed when IJCM was treated with FGF2 antibody compared to 
untreated IJCM (IJCM: 1.2 fold increases in migration compared to 
negative control; FGF2 antibody treated IJCM: 1.1 fold increases in 
migration compared to negative control). *** p<0.001 and **** p<0.0001 
compared to control.  
 
Assessment of MSC migration and characterisation of injury conditioned medium (IJCM) 
 
169 
 
7.3.9 Characterisation of IJCM using antibodies against CXCL12, CXCR4, 
TGFβ3 and FGF2 
In comparison with SF MSCs, neutralising antibodies to TGFβ3 and CXCL12 and 
AMD3100 significantly reduced the migration stimulatory capacity of IJCM in 
BM MSC scratch assays. However, in contrast to SF MSCs, FGF2 antibodies also 
significantly affected IJCM’s ability to induce BM MSC migration (Figure 7.20a). 
When the extent of wound closure was approximately 85% ± (4%) with untreated 
IJCM, it was only 55% ± (3%) (P<0.0001) in the presence of CXCL12 antibody 
in the IJCM, 60% ± (4%) (P<0.0001) when cells were pre-treated with 
AMD3100, 55% ± (4%) (P<0.0001) in the presence of TGFβ3 antibody in the 
IJCM and 52% ± (4%) (P<0.0001) in the presence of FGF2 antibody in the IJCM 
(Figure 7.20b).  
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Figure 7.20: Release of migration stimulatory factors from injured cartilage 
following sharp injury was studied using antibody and receptor antagonists. 
BM MSC migration was studied using scratch assays. (a) Representative image 
of one experiment. Images were taken at x10 magnification. Serum free media 
(DMEM+ 0.1% BSA) was used as negative control. Almost complete wound closure 
was observed with IJCM. Treatment of IJCM with CXCL12, FGF2 and TGFβ3 
antibody and pre-treatment of MSCs with CXCL12 receptor (CXCR4) antagonists 
(AMD3100) reduced the migration stimulatory capacity of IJCM. (b) Graph showing 
percentage reduction in wound width (%) over 17h ± SEM. Wound closure by IJCM 
was approximately 87% ± (4%).  CXCL12 neutralising antibody significantly 
reduced migration stimulatory capacity of IJCM by approximately 33% ± (4%). Pre-
treatment with AMD3100 also significantly reduced the effect of IJCM by 
approximately 28% ± (5%). The migration stimulatory capacity of IJCM was 
reduced by approximately 22% ± (4%) by TGFβ3 antibody and by approximately 
28% ± (6%) by FGF2 neutralising antibody.  
(b) 
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7.3.10 Investigation of mechanisms for the release of migration stimulatory 
factors from the cartilage following sharp injury  
Two mechanisms for the release of factors following injury were investigated: 
synthesis of factors in response to injury and metalloproteinase (MMP) activity 
using the general protein synthesis inhibitor, cycloheximide and the MMP 
inhibitor marimastat. Cycloheximide and not marimastat significantly reduced the 
migration stimulatory capacity of IJCM in SF MSC scratch assays (Figure. 7.21). 
When the extent of wound closure was 100% ± (0%) with untreated IJCM, it was 
only approximately 34% ± (2%) (P<0.0001 compared to IJCM) when cartilage 
was injured in the presence of cycloheximide and 100% ± (0%) when cartilage 
was injured in the presence of marimastat.  
 
 
Figure 7.21: Mechanism for the release of migration stimulatory 
factors following injury was assessed using cycloheximide and 
marimastat. Graphical representation of percentage reduction in 
wound width over 24 h ± SEM. Statistical significances (P values) 
are shown in the graph. *P values represent differences compared to 
DMEM+0.1% BSA (control). 
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7.3.11 IJCM promotes MSC survival  
IJCM was investigated to determine if it could promote MSC survival by plating 
MSCs in tissue culture flasks re-suspended in IJCM and maintained them in the 
IJCM only for 10 days. Both SF and BM MSCs survived in the IJCM for the 10 
day culture period, however, none of the cultures reached confluency. Both MSCs 
formed network of cells following day 2 of culture (Figure 7.22a and d). At day 4, 
both MSCs appeared as elongated cells with protruding ends as seen in scratch 
assays during wound closure (Figure 7.22b and e). By day 10, cells aggregated to 
form long tubes with single cells migrating outwards (Figure 7.22c and f). These 
structures were similar to those seen after initial plating (passage 0) of freshly 
isolated cells forming colony forming units (CFU).  
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Figure 7.22: IJCM promotes MSC survival. MSCs cultured in IJCM. 
Representative time lapse images of SF and BM MSC cultures. Day 2 
images were taken at x4 magnification to visualise the cell network. Day 
4 and d 10 were imaged at x10 magnification.  
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7.4 Chapter discussion  
In this study freshly harvested cartilage was injured in the presence of serum free 
media. The injured cartilage explants were then incubated in the same serum free 
media for 24 h and the media was then collected as injury conditioned media 
(IJCM). The rationale behind this technique was that if cartilage releases any 
migratory factors following injury, the migratory factors would be released into 
the serum-free media. The capacity of IJCM to stimulate MSC migration was 
determined using Transwell and scratch assays. IJCM stimulated significant 
migration of both BM and SF MSCs in both Transwell and scratch assays 
compared to serum free media. Furthermore, histological assessment of injured 
cartilage incubated with SF MSCs in the presence and absence of IJCM suggested 
higher MSC migration to the site of injury in the presence of IJCM compared to 
absence of IJCM.  
IJCM was also tested for its capacity to stimulate chondrocyte and MG-63 cell 
migration. In these assays no significant migration was observed in response to 
IJCM compared to serum free media. These results suggested that following 
injury, articular cartilage released migratory factors which were specific for 
stimulating MSC migration to the site of injury. Further characterisation of IJCM 
suggested that the migration stimulatory factors were CXCL12, TGFβ3 and 
FGF2.  
 
7.5 Chapter Summary  
Previous results suggested that the mechanism through which MSCs detect and 
respond to injured cartilage could occur through migration along the chemotactic 
gradient of cytokines and growth factors released by the injury. These 
chemoattractants are also capable of inducing chondrogenic differentiation of both 
MSCs. Some of these cytokines are possibly released from the cartilage ECM, 
possibly bound to heparin sulphate proteoglycans. The key cytokines identified 
through this study were CXCL12, TGFβ3 and FGF-2. However, our results 
suggested that SF MSCs may have a different migration mechanism compared to 
BM MSCs in terms of what cytokines can trigger migration to the injury site. Our 
findings have the implication of designing a method that can direct a large number 
of endogenous MSCs towards the site of the cartilage injury, maintain these cells 
Assessment of MSC migration and characterisation of injury conditioned medium (IJCM) 
 
176 
 
within the defect and induce chondrogenic differentiation which would increase 
the success of endogenous cartilage repair.   
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Chapter 8 
Priming of SF MSC using extracellular nucleotides  
 
Priming of SF MSC using extracellular nucleotides 
 
178 
 
8.1 Hypothesis  
Cell injury releases short-lived factor(s) which is required to prime MSC to home 
along the chemotactic gradient towards the site of the cartilage injury. 
 
8.2 Chapter introduction 
5’-nucleotide triphosphates such as ATP and UTP are ubiquitous extracellular 
messengers involved in various cell functions such as cell survival, cell death, 
proliferation, migration and differentiation. They act via purinoceptors (P2Rs) 
which are plasma membrane receptors further divided into P2X and P2Y 
subfamilies. P2XRs are selective ion channels formed by two or three identical 
subunits containing two plasma membrane spanning domains and a large 
extracellular loop, permeable to monovalent and divalent ions. P2RYs are seven 
transmembrane spanning G-protein coupled receptors which transduces signal via 
activation /inhibition of adenylate cyclase or the activation of phospholipase C 
[75].  
Previous studies have also reported the involvement of ATP in hematopoietic 
stem cells recruitment to the damaged tissue. It was shown that nucleotides 
released from the damaged tissue were involved in paracrine signalling in 
conjunction with chemokines such as CXCL12 to stimulate stem cell migration to 
the injury site where they may participate in tissue regeneration [75]. Extracellular 
nucleotides have also been shown to be chondrogenic in bovine articular cartilage 
explants. For example, using a pellet culture of chondrocytes, it was shown that 
presence of ATP and UTP enhances accumulation of cartilage collagen and 
proteoglycans [109].  
Therefore, we studied the capacity of extracellular nucleotides to affect migration 
of synovial fluid (SF) and bone marrow (BM) MSCs to the site of the cartilage 
injury. Our results suggested that while ATP and UTP released through cell injury 
was not required for BM MSC migration, they are required to prime SF MSCs 
before migration along the CXCL12 chemotactic gradient.   
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8.3 Results  
8.3.1 Cell injury is required to prime SF MSCs but not BM MSCs  
To assess the requirement for cell activation or cell injury for MSC migration, cell 
exclusion zones were created at the time of cell seeding by using Ibidi silicon 
inserts. Using these inserts also avoided problems such as unevenly thick gap 
created by cell scraping, and reattachment of floating cells in the wound area 
which then migrate towards the monolayer and have the risk of providing 
adulterated results. Migration into the cell exclusion zone was followed 
microscopically over 24 h. Serum free media (DMEM+0.1% BSA) was used as 
negative control. In contrast to its effect on MSC migration in scratch assays, 
IJCM induced little SF MSC migration into the cell free gap and was not 
statistically different from the negative (serum-free) control (Figure 8.2). More 
interestingly, heparin-treated IJCM stimulated 100% wound closure in SF MSC 
cultures in this assay system which was not observed with scratch assays (Figure 
8.2).  
In contrast, using the exclusion zone assays, 100% wound closure was observed 
with BM MSCs in response to IJCM. These results suggested that unlike SF 
MSCs, BM MSCs do not require a short-acting priming signal released through 
cell injury for initiation of migration (Figure 8.1). 
To compare the effect of cell injury with no cell injury on SF MSC migration, a 
‘wound’ was created by producing a fine scratch in the monolayer distant to the 
cell exclusion zone. In this case the IJCM affected rapid wound closure, inducing 
rapid MSC migration into the scratch but little MSC migration was observed into 
the cell exclusion zone. To test if the cell injury from the creation of the ‘wound 
area’ can induce SF MSC migration in response to IJCM into the cell exclusion 
zone, a fine scratch/scraping wound was created very close to the cell exclusion 
zone.  After 24 h, SF MSC migration was induced in both the ‘wound area’ and 
the cell exclusion zone (Figure 8.3a). In contrast, creation of the manual wound 
completely inhibited SF MSC migration into the cell exclusion zone in the 
presence of heparin-treated IJCM (Figure 8.3b).  
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Figure 8.1: BM MSC migration in cell exclusion zone assay where 
creation of wound does not cause cell injury. Images were taken at 
x4 magnification. Cell migration was observed both in the absence of 
serum (control) and IJCM. However, whereas complete wound closure 
was observed in response to IJCM following 24 h migration, wound 
closure was not complete in control experiments.  
DMEM + 0.1% BSA IJCM 
0 h 
24 h 
500 μm 
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Figure 8.2: Cell exclusion zone assays were used to assess SF MSC 
migration in response to IJCM and heparin-treated IJCM. No SF-
MSC migration was observed in response to IJCM but migration was 
observed in response to heparin-treated IJCM. Images were taken at 
x4 magnification.  
Priming of SF MSC using extracellular nucleotides 
 
182 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.3: Investigation of SF MSC migration after wound was created on 
the same cell monolayer, side by side using both a former and manual cell 
scraping. Images were taken at x4 magnification. (a) When a scratch was created 
in one of the monolayers next to the cell exclusion zone, complete wound closure 
was observed in the manual scratch but not in the cell exclusion zone. Migration 
in response to IJCM was observed in this system when a cell injury was created 
(by scraping off cells) closer to the cell exclusion zone. (b) In contrast, creating a 
manual wound inhibited MSC migration into the cell exclusion zone in response 
to heparin-treated IJCM 
0 h 24 h 
500 μm 
IJCM 
Heparin-treated IJCM 
(a) 
(b) 
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8.3.2 Factors released through cell injury in combination with IJCM are 
required to stimulate migration  
To test if migration in the exclusion zones were induced by release of stimulatory 
factors from the cell injury, chondrocytes were grown to confluency and the cell 
layer was then injured using 200 µl pipette tip in the presence of serum free 
media. The medium was collected after 30 mins for either immediate use or 
immediately stored at -20°C. The cell exclusion zone assay was carried out using 
a combination of IJCM and cell injury conditioned medium (CIJM) and the 
degree of migration measured after 24 h assay. Significant MSC migration was 
observed in response to this combined conditioned medium compared to both 
control and IJCM alone (Figure 8.4a). Hence, when wound closure was 77% ± 
(2%) with combined conditioned medium, it was only 21.1% ± (3%) with IJCM, 
13% ± (3%) with CIJM alone and 16% ± (2%) with serum free control (Figure 
8.3b). To test whether the cell injury factors were released specifically from the 
chondrocytes or simply through any cell injury, BM MSCs grown to confluence 
were injured similarly to chondrocytes in the presence of serum free medium and 
CIJM was collected after 30 mins. Cell exclusion zone assay carried out using the 
BM MSC CIJM combined with IJCM also induced significant MSC migration 
(72% ± (7%) into the cell free gap (Figure 8.4b). 
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Figure 8.4: In the cell exclusion zone assay, no SF MSC migration was 
observed in response to IJCM. (a) Images were taken at x10 
magnifications. Combination of  IJCM and cell injury conditioned media 
(CIJM) stimulated SF MSC migration into the cell exclusion zone of non-
injured MSC cultures. (b) Graph showing % reduction in wound width (%) 
± SEM in response to IJCM and IJCM supplemented with CIJM either 
collected by injuring BM MSC monolayer cultures (BM MSC CIJM) or 
bovine articular chondrocyte monolayer cultures (BAC CIJM). Significant 
reduction in wound width was observed with both BM MSC CIJM and 
BAC CIJM supplementation with IJCM compared to control. **** 
p<0.0001 compared to negative control.  
(DMEM+0.1% BSA) 
0 h 
24 h 
Control IJCM  
IJCM +  
BM MSC CIJM 
IJCM +  
BAC CIJM (a) 
200 μm 
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8.3.3 Effect of purines UTP and ATP on the IJCM mediated migration of SF 
MSC 
The experiments with the cell injury conditioned medium (CIJM) strongly 
suggested that cell injury released active factors which were required for initiation 
of MSC migration in response to IJCM. Since, ATP has been reported to 
influence MSC migration, whether ATP/UTP accounted for all or part of the 
activity of the CIJM was tested. Preliminary cell exclusion zone assays were 
performed using IJCM supplemented with ATP (250 µM) or UTP (250 µM). 
These experiments were performed using two different types of silicon inserts 
provided by Ibidi (measures % reduction in wound width) and Platypus 
Technologies (Oris-FLEX, measures % reduction in wound area).  Results of the 
assay are summarised below in table 1.  
 
Table 8.1: Results from cell exclusion zone assays performed using two 
different types of silicon inserts. MSC migration was assessed in response to 
IJCM and IJCM supplemented with extracellular nucleotides.   
 Ibidi Inserts (% 
reduction in wound 
width ± SEM); p value 
Oris-FLEX (% 
reduction in wound 
area ± SEM); p value 
Negative control 12 ± 2 17 ± 2 
IJCM 23 ± 4; NS 14 ± 3; NS 
IJCM +BM-MSC 
CIJM  
72 ± 7; p<0.0001 Not tested 
IJCM +BAC 
CIJM 
77 ± 2; p<0.0001  37 ± 3; p<0.01 
IJCM + ATP 43 ± 6; p<0.001 34 ± 1; p<0.001 
IJCM + UTP 66 ± 3; p<0.0001 41 ± 3; p<0.0001 
. 
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A significant increase in SF MSC migration in response to IJCM supplemented 
with CIJM and IJCM supplemented with extracellular nucleotides was observed 
compared to IJCM alone with both Ibidi and Oris-FLEX inserts. However, when 
Ibidi inserts were used, addition of ATP could not induce similar degree of 
migration compared to addition of CIJM. Further, we also observed a significant 
increase in migration with UTP compared to ATP (Figure 8.5a and b). In contrast, 
no such differences were observed with Oris-FLEX inserts (Figure 8.6). However, 
both inserts suggested no significant increase in migration in response to IJCM 
compared to control. These results suggest that Ibidi inserts may be more sensitive 
at detecting differences in MSC migration compared to Oris-FLEX inserts.  
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Figure 8.5: (a) Influence of extracellular nucleotide on SF MSC migration 
evaluated using cell exclusion zone assay. Images were taken at x10 
magnification using light microscopy. Addition of both ATP and UTP to IJCM 
reduced wound width following 24h migration similar to BM MSC CIJM and BAC 
CIJM. (b) Graph showing percentage reduction in wound width (%) ± SEM 
following 24h migration in response to IJCM, IJCM supplemented with CIJM and 
IJCM supplemented with extracellular nucleotides. Significant reduction in wound 
width was observed with both IJCM supplemented with CIJM and IJCM 
supplemented with ATP and UTP compared to negative control. No significant 
reduction in wound width was observed with IJCM compared to control. Further, 
both CIJM and extracellular nucleotide supplementation significantly reduced 
wound width compared to IJCM. IJCM with BM MSC CIJM and BAC CIJM 
(p<0.0001), IJCM with ATP (p<0.05) and IJCM with UTP (p<0.0001).  Moreover, 
significant reduction in wound width was observed with both CIJM addition (BM 
MSC CIJM p<0.01; BAC CIJM p<0.001) compared to addition of ATP. Similarly, 
UTP was more potent at inducing MSC migration (p<0.01) compared to ATP and 
no significant reduction in wound width was observed between UTP and CIJM.  * 
p<0.01, **** p<0.0001 compared to control.  
DMEM + 0.1% BSA 
0 h 
24 h 
IJCM IJCM + UTP IJCM + ATP (a) Control 
200 μm 
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Figure 8.6: Influence of extracellular nucleotide on SF MSC migration 
evaluated using cell exclusion zone assay. Images were taken at x4 
magnification using light microscopy. Oris-FLEX inserts bought from 
Platypus Technology Inc. was used. Addition of both CIJM (BAC CIJM) and 
extracellular nucleotides enhanced MSC migration into the exclusion zone and 
higher reduction in wound area was observed. (b) Graph showing percentage 
reduction in wound area (%) ± SEM following 24h migration in response to 
IJCM, IJCM supplemented with BAC CIJM and IJCM supplemented with 
extracellular nucleotides. Wound area was calculated by measuring diameter 
of the cell exclusion zone void of cells. Significant reduction in wound area 
was observed with both IJCM supplemented with CIJM and IJCM 
supplemented with ATP and UTP compared to negative control. No 
significant reduction in wound area was observed with IJCM compared to 
control. Further, both CIJM and extracellular nucleotide supplementation 
significantly reduced wound area compared to IJCM. IJCM with BAC CIJM 
(p<0.01), IJCM with ATP (p<0.01) and IJCM with UTP (p<0.0001).  
Moreover, no significant difference in reduction of wound area was observed 
between addition of either CIJM or extracellular nucleotides or between 
addition of ATP and UTP. * p<0.01, **** p<0.0001 and NS represents non-
significant.  
(b) 
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8.3.4 Effect of UTPγS and ATPγS on IJCM mediated migration of SF MSC 
Since, ATP and UTP are rapidly degraded by extracellular endonucleases, stable 
nucleotide analogues were used. ATPγS and UTPγS (250 µM) (stable analogue of 
ATP and UTP) were added to IJCM and cell exclusion zone assay of SF MSC 
was performed. There were significantly enhanced wound closures for both 
ATPγS and UTPγS when added with IJCM (Figure 8.7). With ATPγS, the wound 
closure of SF MSC was 83% ± (4%) and with UTPγS it was 84% ± (3%) in 48 h 
assays compared to 21% ± (3%) with IJCM (Figure 8.8).  
In order to characterise the nucleotide receptor identity, time dependent cell 
exclusion zone assay was carried out using IJCM supplemented with ATPγS and 
UTPγS. Higher wound closure with UTPγS suggested that the receptor 
responsible for MSC priming was P2Y rather than P2X which predominantly 
binds ATP (Figure 8.9).  
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Figure 8.7: Influence of stable analogues of extracellular nucleotides on 
SF MSC migration evualuated using cell exclusion zone assay. Wound 
area was created using Ibidi inserts. Images were taken at x10 
magnification. (a) IJCM and CIJM alone did not enhance MSC migration 
to a greater extent compared to control. (b) Similarly, the extracellular 
nucleotides (ATPγS and UTPγS) alone did not enhance MSC migration to 
a greater extent compared to control. However, addition of CIJM or 
extracellular nucleotides to IJCM led to enhanced MSC migration ( higher 
reduction in wound width) compared to control.  
(a) 
(b) 
48 h 
0 h 
48 h 
0 h 
200 μm 
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Figure 8.8: Influence of stable analogues of extracellular nucleotides on 
SF MSC migration evualuated using cell exclusion zone assay. Wound 
was created using Ibidi inserts. Graph showing percentage reduction in 
wound width (%) ± SEM following 48h migration in response to IJCM, 
IJCM supplemented with CIJM (BAC CIJM) and IJCM supplemented with 
stable analogues of extracellular nucleotides. No significant reduction in 
wound width was observed with IJCM or CIJM alone compared to control. 
Similarly, the extracellular nucleotides alone did not significantly reduce 
wound width compared to control. Addition of CIJM to IJCM significantly 
reduced wound width compared to both control (p<0.0001) and IJCM alone 
(p<0.0001). Similarly, addition of both ATPγS and UTPγS also 
significantly reduced wound width compared to control (ATPγS: 
p<0.0001); UTPγS: p<0.0001) and IJCM (ATPγS: p<0.0001); UTPγS: 
p<0.0001). Further, both (ATPγS and UTPγS significantly reduced wound 
width compared to IJCM with CIJM (p<0.0001). And no significant 
difference in wound width was observed between ATPγS and UTPγS. ****, 
p<0.0001 and NS represents non-significant. .  
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Figure 8.9: Influence of stable analogues of extracellular nucleotides 
on SF MSC migration evualuated using cell exclusion zone assay at 
various time intervals. Graph showing percentage reduction in wound 
width (%) ± SEM following 48h migration in response to IJCM and 
IJCM supplemented with stable analogues of extracellular nucleotides.  
Cell injury releases ATP which interacts with a purine receptor which is 
required to prime the MSCs for migration. Enhanced response to UTP is 
suggestive that the purine receptor is of P2Y classification. 
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8.3.5 Influence of purinergic receptor antagonists (P2R antagonists: suramin) 
on SF MSC migration evaluated using scratch assays. 
To further test the involvement of P2R in MSC migration, MSCs were first 
incubated for 30 mins with a non-selective P2 purinergic antagonist (Suramin 
hexasodium salt) prior to determining the migratory capacity using the scratch 
assays. Pre-treatment with P2R antagonists significantly reduced SF MSC 
migration in response to IJCM by 60%. Hence, when 91% ± (3%) wound closure 
was observed with IJCM in untreated MSCs, only 31% ± (2%) wound closure was 
observed with IJCM in MSCs pre-treated with P2R antagonists. Moreover, there 
was no significant difference in wound closure between serum free negative 
control in untreated MSCs (46% (±6%)) and IJCM in pre-treated MSCs (Figure 
8.10).  
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(b) 
Figure 8.10: Influence of purinergic receptor antagonists (P2R 
antagonists: suramin) on SF MSC migration evualuated using 
scratch assays. Mnolayer cultures of SF MSCs were pre-treated with 
P2R antagonists for 1h before addition of IJCM. (a) Images were 
taken at x10 magnification. IJCM ehnanced SF MSC migration 
compared to control (p<0.01). This effect of IJCM on SF MSC 
migration was blocked using P2R antagonists. (b) Graph showing 
percentage reduction in wound width (%) ± SEM over 24h. IJCM 
significantly reduced wound width compared to control (p<0.01). 
Pre-treatment of cells with P2R antagonists prior to addition of IJCM 
signficantly reduced this response of IJCM (p<0.001) and no 
significant difference in migration was observed between control and 
IJCM in pre-treated assays. * p<0.01 and NS represents non-
sgnificant. .  
(a) 
200 μm 
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8.3.6 Measurement of ATP content in IJCM and CIJM 
An ATP bioluminescence assay was used to validate the presence of ATP in 
CIJM. Both IJCM and CIJM were collected at 30 min, 1 h, 2 h and 4 h. In 
addition the ATP content of IJCM collected after 24 h was also determined. The 
results indicated the presence of ATP in the CIJM and also suggested a time-
dependent depletion of ATP content in CIJM. For example, a significant depletion 
in ATP of CIJM was observed from 30 mins to 2 h (189.3 μM ATP to 60.8 μM; 
p<0.0001) which further depleted at 4 h (189.3 μM to 24.1 μM; p<0.0001). In 
contrast, no significant difference in ATP content of IJCM was observed from 
30min (41.1 μM) to 24 h (46.8 μM) (Figure 8.11). 
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Figure 8.11: Measurement of ATP concentration (µM) in cell 
injury conditioned media (CIJM) and IJCM. Confluent 
chondrocyte monolayers were scratched extensively using a 200 
µL pipette tip in the presence of serum free media and incubated 
for various time (h). Following incubation, media was collected as 
CIJM. Chondral flakes were finely cut into very small pieces using 
scalpel blade and incubated in serum free media for various time 
(h). Following incubation media was collected as IJCM. 50 µL 
from each sample was added into a 96-well black opaque-walled 
plate in triplicates and mixed with 50 µL luciferase reagent per 
well. The actual ATP content was calculated from the trend line 
equation generated from the standard curve using GraphPad Prism.   
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8.3.7 Potential of IJCM to stimulate MSC chondrogenesis   
One question we need to answer is whether the injury factors also stimulate MSCs 
to mature/differentiate into cartilage tissue-forming cells (i.e. chondrocytes) which 
are required for the homeostatic cartilage repair process following MSC migration 
to the site of injury. Therefore, micromass cultures of SF and BM MSCs were 
stimulated with IJCM for 10 days. GAG deposition was detected using alcian blue 
staining. IJCM stimulated chondrogenic differentiation of both SF and BM MSCs.  
 
8.3.8 Effect of purinergic stimulation on IJCM mediated chondrogenic 
differentiation of MSCs 
In order to determine the effects of the extracellular nucleotide on IJCM 
stimulated MSC chondrogenic differentiation, micromass cultures of MSCs were 
treated with IJCM, ATP (250 µM) and IJCM containing ATP (250 µM). 
Treatment with ATP alone did not induce MSC differentiation whereas presence 
of ATP in the IJCM consistently produced stronger alcian blue staining compared 
to IJCM alone (Figure 8.12). After 10 days of culture, IJCM stimulated cultures 
showed focal areas of proteoglycan deposition in all micromasses. Staining was 
asymmetrical such that some micromasses showed stronger matrix deposition at 
the edges of the micromasses whereas in some micromasses stronger deposition 
was in the middle of the micromass. In contrast, IJCM with ATP showed more 
symmetrical matrix deposition and strong staining was detected throughout the 
micromass suggesting ATP stimulation may have enhanced IJCM stimulated 
differentiation. Similar alcian blue staining was observed between standard 
chondroinductive media and SF MSC micromass cultures maintained in IJCM 
supplemented with ATP whereas BM MSC micromass cultures appeared more 
compact under alcian blue staining.  
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Figure 8.12: IJCM promotes MSC survival and chondrogenesis. 
Micromass cultures of MSCs were stimulated with IJCM for 10 
days. MSC media (DMEM containing 10% serum) was used as 
negative control and standard chondroinductive media was used as 
positive control. Metachromatic staining with alcian blue, indicative 
of cartilage matrix was used to detect chondrogenesis. Serum 
containing media did not induce chondrogenesis following 10 days. 
Similar colour intensity suggests IJCM induced similar level of 
chondrogenesis as standard chondroinductive media.  
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We also investigated the effect of stable nucleotide analogues ATPγS and UTPγS 
on SF MSC chondrogenic differentiation. Micromass cultures were treated with 
IJCM supplemented with either ATPγS (250 µM) and UTPγS (250 µM) and 
presence of extracellular matrix deposition was visualised by alcian blue staining. 
After 10 days, both ATPγS and UTPγS stimulated chondrogenesis in all the 
micromasses and symmetrical matrix deposition throughout the micromass was 
detected (Figure 8.13). ATPγS stimulated micromasses had similar coloration as 
standard chondroinductive media and IJCM with ATP however, the micromasses 
appeared bigger compared to them. Similarly, UTPγS stimulated micromasses 
appeared more compact and had stronger coloration.  
To test whether TGFβ3 or CXCL12 accounted for all or part of the chondrogenic 
ability of the IJCM we used neutralising antibody against TGFβ3 and the CXCR4 
receptor blocker (AMD3100). Neither the TGFβ3 neutralising antibody nor pre-
treatment with CXCR4 antagonist affected the ability of IJCM to stimulate 
chondrogenesis. However, less intense coloration was observed in the presence of 
TGβ3 antibody compared to IJCM and pre-treatment with CXCR4 antagonist 
(Figure 8.13).  
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Figure 8.13: Influence of stable analogues of extracellular nucleotides, 
TGFβ3 antagonists and CXCL12 receptor antagonist (AMD3100) on 
SF MSC chondrogenesis assessed using micromass cultures. 
Differentiation was detected using alcian blue following 7 days 
stimulation. IJCM stimulated MSC differentiation. Both ATPγS and 
UTPγS stimulated chondrogensis in all the micromasses and symmetrical 
matrix deposition throughout the micromass was detected with intense 
coloration detected in some micromasses but not in all cultures.  ATPγS 
stimulated micromasses had similar coloration as standard 
chondroinductive media and IJCM with ATP however, the micromasses 
appeared bigger compared to them. Similarly, UTPγS stimulated 
micromasses appeared more compact and had stronger coloration. 
Micromasses were pre-treated with AMD3100 before addition of IJCM. 
Even though blocking TGFβ3 did not completely block differentiation, 
reduced coloration was observed compared to IJCM. In contrast, blocking 
CXCL12 receptor did not affect chondrodrogenesis. 
Note: The IJCM images are same as those shown above in figure 8.12. 
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8.4 Chapter Discussion  
SF MSCs need to be primed by extracellular UTP and to a lesser extent ATP 
released through cell injury before migration along the CXCL12 chemotactic 
gradient. In the previous chapter we have shown that following injury cartilage 
releases factors which are stable for 24 h and these factors can stimulate MSC 
migration to the site of the injury. In this chapter exclusion zone assays were used 
for studying MSC migration in the absence of cell injury. Using this assay system 
it was demonstrated that in the absence of cell injury, SF MSCs do not respond to 
the chemotactic gradient of the IJCM. Furthermore, it was demonstrated that ATP 
and UTP enhanced MSC migration in response to the IJCM.  
To separate the effect of cell injury from the IJCM, chondrocyte monolayers were 
injured using a 200 µl pipette tip in the presence of serum-free media and the 
injured cells cultured for 30 mins. It was hypothesised that factors released 
through cell injury would be released in this media and therefore the injury 
conditioned media (CIJM) was collected 30 mins after the chondrocyte 
monolayers had been injured. Cell exclusion zone assays of SF MSCs in the 
presence of IJCM and CIJM together showed rapid wound closure suggesting that 
CIJM contained factors which is required in conjunction with IJCM to trigger 
significant MSC migration. This also supports our previous results where no 
CIJM was required in ‘classical wound healing’ assays where the wound area was 
created by a manual scratch. It is therefore conceivable that the scrapping of the 
cell monolayer created cell injury, releasing the required factors for MSC 
stimulation.  
The observation that IJCM alone cannot stimulate MSC migration in the absence 
of injury suggests that the factors released through cell injury are not present in 
the IJCM and are therefore not stable for 24 h making short-acting factors the 
most probable targets.  
There are few studies showing the effect of purine nucleotides on MSC migration 
or migration. Previous studies have reported ATP to potentiate haemopoietic stem 
cell chemotactic response to CXCL12 and increase spontaneous migration [75]. 
Other studies have reported the presence of P2R subtypes such as P2X6, P2Y4 
and P2Y14 playing a major role in adipose tissue-derived MSC commitment to 
adipogenic and osteogenic differentiation [110]. The effect of adding ATP and 
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UTP to IJCM in the cell exclusion zone assay was investigated and it was 
demonstrated that the presence of these extracellular nucleotides triggered rapid 
wound closure compared to IJCM alone. Although, the purinoreceptor expression, 
of SF MSCs was not analysed, the increased chemotactic response of SF MSCs is 
in line with signalling pathways initiated by P2 receptors.  
Recent studies have suggested that UTP and ATP may play a role in 
hematopoietic stem cell motility and migration to bone marrow niches in synergy 
with CXCL12 via activation of Rho GTPase transduction pathway [75]. ATP and 
UTP functions are mediated by P2 nucleotide receptors P2Rs. P2Rs are further 
divided into P2X and P2Y. P2Y receptors (P2YRs) are also 7 transmembrane 
spanning receptors coupled to G-proteins. Signal transduction of UTP binding to 
P2YR is mediated by either activation of phospholipase C or activation/inhibition 
of adenylate cyclase. Our results of increased wound closure with UTPγS 
compared to ATPγS suggested that P2Y receptors (characterised by a greater 
binding affinity and biological activity for UTP over ATP) rather than P2X 
receptors (which has a greater binding affinity and biological activity for ATP 
over UTP) was responsible for the SF-MSC priming.  
Additionally, BM MSCs did not require this priming system to migrate in 
response to the IJCM chemotactic gradient. This suggested that priming maybe a 
specific requirement for SF MSCs. Moreover, since, these extracellular 
nucleotides are released through cell injury; SF MSCs could be the first cell type 
to detect the release of the nucleotides whereas BM MSCs do not have access to 
the nucleotides unless the injury extends to the subchondral bone. As a result, BM 
MSCs have a different method of migration involving other key chemokines such 
as TGFβ3 and bFGF2, one of which is not required by SF MSCs for migration. 
This result would explain the fact that other major chemokines such as TGFβ3 
(22.3%) and bFGF2 (33.6%) were also able to partiality block the activity of the 
IJCM in BM MSC migration assays.  
Chondrocytes when either damaged or have an altered metabolic activity such as 
in osteoarthritis (OA) and rheumatoid arthritis (RA) may release ATP into the 
synovial fluid [109]. Studies analysing the MSC gene expression profile showed 
that in ATP-stimulated human bone marrow derived MSCs, genes involved in cell 
migration were strongly upregulated [75]. Therefore, it is possible that ATPs 
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released from the damaged chondrocytes through cartilage injury into the synovial 
fluid may stimulate the synovial derived MSCs and prime them through 
upregulation of migratory genes. This priming could then enhance MSC migration 
along the chemotactic gradient of CXCL12 leading them to the site of the injury. 
However, it is known that ATP is rapidly hydrolysed by synovial fluid from both 
normal and osteoarthritic joints [109] and by ectonucleotidases on the plasma 
membrane of chondrocytes [111]. This could prevent priming of sufficient 
number of MSCs and could be one of the reasons why sufficient number of MSCs 
does not migrate to the injury site. Therefore, inhibition of the action of 
ectonucleotidases in the joint may be one potential mechanism to prime sufficient 
MSCs for migration.  
 
8.5 Chapter summary 
The aim of this study was to investigate if cell injury released factors which were 
required for MSC migration to the site of the cartilage injury. We found that SF 
MSCs but not BM MSCs need to be primed by extracellular UTP and to a lesser 
extent ATP released through cell injury before migration along the CXCL12 
chemotactic gradient. 
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Chapter 9 
General Discussion  
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Current surgical interventions in place to treat cartilage injury such as ACI and 
MACI require two surgical procedures. First a biopsy of donor articular cartilage 
tissue is required from which the chondrocytes are isolated. After a period of in 
vitro culture to expand the numbers of isolated cells a second operative procedure 
is required for implantation of the cultured cells into the cartilage defect; either 
directly (ACI) or through implantation of a biomaterial membrane onto which the 
cells have been seeded (MACI). However, there are several potential concerns 
which can arise with these procedures such as the need for extensive cell 
expansion in culture, donor site morbidity, limited integration between host and 
repair tissue and repair through formation of fibrocartilage instead of the original 
hyaline cartilage [27, 49, 50, 112].. Therefore, it is important to develop new 
therapeutic strategies which eliminate the need for multiple surgical procedures 
and ex vivo cell manipulation prior to implantation as these strategies would 
minimise the, the amount of clinical time and resources required to surgically treat 
the damaged cartilage. One potential way to bypass the issues associated with 
cell-based therapies is to use the body’s own resources and repairing capacities by 
targeting host ‘repair cells’ i.e. mesenchymal stem cells (MSCs) and recruiting 
them to the site of injury. Therefore, a model of articular cartilage damage was 
established in which the potential responses of bone marrow-derived (BM) and 
synovial fluid-derived (SF) MSCs to the injured cartilage could be investigated.  
 
9.1 Characterisation of the optimal culture conditions for isolation and 
expansion of bovine BM and SF MSCs 
9.1.1 Effect of serum  
The data shown in this thesis indicated that culture parameters such as serum, 
glucose concentration, quality of the plastic surface of the culture flasks and stable 
glutamine greatly affected the survival and proliferation of MSCs in culture. In 
early preliminary experiments, MSCs were cultured using low glucose DMEM 
containing 10% FCS and 5 ng/ml of FGF2. However, both SF and BM MSCs 
failed to proliferate and appeared to senesce within 4-5 days after plating in 
culture flasks. The serum used for the preliminary experiments was likely to be 
the cause of the failure of these cell cultures The serum used is a critical step in 
the establishment and optimisation of MSC cultures as it contains important 
biological factors required for cell proliferation, binding proteins for the transport 
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and utilisation of other essential molecules, hormones, substrates for attachment 
molecules and nutrient molecules for cell growth [113]. For example, it has been 
suggested that replicative senescence of MSC (aging with passage) can be 
influenced by serum supplements and platelet lysate was found to be more potent 
at inducing MSC proliferation before the cells reached senescence compared to 
the commonly used FCS [114]. Furthermore, appropriate selection of serum has 
also been reported to influence MSC differentiation such that certain serums may 
contain inhibitors of cell differentiation [115]. Variations in the levels of 
biological factors among different sera means that different serum batches have 
varying capacities to maintain MSC characteristics in vitro. Hence, a commercial 
MSC qualified serum was tested and used throughout the project as it was quality 
assured by the manufacturer as supporting MSC proliferation, viability and 
multipotency in culture.  
 
9.1.2 Effect of plastic surface  
Quality of the culture surface is also known to affect MSC cultures [115]. For 
example, one study investigated the impact of plastic adherence using culture 
flasks from four different companies and found that compared to Greiner, Nunc 
and Costar, Falcon flasks allowed significantly higher MSC proliferation over 4-
week culture. All four flasks tested were made from polystyrene where the culture 
surface was made permanently hydrophilic using corona discharge under high 
voltage. The usual laboratory Corning culture flasks were found to be suboptimal 
for SF- and BM-MSC culture in this study and changing to a class of Sarstedt 
flasks considerably improved MSC growth and proliferation.  
 
9.1.3 Effect of L-glutamine  
L-glutamine is a necessary component for protein and nucleic acid synthesis as 
well as for energy production by cells during in vitro culture. Hence, it is 
commonly supplemented into the culture media [116]. However, L-glutamine is 
known to be unstable in culture media and its degradation can lead to ammonia 
formation which can inhibit cell growth. To avoid this, alternative and stable 
substitutes of L-glutamine such as GlutaMax (L-alanyl-L-glutamine dipeptide) 
have been developed. One previous study comparing expansion efficacy of human 
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BM MSCs among 8 different basal media and glutamine supplementation found 
αMEM supplemented with GlutaMax provided the most optimal conditions for 
MSC expansion [117]. However, in the study reported in this thesis it was 
observed that L-glumatine instead of GlutaMax was more consistent in supporting 
bovine BM and SF MSC growth. This was probably due to a greater ease of the 
MSCs to utilise the glutamine over GlutaMax which requires the release of 
aminopeptidases by the MSCs to cleave the L-alanyl-L-glutamine dipeptide to 
release the L-glutamine (and L-alanine) which can then be taken up by the cells. .  
Following, the optimisation of serum, culture flasks and glutamine 
supplementation, consistent culture of both SF and BM MSCs was achievable.  
9.1.4 Passage number  
During this study an apparent constant growth rate was observed in SF MSC 
cultures for 7 consecutive passages when maintained at subconfluency; whereas 
BM MSCs had a progressive reduction in the apparent rate of proliferation and 
appeared to enter into senescence in culture following 5 consecutive passages. 
 
At this passage the BM MSCs started to become enlarged, appeared to have a 
morphology also known as ‘fried egg morphology’ and the cells appeared to have 
ultimately underwent growth arrest which is characteristic of senescence [118]. 
MSCs like any other stromal cells have limited lifespan in vitro and hence can 
only be expanded for a restricted number of times before cells start to become 
senescent. Moreover, many have previously reported that long-term in vitro 
expansion impairs MSC differentiation potential [119-122]. Previous studies have 
demonstrated that such replicative senesce was associated with gene expression 
alterations in MSCs similar to those observed in age-related changes between 
young and old donor [122, 123]. Therefore, there is a suggestion that changes 
observed during long-term cultures might be regulated by the same mechanism 
which regulates age related changes.  
Hence, in this study MSCs (both SF and BM MSCs) were only expanded until 
passage 3when they were used for experiments. 
 
In this study it was also observed that maintenance in culture was dependent on 
how long the cells were exposed to trypsin/EDTA during passaging. Hence, along 
General Discussion 
 
209 
 
with reducing the time of the trypsinisation, the trypsin/EDTA was diluted at a 
75:25 ratio with phosphate saline buffer (PBS) in order to obtain the highest 
number of healthy MSCs.  
 
9.2 Difference in morphology and differentiation potential between BM and 
SF MSCs 
9.2.1 Morphology 
SF and BM aspirates were obtained from the bovine metacarpophalangeal joints. 
No obvious correlation between the yield of cells and the volume of SF and BM 
obtained with an aspirate was observed. Furthermore, visual microscopic 
evaluation of the cultured cells also suggested that there was no apparent 
correlation between the rate at which the cells proliferated and the initial seeding 
density of the cells. Studies investigating the optimal conditions for culturing 
human BM MSCs suggested the presence of three morphologically distinct cell 
types  [124, 125]. Similarly, three morphologically distinct types of cells was also 
observed in our bovine BM MSC cultures: 1). small and rounded spindle shaped, 
2). thin spindle shaped and 3) thin and elongated spindle shaped (as shown in 
Figure 4.1). However, no differences in cell morphology were observed following 
day 8 when the cultures reached approximately 60-70% confluency. In contrast, 
no heterogeneity in SF MSC morphologies was observed throughout the culture 
period from initial plating to 100% confluency which is in agreement with 
previous reports [126].  
Morphologically, BM MSCs appeared to be different from the SF MSCs. 
Following plating into tissue culture flasks, BM MSCs appeared to be spindle-
shaped whereas, SF MSCs appeared to be stellate or squat shaped.  
9.2.2 Differentiation potential 
Differentiation assay to validate MSC tri-potentiality suggested that BM and SF 
MSCs were also different in their biology. For example, BM MSCs had higher 
adipogenic capacity as seen from higher number of fat-laden cells following 
stimulation with standard adipoinductive media compared to SF MSCs (Figure 
4.3). This is consistent with previous studies where SF MSCs were found to have 
consistently low adipogenic capacity compared to their BM counterparts [29]. In 
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the present study the chondrogenic differentiation capacity between BM and SF 
MSCs was not quantified. Both alcian blue staining, indicative of GAG deposition 
and immunohistochemical staining for collagen II deposition suggested that both 
BM and SF MSCs had strong chondrogenic capacity. However, the differentiation 
capacity among different individual BM and SF MSC colonies was not analysed. 
SF MSC clones have previously been reported to be very homogenous in their 
mesenchymal lineage differentiation capacity [29] compared to BM MSC clones 
which have been shown to be highly variable in their differentiation capacity. It is 
suggested that the good chondrogenic capacity of SF MSCs could be due to the 
expression of hyaluronan receptor CD44 which was expressed at a higher level 
and more consistently on the surface of SF MSCs compared to BM MSCs [126].  
9.3 Models of cartilage injury  
In order to study the role of the MSCs in the healing of articular cartilage defects 
it was first important to define the model of cartilage injury. Potential models of 
articular cartilage injury were investigated using standard surgical tools such as 
biopsy punch, post-mortem blades, no.11 scalpel blade, no. 22 scalpel blade and 
hammer. The range of instruments enabled study of both blunt and sharp injury on 
the cartilage. Damage to the cartilage was assessed using live/dead staining of 
chondrocyte viability following induction of injury. Injuring cartilage with a sharp 
cutting edge gave a   more reproducible injury with less extensive chondrocyte 
death compared to blunt injuries (Section 6.3.2). Therefore, a sharp injury was 
chosen as the model of cartilage injury to investigate the MSC migration in 
response to the cartilage injury. 
9.4 Migration assay  
In this study three different types of migration assays were used to assess MSC 
migration in response to cartilage injury. A commercial Transwell assay system 
was used to study MSC migration in response to injured cartilage discs. The 
scratch assay system was used as a high-throughput method to screen the injury 
conditioned media (IJCM) produced by incubating injured cartilage with serum-
free medium (section ????) and experiments characterising potential biological 
agents responsible for stimulating MSC migration in response to cartilage injury 
(Sections ???). Cell exclusion zone assays were used to assess MSC migration in 
response to IJCM in the absence of cell injury (Sections ???).  
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9.5 Migration capacity of SF- and BM MSC to cartilage injury  
In the present study we investigated the response of two types of MSCs; SF-
MSCs and BM-MSCs to articular cartilage injured by cutting with a scalpel. 
PKH67-labelled SF-MSCs specifically adhered to the freshly cut edges of 
cartilage but not to edges cut previously (i.e. during tissue isolation) or to the body 
of the cartilage. These results indicated that MSCs could ‘home’ to injured 
articular cartilage and were supported by quantitative experiments showing that 
both SF- and BM-MSCs significantly migrated to a greater extent to injured 
cartilage compared to non-injured cartilage.   
9.6 Source of biological factors in the injury conditioned media (IJCM) 
9.6.1 Released from extracellular matrix 
A range of proteins such as proteolytic enzymes, growth factors and chemokines 
have binding sites for sulphated GAGs (such as heparin) and can be found 
sequestered in the cartilage extracellular matrix (ECM) by binding to sulphated 
GAG side chains of proteoglycans in the ECM. There are various sulphated 
GAGs in the cartilage ECM including heparan sulphate and dermatan sulphate. 
Heparan sulphate is a GAG that is known to bind chemokine and growth factors 
in vivo and is present in the ECM as extended O-linked chains of proteoglycans 
such as perlecan, versican and syndecan. The biologically active factors bound to 
these sulphated GAGs can be mobilised when required or can act as concentration 
gradients of chemokines for inducing cell migration [127]. The sequestering of 
biologically active factors by the sulphated GAGs is an important mechanism to 
prevent these factors from being chemically and proteolytically degraded. 
Therefore, it was feasible that the migration inducing factors in the IJCM may 
bind to sulphated GAGs. Hence, IJCM was treated with immobilised heparin (a 
mimic for heparan sulphate) in vitro. The rationale for treating IJCM with 
immobilised heparin was the following: if the factors were GAG-binding proteins 
(synthesised by the cells or released from the ECM ) they would be removed by 
heparin treatment, then the treated IJCM will be less potent in inducing MSC 
migration compared to untreated IJCM. In fact, treatment of IJCM with heparin 
was found to significantly reduce the migratory capacity of IJCM for both SF and 
BM MSCs (Figure 7.10). 
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Heparin-treatment of IJCM also affected adhesion of MSCs to the plastic surface. 
Interestingly, when BM MSCs were cultured in 24-well plates not coated with 
fibronectin, some BM MSCs lost plastic adherence when exposed to heparin-
treated IJCM but all BM-MSCs appeared to remain attached in the presence of 
untreated IJCM. All BM MSCs identified to date have been shown to need 
adhesion to a substrate for their isolation, survival and expansion in vitro [128, 
129]. These results suggested that the heparin treatment removed one or more 
heparin-binding factors which were required for cell adhesion. Such examples 
could be fibronectin which is present in articular cartilage ECM.  
However, it was observed that the detached BM MSCs were capable of surviving 
independently of adhesion as single floating cells (Section 7.3.5). This has been 
previously shown in one study where adult human BM MSCs were observed to 
survive in a stirred suspension as individual cells in a cytokine-dependent manner 
while preserving their capacity to differentiate into osteoblastic cells [130]. Their 
cytokine cocktail consisted of stem cell factor (SCF), IL-3 and PDGF which 
stimulated cell expansion in cell suspensions. All of these factors have been 
implicated as potent mitogen for MSC adherence and survival [131]. IJCM was 
not analysed in this project for the presence of SCF, IL-3 and PDGF. However, 
since all three of these factors bind to heparin [132-135], it was possible that they 
were removed from the IJCM by the heparin treatment and so were not present in 
the heparin-treated IJCM. It was observed that only 40% of cells in monolayer 
losing their plastic adherence in response to heparin-treatment also suggests a 
heterogeneous BM MSC cell population which have been extensively reported in 
the past [113, 115, 117, 124-126, 136-140] 
9.6.2 Released from the cells  
Even though treatment with heparin reduced the migration stimulatory capacity of 
IJCM, for both SF- and BM-MSCs, migration of the cells by heparin-treated 
IJCM was still significantly greater (SF-MSCS: P=0.002, BM-MSCs: P=0.0254) 
than that in serum-free control media (Figure 7.10). This suggested that perhaps, 
not all active components of IJCM were heparin-binding proteins. To assess if 
injury stimulated  
To assess if injury stimulated synthesis of some of the factors prior to release 
cartilage was injured in the presence of cycloheximide (protein synthesis 
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inhibitor). Cycloheximide caused significant inhibition in SF-MSC migration 
capacity of IJCM.  Therefore, production of migration factors by the injured 
cartilage may require de novo synthesis or secretion themselves or of one or more 
components (but not MMPs; Figure 7.21) required to release migration factors 
from the cartilage.  
9.7 Characterisation of IJCM 
9.7.1 Identification of migration factors in IJCM using neutralising 
antibodies and receptor antagonists 
Neutralising antibodies and receptor antagonists against common heparin 
interactome members reported to stimulate chondrogenesis and MSC migration 
[89] were used to characterise IJCM-migratory factor(s).  
Likely heparin-binding candidates were CXCL12 (a well-known MSC migration 
chemokine), CX3CL1, CCL2, CCL3, CCL5, TGFβ family and FGF family. In 
addition, other cytokines such as TNFα could be released during the injury 
process. Initial preliminary scratch migration assays showed that SF MSC 
migration was significantly stimulated by addition of recombinant CXCL12, 
CCL2, CCL5, CXCL12, TGFβ3 (Figure 7.14). However, TNFα, CCL3 and FGF2 
had no significant effect (Figure 7.14) on SF MSCs although BM MSCs migrated 
also to FGF2.  Therefore, neutralising antibodies to TGFβ3, CXCL12, CCL2, 
CCL5 and the CXCR4 receptor antagonist AMD 3100 were used to investigate 
the identity of the heparin-binding moietie(s) which caused the migratory activity 
of IJCM.   
Experiments using the CXCR4 inhibitor, AMD3100, the CXCL12-neutralising 
antibody and TGFβ3 neutralising antibody strongly suggested that CXCL12 and 
TGFβ3 is released from the injured cartilage within 24 h of injury. When these 
antibodies were tested with BM MSCs, similar significant reduction in migration 
was observed which further validated our findings. However, in contrast to SF 
MSCs, BM MSC migration was also affected by the presence of FGF2 antibody 
in the IJCM suggesting that FGF2 was also released from the injured cartilage 
within 24 h of injury [Figure 6 and 7].   
CXCL12 is a member of a large chemokine family and has been shown to play a 
major role in the migration of BM MSCs. For example, using bioluminescence 
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imaging Granero-Molto et al showed that dynamic migration of BM MSC is 
exclusively dependent on the CXCR4 receptor [141]. Similarly, recruitment of 
BM MSCs to sites of bone healing for endochondral bone repair was also shown 
to be critically dependent on the CXCL12/CXCR4 axis [142]. The importance of 
CXCL12/CXCR4 axis for MSC migration has also been implicated in non-
musculoskeletal tissues. In addition, genetically modified MSCs overexpressing 
the CXCR4 receptor were found to home towards the coronary infarct in greater 
numbers as compared to untransduced MSCs [143]. This axis also mediated 
migration of transplanted BM MSCs to the site of the brain injury and induction 
of BM MSC mobilisation to the burn wounds [89].  
Results presented in this thesis also suggested that CXCL12 was released from the 
injured cartilage within 24 h of injury. This observation is in common with others 
showing CXCL12 release during tissue damage. Previous studies have reported 
the increase in secretion of CXCL12 during tissue damage such as heart infarct 
[144], liver damage due to toxicity [145], excessive bleeding [144] and tissue 
damage following chemotherapy [146]. Studies investigating release of CXCL12 
following fracture suggested that transcription factor HIF-1α may drive the 
increased production of CXCL12 in the damaged tissues [96]. This report [49] 
also suggested that in the absence of injury, PHD2 (prolyhydroxylase domain 
protein 2) degrades HIF-1α. However, low levels of O2 at the damaged site 
reduces PHD2 activity, leading to stabilisation of HIF-1α which then translocates 
to the nucleus, binds to the promoter region of the CXCL12 gene and thereby 
increases the production of CXCL12 in the damaged tissues. Cartilage is 
maintained in a hypoxic environment under normal physiological condition. 
Therefore, it is possible that release of CXCL12 from the injured cartilage was not 
through the same mechanism.  However, previous studies have reported that HIF-
2α and not HIF-1α was critical for the hypoxia induced cartilage matrix synthesis 
[147]. Therefore, it is also possible that HIF-1α only increases in the cartilage 
following injury which then stimulates the release of CXCL12. This is also 
consistent with the findings presented in this thesis where a significant reduction 
in SF MSC migration was observed when media was conditioned by injuring 
cartilage in the presence of the protein inhibitor cycloheximide and the injury 
conditioned media was used to stimulate SF MSC migration in scratch assays 
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suggesting that injury may stimulate the production of migration stimulatory 
factors in the cartilage (Figure 7.21). 
Another possibility is that CXCL12 was released from an extracellular reservoir 
following mechanical injury. Extracellularly, they are likely to be sequestered in 
the ECM bound to heparan sulphate containing proteoglycans. This concept of 
release of proteins from an extracellular reservoir following mechanical injury of 
cartilage have already been demonstrated for FGF2 where FGF2 was shown to be 
released immediately following cutting injury [46]. This is also consistent with 
our findings where significant reduction in BM MSC migration in response to 
IJCM was observed when neutralising antibody against FGF2 was added to the 
IJCM [Fig 7]. This suggested that FGF2 was released from the injured cartilage 
following cutting injury and was partly responsible for stimulating BM MSC 
migration in response to IJCM.  
Application of FGF2 has been shown to promote cartilage repair in partial 
thickness defects in both immature [24] and mature rabbits [148]. Further, 
administration of FGF2 antibody into the full-thickness defects in rabbits was 
shown to prevent cartilage formation in the defects, even 4 weeks post-defect 
creation [149]. Whereas, administration of FGF2 into the full thickness defects 
improved cartilage repair and restored the original bone-articular cartilage 
junction. Mechanism of cartilage repair by FGF2 is still not clearly known. 
Marked increases in endogenous FGF2 production in repair tissue have been 
previously reported. Moreover, FGF2 has been reported to promote rapid 
proliferation of chondroprogenitor cells while maintaining their stemmness in 
vitro [150]. These suggest that MSCs are the target of FGF2 during the reparative 
process. In agreement with previous observations, in this present study it was 
demonstrated that FGF2 promotes cartilage repair by stimulating migration of BM 
MSCs to the site of the injury where MSCs then take part in the repair of the 
cartilage defect.  
The results presented in this thesis also suggested the release of TGFβ3 from the 
cartilage following sharp injury. For example, significant reduction in both SF and 
BM MSC migration was observed in scratch assays in response to IJCM when the 
IJCM was pre-treated with TGFβ3 antibody. Previous studies have suggested a 
decrease in TGFβ3 expression in the damaged cartilage [151]. However, in that 
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study, they used a model of OA in contrast to this study where an immediate 
response following injury was investigated. Furthermore, they observed a strong 
increase in TGFβ3 expression in other compartments of the joint such as the 
synovial tissue which is consistent with TGFβ3 being released into the joint cavity 
following injury, similar to our results found in this study. TGFβ3 has already 
been demonstrated to be a potent inducer of chondrogenesis and cartilage matrix 
synthesis [152] suggesting that TGFβ3 plays an important role in cartilage 
maintenance. Therefore, our findings that TGFβ3 released from the injured 
cartilage stimulates both SF and BM MSC migration to the site of injury, is 
suggestive that TGFβ3 also may play an important role in cartilage repair.  
Differences in response to injured cartilage between SF and BM MSC migration 
was also observed in this study. For example, with SF MSCs a significant 
reduction in migration in response to heparin-treated IJCM compared to untreated 
IJCM was observed. In contrast, in the absence of ECM coating in the plates, 
when BM MSCs were stimulated with heparin-treated IJCM, they lost their plastic 
adherence to plate and formed cell aggregates whereas cells stimulated with 
untreated IJCM remained attached to the uncoated plastic. This suggested that 
heparin-treatment might be removing factors which were required for BM MSC 
adherence but not for SF MSC adherence and therefore, BM and SF MSCs might 
use different pathways for cell attachment. Further, analysis of cell migration in 
scratch assays suggested that while SF MSCs migrated as single cells, BM MSCs 
migrated as a sheet of cells. Moreover, while BM MSCs migrated significantly 
more to dead cartilage compared to non-injured cartilage, this difference in 
migration was not observed with SF MSCs. BM MSCs and SF MSCs also 
responded to different growth factors in the IJCM. For example, significant 
reduction in BM MSC migration in response to IJCM was observed when 
neutralising antibody against FGF2 was added to the IJCM. However, no 
reduction in migration was observed with SF MSCs in response to FGF2 
antibody. Therefore, it is possible that dead cartilage also released FGF2 which 
then promoted BM MSC migration in response to the dead cartilage.  
Cartilage injury usually progress to degeneration of the cartilage since it has 
limited capacity to repair. Our results suggest that cartilage following sharp injury 
releases CXCL12, TGFβ3 and FGF2 which may act as signals to attract both SF 
and BM MSCs to the site of the injury. Further, in partial-thickness defects, where 
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BM-MSCs do not have a direct access to the injury site, SF-MSCs could be 
involved in the regeneration of the injured cartilage.  
9.7.2 Differential response between SF – and BM MSCs in response to IJCM 
Differences in response to injured cartilage between SF and BM MSC migration 
was also observed in this study. For example, with SF MSCs a significant 
reduction in migration in response to heparin-treated IJCM compared to untreated 
IJCM was observed. In contrast, in the absence of ECM coating in the plates, 
when BM MSCs were stimulated with heparin-treated IJCM, they lost their plastic 
adherence to plate and formed cell aggregates whereas cells stimulated with 
untreated IJCM remained attached to the uncoated plastic. This suggested that 
heparin-treatment might be removing factors which were required for BM MSC 
adherence but not for SF MSC adherence and therefore, BM and SF MSCs might 
use different pathways for cell attachment. Further, analysis of cell migration in 
scratch assays suggested that while SF MSCs migrated as single cells, BM MSCs 
migrated as a sheet of cells. Moreover, while BM MSCs migrated significantly 
more to dead cartilage compared to non-injured cartilage, this difference in 
migration was not observed with SF MSCs. BM MSCs and SF MSCs also 
responded to different growth factors in the IJCM. For example, significant 
reduction in BM MSC migration in response to IJCM was observed when 
neutralising antibody against FGF2 was added to the IJCM. However, no 
reduction in migration was observed with SF MSCs in response to FGF2 
antibody. Therefore, it is possible that dead cartilage also released FGF2 which 
then promoted BM MSC migration in response to the dead cartilage.  
Cartilage injury usually progress to degeneration of the cartilage since it has 
limited capacity to repair. Our results suggest that cartilage following sharp injury 
releases CXCL12, TGFβ3 and FGF2 which may act as signals to attract both SF 
and BM MSCs to the site of the injury. Further, in partial-thickness defects, where 
BM-MSCs do not have a direct access to the injury site, SF-MSCs could be 
involved in the regeneration of the injured cartilage. 
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9.8 Purinergic priming factors and their importance in MSC migration   
9.8.1 Comparison between Scratch and Cell exclusion zone migration assays  
In this study two different types of wound healing assays were used to study SF 
MSC migration in response to IJCM. ‘Classical’ scratch assays were used to study 
SF MSC migration in response to IJCM in the presence of cell injury. Making the 
‘scratch’ in the cell layers is done manually therefore to increase precision cell 
exclusion assays were carried out (Chapter 8).  
In contrast to the results found with the scratch assay (and Transwell assays).  
IJCM did not promote cell migration in SF MSCs in the cell exclusion assays. 
Also, in contrast to scratch assays, heparin treatment significantly increased the 
migration stimulatory capacity of IJCM and cell migration to heparin-treated 
IJCM was observed in the cell exclusion assays (Figure 8.2). Hence, when no 
significant SF MSC migration was observed in response to untreated IJCM 
compared to serum free media, almost always 100% wound closure was observed 
with heparin-treated IJCM. These differences between the Scratch and cell 
exclusion assays in terms of the effects of IJCM and heparin-treated IJCM were 
reproducible. 
However, the two assays have one fundamental difference in their mode of 
operation. A small injury is made in the cell layer in the scratch assay whereas no 
injury is made in the cell exclusion assays. To determine if this was the reason, 
cell migration assays were performed for 24 h in the cell exclusion assay system. 
After the 24 h period, a small scratch was made in the cell layer and the plates 
incubated for a further 24 h and the cell migration measured (Figure 8.3a).  It was 
evident that after creating the scratch in the cell layer the cells migrated in 
response to the IJCM. In addition, the migration seen in the cell exclusion assays 
to heparin-treated IJCM was inhibited by creating a scratch (similar to one made 
in scratch assays) close to the cell exclusion zone (Figure 8.3b). The reason for 
this migration stimulatory effect of heparin-treated IJCM in cell exclusion zones 
is unclear. It could be deduced that IJCM contained both migration stimulatory 
and inhibitory factor(s). The inhibitory factor(s) were not heparin-binding proteins 
and hence, were not removed by heparin treatment of IJCM. However, it was 
clear that a small ‘fresh’ wound/scratch was needed to enable the migration of SF 
and BM MSCs in response to the IJCM. Therefore, these studies indicated that 
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one or more labile agents was released by the cells which was not present after 24 
h (i.e. not present in the IJCM) but was present immediately after wounding i.e. 
scratching the cell layers. One class of biological mediators which are very labile 
are the extracellular nucleotides which have been indicated in various cell 
signalling pathways [153, 154]. Therefore, it was decided to look for ATP release 
by the injured cell layers and whether purine nucleotides influenced the migration 
of SF and BM MSCs in response to IJCM. 
9.8.2 Why does injured cartilage release both migration stimulatory and 
inhibitory factors?  
Characterisation of IJCM suggested that IJCM not only contained factors for 
MSC migration, it also contained factors for MSC survival and chondrogenesis. 
For example, SF MSCs cultured in IJCM had two main characteristics: elongated 
single cells with protruding ends suggestive of cell migration and condensation to 
form elongated tubes of cell aggregates which have previously been shown to be a 
pre-requisite step for chondrogenesis [155]. IJCM’s ability to induce 
chondrogenesis was further shown by stimulating micromass cultures of MSCs 
with IJCM for 10 days and detecting GAG deposition using alcian blue staining. 
For successful repair through MSC migration and formation of repair tissue 
through MSC chondrogenesis, it is important that the timing between migration 
and tissue formation is well co-ordinated such that the necessary signals for tissue 
remodelling do not come before the MSCs have migrated to the site of injury. 
Therefore, it is possible that the migration inhibitory factors present in the IJCM 
plays a role in the timing between MSC migration and MSC condensation.  
9.8.3 Role of extracellular nucleotides 
To further understand the active components released through cell injury; 
monolayers of chondrocytes and BM MSCs were injured in the presence of serum 
free media and collected after 4 h. Addition of this cell injury conditioned media 
(CIJM) to IJCM in cell exclusion zone assay was able to initiate SF MSC 
migration but it was not sufficient to induce significant wound closure. This 
suggested that the factor(s) responsible for initiating migration were short lived 
and was possibly degraded by 4 h. Reduction of the collection time of CIJM to 30 
mins strongly enhanced the effect of CIJM such that significant wound closure 
was observed in cell exclusion zone assays with IJCM+CIJM.  
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Drastic reduction in CIJM potency between 30 mins and 4 h suggested that the 
factor(s) responsible for initiating migration in response to IJCM+CIJM were 
short-lived. Previous experiments have suggested that extracellular nucleotides 
such as ATP or UTP are released from injured or non-apoptotic cells where it acts 
as a danger signal or damage-associated molecular pattern (DAMP) signal  by 
activating the innate immunity [156]. For example, ATP has been shown to be 
locally released following myocardial infarction where it plays a critical role in 
inducing inflammation by activating NLRP3 and caspase-1 [157]. DAMPs are 
intracellular molecules which are hidden in order to avoid recognition by the 
immune system under physiological conditions. However, when cells or tissue are 
injured, DAMPs are either presented on the surface of the stressed/injured cells; 
secreted passively into the surrounding extracellular environment from the dying 
cells or the injured ECM or they can be actively secreted by the stressed cells 
[158]. Secreted DAMPs are recognised by pattern-recognition receptors (PPRs) 
which then activate the innate immunity.  
Analysis of CIJM using bioluminescence assay confirmed the presence of 
micromolar levels of ATP in the cell injury media. This also suggested that 
immediately following cartilage damage, injured chondrocytes may release 
extracellular nucleotides into the synovial fluid where the nucleotides might act as 
damage signals. Injury-induced DAMPs play a critical role in inflammation and 
fibrosis-mediated wound healing [159]. Secretion of DAMPs has been shown to 
be correlated with the degree of severity of injury in traumatic diseases which 
varies from small cuts to trauma from blunt injury to bone fracture or large severe 
injuries. In all these cases, DAMPs were not only responsible for inducing acute 
inflammatory response but together with the surrounding growth factors and 
cytokines were responsible for wound healing [160]. This is consistent with the 
findings presented in this thesis where extracellular nucleotides were released 
immediately following injury and were responsible for priming SF MSCs to 
migrate along the chemotactic gradient of cytokines and growth factors (released 
from the ECM of the injured cartilage) to the site of injury and stimulate tissue 
repair.  
The identity of the putative purinergic receptor causing the priming effect on the 
SF MSCs is unknown. However, using ectonucleotidase resistant analogues to 
prevent/reduce degradation of the purine nucleotides, UTP-ƔS showed a greater 
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potency over ATP- ƔS. Therefore, it may be possible that the priming effect of 
the purine nucleotides occurs through activation of a P2Y receptor. This was also 
supported by use of the P2 receptor antagonist suramin which inhibited SF MSC 
migration in scratch assays (Figure 8.10). However, this suggestion is tentative 
and needs to be confirmed by further research. 
It was also found that SF MSCs but not BM MSCs required priming by 
extracellular nucleotides prior to migration in response to IJCM. One study 
suggested that extracellular nucleotides induced a localised and transient response 
to stimulate rapid cell-cell communication [78]. Furthermore, this cell-cell 
communication was an earlier event prior to cells becoming migratory and was 
actively repairing the defect caused by the injury. Therefore, it can be reasoned 
that by the time BM MSCs will come in contact with the extracellular nucleotides 
released into the synovial fluid, these MSCs have already become migratory and 
hence, no longer require the priming signal of  the extracellular nucleotides at the 
site of injury.  
In the study presented in this thesis, the IJCM was observed to promote 
chondrogenesis by SF MSCs and BM MSCs (Figure 8.12).  The molecular 
identity of the chondrogenic factors present in the IJCM was not carried out. 
However, inhibition of either TGFβ3 or CXCL12 using neutralising antibodies or 
receptor antagonists in the IJCM which inhibited the migratory response of SF 
MSCs to IJCM did not inhibit SF MSC chondrogenesis by IJCM suggesting that 
these factors were not the only factors responsible for MSC chondrogenesis in 
response to IJCM (Figure 8.13). In addition, the neutralising antibody was to 
TGFβ3 only and chondrocytes are known to synthesis TGFβ1 which is 
chondrogenic. It is known that FGF2 was present in the IJCM but it was not 
investigated if FGF2 was responsible for the chondrogenesis. FGF2 have 
previously been shown to promote chondrogenic differentiation of both rat and 
human MSCs [161-164]. Therefore, it was possible that FGF2 present in the IJCM 
was responsible for the induction of chondrogenesis. Furthermore, addition of 
ATP-ƔS or UTP ƔS to IJCM appeared to induce deeper levels of Alcian Blue 
staining compare to IJCM alone suggesting a possible chondrogenic effect. It may 
be that purinergic stimulation promotes chondrogenic differentiation. Purinergic 
nucleotides have been shown to stimulate chondrogenesis in chondrocytes [155]. 
Since, ATP can stabilise FGF2 by binding to the growth factor through the 
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heparin-binding domain [165], it was also possible that this stabilisation was the 
reason for the enhanced chondrogenesis seen in response to ATPƔS and UTPƔS 
containing IJCM.  However, it is likely that the IJCM contains other growth 
factors and biological agents in addition to CXCL12, TGFβ3 and FGF2 which 
were responsible for MSC chondrogenesis.  
 
9.9 Current limitations and Future directions   
While the present study has provided a novel mechanism through which injured 
cartilage can repair itself by stimulating MSC migration, it has limitations that 
must be acknowledged. These include further optimisation of the Transwell 
migration assay by testing a broad range of cell seeding densities. Finding an 
optimal cell seeding density which will reliably show the difference in migration 
in response to various experimental conditions will allow automation of the cell 
number quantification using Image J. Furthermore, even if cells were counted 
manually using the cell counter option on ImageJ, it would still be far easier to 
detect and discriminate between individual cells. In my research most of the 
chemokine/inhibitor concentrations were selected based on the suggested 
concentration on the product data sheet.  This means in some cases it is possible 
that lack of inhibition of migration can be attributed to low concentration of 
inhibitors. Therefore, it is important to further investigate several concentrations 
of chemokines/inhibitors in order to find the optimal conditions for inhibition. 
Moreover, only the result of CXCL12 neutralising antibody was validated using 
small-molecule inhibitor AMD3100. Further experiments should also validate 
FGF2 and TGFβ3 signalling by blocking FGF receptor signalling using small-
molecule inhibitor SB402451 and TGFβ signalling using SB431542.  This study 
has only indirectly shown the presence of CXCL12, TGFβ3 and FGF2 in the 
IJCM by using cytokine specific inhibitors. Therefore, it is important to directly 
show the presence of these molecules in the IJCM using both ELISA and Western 
Blot and further validate the results using immunohistochemistry.  
 
There are still several questions that remain to be answered with further studies. 
We did not investigate the contribution of chondrocytes in the production and/or 
release of the injury factors. To do this, further studies should investigate ‘injured’ 
dead cartilage along with ‘non-injured’ dead cartilage (investigated in this study) 
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and compare their effects on MSC migration. Furthermore, we have only 
identified three key molecules present in the IJCM responsible for MSC 
migration. It is possible there are several other molecules which are important for 
this pathway. Therefore, the IJCM needs to be fully characterised using mass 
spectrometry to identify all proteins present in the IJCM. Initially, this 
characterisation may be restricted to identifying only the members of the heparin 
interactome. Later, the identified molecules need to be further tested for their 
effect on the MSC migration. More importantly, all these molecules need to be 
tested to see how do molecules released upon cartilage injury influence MSC 
activity in general – by driving MSC migration, adhesion, proliferation and 
chondrogenic differentiation? Similarly, this study only provided preliminary data 
on the influence of purinergic system on MSC migration in response to cartilage 
injury. Further studies is needed to first show the presence of purinoceptors, 
identify which purinoceptors are present and then show which purinoceptors are 
required for the priming of the SF MSCs.  
 
Another question yet to be answered is the translation of this data from the animal 
model to a human model. Although, it is relatively safe to say that human MSCs 
will also migrate in response to IJCM, we still need to provide experimental 
evidence to show that both SF- and BM MSCs from human will also migrate in 
response to CXCL12, TGFβ3 and FGF2. Furthermore, will we see the same 
differences between the SF- and BM MSC migration in a human model?  Another 
important factor to consider is how much variability will be present among the 
response of the MSCs harvested from different individuals? Will we still see a 
homogenous response to IJCM as observed with bovine MSCs?  
 
Lastly, it is imperative to understand is the response to injury the same in human 
osteoarthritic, normal aged as well as young healthy cartilage? Once, all these 
questions have been answered using the in vitro model further investigations can 
focus on studying this MSC migration pathway in an in vivo model of cartilage 
injury. An excellent model has already been developed by Eltawil et al [33]. This 
model can be back-crossed with knockout animals to create mutant strains s (e.g. 
FGF2
-/-
, CXCL12
-/-, TGFβ3-/-) in order to see whether lack of these molecules can 
impair normal regeneration of the injured cartilage. An alternative strategy would 
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be to use small molecular inhibitors as used in this study (AMD3100) to block 
growth factor signalling.   
 
MSC migration is a critical step in the repair and regeneration of the injured 
cartilage. However, the signalling pathway leading to the MSC migration is still 
lacking. Migration is a complex cellular process and results from the coordinated 
assembly and disassembly of focal adhesion complexes [166, 167]. Extracellular 
signals can stimulate specific intracellular pathways by activating mitogen-
activated protein kinases (MAPK) namely extracellular signal-regulated kinases 
(ERK), c-Jun NH2-terminal kinases (JNK) and p38 MAPKs [168, 169]. Once 
activated these MAPKs can phosphorylate other transcription factors within the 
cell nucleus and stimulate the activation of a number of cellular functions 
including survival, proliferation, differentiation and apoptosis. Previous studies 
have also reported the importance of MAPKs in cell migration of diverse cell 
types including fibroblasts, breast cancer cells, endothelial cells and Schwann 
cells [168, 170, 171]. Furthermore, Vincent et al have shown that FGF2 released 
from the cartilage following cutting rapidly activated ERK [46]. Therefore, it is 
important to investigate if CXCL12 and FGF2-induced activation of ERK1/2 is 
required for SF and BM MSC migration.  
Data from this study suggested that when chondrocytes are injured it released 
ATP.  One study investigating the wound healing in corneal epithelial cells have 
suggested that ATP released following epithelial injury acts as a signal to 
stimulate shedding of heparin-binding epidermal growth factor-like growth factor 
(HB-EGF) [172, 173]. Therefore, future studies can also test if ATP released from 
the injured cartilage through chondrocyte injury also induced the release of 
CXCL12, TGFβ3 and FGF2 which then acts as attractants for MSCs to stimulate 
MSC migration to the injury site.  
 
9.10 Possible therapeutics that can be developed based on this work 
Successful regeneration of damaged tissues is firstly critically dependent on 
identification of the range of molecules that promotes organ-specific stem cell 
migration and secondly on manipulation of the activity of these molecules to 
enhance stem cell migration.  
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Possible therapeutic strategies that can be developed using the knowledge from 
this study include developing ‘smart’ cell-free implants. These implants will be 
divided into four key working parts. The first part will contain inhibitors of 
ectonucleotidases to prevent the breakdown of ATPs released from the injury. 
This will allow the ATPs released from the injury to act as DAMPs and call in the 
necessary molecules to the injury site. Furthermore, reduced breakdown of ATP 
will also allow larger number of SF MSC priming which can then migrate to the 
injury site. The second part will be functionalised by attaching heparin-binding 
motifs which can then bind CXCL12, TGFβ3 and FGF2. This part will be 
responsible for creating a chemotactic gradient for MSC migration. The third part 
of the implant will contain an ATP-generating mechanism which in conjunction 
with the first part will stimulate priming of large number of SF MSCs. Finally, the 
fourth part of the implant will contain factor(s) (yet to be identified) that will 
stimulate chondrogenesis of the MSCs present at the injury site.  These implants 
will be placed at the injury site through a small microfracture which will allow 
BM MSCs to invade the injury site.  
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Conclusions  
Traumatic cartilage injuries are a known risk factor for development of 
osteoarthritis (OA). Classically articular cartilage is seen as poorly repairing. 
However, cartilage injuries in very young animals can heal although the 
mechanism of this repair is unknown. The aim of this project was to investigate if 
SF and BM MSCs can respond to cartilage injury and to determine the 
mechanisms by which this occurred. The conclusions from this study are 
summarised below:  
1. Articular cartilage, SF and BM MSCs were isolated from the bovine 
metacarpophalangeal joints and the protocol for in vitro culture expansion 
of SF and BM MSCs was optimised.  
2. Multipotentiality of the MSCs using classical differentiation assays was 
demonstrated and cultured SF and BM MSCs could be differentiated into 
chondrogenic, osteogenic and adipogenic lineages. However, SF MSC 
showed a lower adipogenic capacity than BM MSC.  
3. An in vitro scalpel-induced cartilage injury model was developed. 
Cartilage discs were collected using a 6 mm biopsy punch and a no.11 
scalpel blade attached to no.3 scalpel handle. Freshly collected cartilage 
discs were allowed to rest in high glucose DMEM supplemented with 10% 
FCS and 10
-7
 M dexamethasone to obtain non-injured cartilage. Dead 
cartilage was obtained by irradiating cartilage discs and subsequently 
freezing them at -20°C. ‘Rested cartilage’ was injured using no.11 scalpel 
attached to no. 3 scalpel handle. Multiple cuts were made in the push-
through mode by passing the scalpel blade perpendicular to the long axis 
of the discs in a straight line.  
4. Significantly greater numbers of SF and BM MSCs migrated to injured 
cartilage compared to non-injured cartilage. However, in contrast to SF 
MSCs, significantly higher numbers of BM MSCs also migrated to dead 
cartilage compared to non-injured cartilage.  
5. Use of fluorescently labelled MSCs, showed that MSCs migrated 
specifically to the site of the injury and adhere along the edges of the 
injury.  
6. Incubation of freshly isolated articular cartilage explants with serum-free 
DMEM for 24 h yielded injury conditioned media (IJCM). The IJCM 
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significantly stimulated SF and BM MSCs migration compared to the 
serum free control media in both Transwell and Scratch migration assays 
which indicated that cartilage following injury released migration 
stimulatory factors into the media.  
7. Characterisation of IJCM using neutralising antibodies and receptor 
inhibitors identified three key biological factors which were responsible 
for the migratory activity of IJCM. These were CXCL12, TGFβ3 and 
FGF2. Inhibition of these factors with neutralising antibodies inhibited SF 
and BM MSC migration.  BM MSCs migrated in response to all three 
factors in the IJCM. In contrast, SF MSCs only migrated in response to 
CXCL12 and TGFβ3 present in the IJCM.  
8. Cell exclusion zone assays demonstrated that in the absence of an injury in 
the cell layer, SF MSCs do not respond to the chemotactic gradient of the 
IJCM.  However, migration in response to IJCM was observed in this 
system when a cell injury was created (by scraping off a small number of 
cells) close to the cell exclusion zone.  
9. Creating the ‘scratch’ wound caused release of ATP from the injured cells 
which were validated using ATP-bioluminescence assay to quantify the 
ATP released.  
10. Supplementation of ATP or UTP or stable purine analogues ATP-γS or 
UTP- γS with IJCM stimulated MSC migration in cell exclusion zone 
assays suggesting a role for a putative P2 receptor. The apparent greater 
response to UTP- γS compared to ATP-γS suggested that the P2 receptor 
may be a member of the P2Y class.  Involvement of a P2Y receptor was 
further validated by demonstrating that IJCM-stimulated SF MSC 
migration could be completely inhibited in scratch assays using P2 purine 
receptor antagonist suramin. 
11.  In contrast to SF MSCs, IJCM induced significant BM MSC migration in 
cell exclusion zone assays suggesting a lack of requirement of 
extracellular nucleotides for BM MSC migration.  
12.  IJCM could maintain MSCs viability in in vitro culture in the absence of 
FCS.  Furthermore, IJCM could also induce chondrogenesis of MSCs and 
this IJCM-induced chondrogenesis could be enhanced by addition of ATP 
or UTP to the IJCM. Chondrogenic factors in the IJCM were not identified 
in this study. However, inhibition of CXCL12 enhanced IJCM-induced 
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chondrogenesis as seen from the stronger alcian blue staining. 
Furthermore, inhibition of TGFβ3 reduced the IJCM-induced 
chondrogenesis as indicated by the reduction in the intensity of alcian blue 
staining.  
Therefore, this study demonstrated that cartilage following injury released ATP, 
CXCL12, TGFβ3 and FGF2. ATP was required to prime the SF MSCs before 
their migration along the chemotactic gradient of CXCL12 and TGFβ3. In 
contrast, BM MSCs did not require priming before their migration along the 
chemotactic gradient of CXCL12, TGFβ3 and FGF2. Migration of MSCs in 
response to these chemokines enabled the MSCs to home towards the injured 
cartilage and specifically to the site of the injury where they may then take part in 
the regeneration of the injured cartilage since the injury caused release of factors 
which stimulated chondrogenesis. Therefore, in this study a migration mechanism 
through which MSCs migrated to the site of the cartilage injury and then take part 
in repair and regeneration of the injured cartilage was established Furthermore, 
migration stimulatory factors identified in this study can be incorporated into 
implants which could then be used to mobilise endogenous MSCs to the site of the 
injury. Such a technique would provide a less invasive and cost effective 
alternative to repair and regenerate the injured cartilage. 
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